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Medicinal   plants  are  one  of   the  biggest   sources  of   natural   products  with  
therapeutic   importance.   There   are   currently   over   28,000   plants   with   putative  
medicinal  values.  Plant-­derived  compounds  have  been  explored  extensively   for  
various   biological   activities   ranging   from   anti-­cancer,   immune-­boosting   to   anti-­
inflammatory  and  anti-­oxidant.  Some  of  the  most  important  therapeutic  agents  are  
of   plant-­origin,   such   as   paclitaxel   from   Pacific   yew   (Taxus   brevifolia)   and  
artemisinin  from  qinghao  su  (a  Chinese  medicinal  herb;;  a.k.a.  Artemisia  annua)  to  
name  a  few.  
The  study  presented  in  this  thesis  started  out  as  classical  pharmacognosy  
research,   which   focused   on   the   identification   of   immunostimulatory   factors   in  
Juzen-­taiho-­to  (JTT),  a  Japanese  herbal  formulation  with  well-­established  clinical  
safety   and   efficacy.   The   study,   however,   led   to   an   unexpected   discovery   that  
immunostimulatory   factors   are   not   of   plant-­origin;;   instead,   they   are   from   plant-­
associated  bacteria.  The  ensuing  studies  presented  in  this  thesis  as  well  as  several  
studies  by  others  gave  rise  to  an  emerging  new  hypothesis  that  can  fundamentally  
transform  the  way  we  understand  the  immune-­boosting  activity  of  medicinal  plants.  
Chapter  1  gives  a  brief  introduction  and  history  of  the  most  widely  accepted  
herbal  medicinal  practices  around  the  world.  Additionally,  some  of  the  well-­known  
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bio-­active  compounds  derived  from  medicinal  plants  are  described.  The  chapter  
also  highlights  the  issue  of  batch-­to-­batch  variability,  which  is  a  common  issue  of  
herbal  medicines.  Batch-­to-­batch  variability  is  a  major  problem  because  it  raises  
concerns  about  quality,  safety  and  efficacy  (QSE)  of  herbal  medicines.  In  order  to  
reduce  the  batch-­to-­batch  variability,  therapeutically  relevant  compounds  have  to  
be  identified  and  used  to  standardize  herbal  medicines.  However,  identification  of  
therapeutically  relevant  compounds  is  not  a  trivial  task  as  exemplified  in  our  quest  
to  identify  immunostimulatory  factors  in  JTT.  
The  focus  of  Chapter  2  is  the  identification  of  immunostimulatory  factors  in  
JTT.   Although   it   was   relatively   easy   to   purify   the   fractions   enriched   with  
immunostimulatory  activity,  it  was  difficult  to  identify  the  immunostimulatory  factors  
in   the   fractions.   The   readily   observable   compounds   were   all   plant-­derived  
metabolites   with   little   or   no   immunostimulatory   activity.   Ensuing   biochemical,  
chemical,   and   immunological   studies   eventually   led   us   to   the   discovery   that  
immunostimulatory   factors   arise   from   lipopolysaccharides   (LPSs)   of   Gram-­
negative   bacteria   that   are   associated   with   the   component   herbs   of   JTT.   This  
finding  opened  a  possibility   that  medicinal   herbs   in   JTT  may   contain   “immune-­
boosting”  bacteria  that  can  safely  stimulate  the  human  immune  system.    
With  this  knowledge,  we  wondered  about  the  identities  of  these  bacteria.  It  
was   an   opportune   time   to   ask   this   question   as   the   powerful   next-­generation  
sequencing  tools,  such  as  Illumina  sequencing  were  becoming  widely  available  at  
that   time.   Chapter   3   addresses   this   question   by   characterizing   the   microbial  
communities  in  Angelica  sinensis,  which  is  the  most  potent  immune-­boosting  herb  
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in   JTT.   The   sequencing   identified   several   bacterial   taxa   that   are   reproducibly  
observed  in  multiple  samples  of  A.  sinensis.  In  particular,  Rahnella  aquatilis  was  
identified   as   the   most   abundant   bacterial   species   that   is   associated   with   the  
immunostimulatory   activity   of   A.   sinensis.   In   addition,   the   sample-­to-­sample  
variability  of  bacterial  community  provided  important  new  clues  to  understand  the  
batch-­to-­batch  variability  of  herbal  medicines.  
Chapter  4  describes  our  study  to  characterize  the  LPS  of  R.  aquatilis.   In  
particular   the  study   focused  on   the   lipid  A   (LA)  moiety  of  LPS,  because   the  LA  
moiety   is   the   so-­called   pathogen-­associated   molecular   pattern   (PAMP)  
responsible   for   the   activation   of   innate   immune   cells,   such   as  monocytes   and  
macrophages.  At  that  time,  little  was  known  about  the  LA  variants  produced  by  R.  
aquatilis.   The   working   hypothesis   explored   here   is   that   R.   aquatilis   produces  
structurally   unique   variants   of   LA   that   give   rise   to   safe   and   effective  
immunostimulatory   activity   as   observed   for   JTT.   Fractions   enriched   with   R.  
aquatilis   LAs   were   purified   and   evaluated   with   chromatographic   and  
immunological  methods.  Although  we  could  not  isolate  individual  R.  aquatilis  LAs,  
the  study  suggested  that  R.  aquatilis  LAs  were  structurally  and   immunologically  
different   from  endotoxic   LAs.  However,  R.  aquatilis   LAs  appear   to   retain   some  
endotoxicity.  
R.  aquatilis  LAs  were  not  completely  devoid  of  endotoxicity.  Yet,  A.  sinensis  
is  not  known   for   its   toxicity;;   it   is   in   fact  quite  safe.  Other   research  groups  have  
observed  similar  endotoxic  LAs  in  Echinacea,  another  immune-­boosting  herb.  The  
observation   of   endotoxic   LAs   in   different   immune-­boosting   herbs   raised   a  
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possibility   that   plant   metabolites   might   attenuate   undesirable   immunological  
effects   of   endotoxic   LAs,   thereby   making   the   immune-­boosting   herbs   safe   for  
human   consumption.   Chapter   5,   therefore,   investigates   the   role   of   plant  
compounds   from  another   immunomodulatory  medicinal   plant,  Ashwagandha,   in  
attenuating  the  adverse  effects  of  endotoxic  LAs.  The  study  indicated  that  plant-­
derived  anti-­inflammatory  compounds  might  be  responsible  for  the  attenuation  of  
the  pro-­inflammatory  effect  of  endotoxic  LAs.    
In  conclusion,  this  thesis  work  identified  bacterial  LPSs  as  the  key  immune-­
boosting   factors   of   JTT   and   Ashwagandha.   Our   findings,   together   with   the  
discovery   of   similar   bacterial   LPSs   in   Echinacea,   suggest   that   the  
immunostimulatory   activity   of  many   other  medicinal   plants  might   originate   from  
bacterial   LPSs   as   well.   Yet,   this   thesis   work   also   indicated   that   plant-­derived  
metabolites  appear  to  play  an  important  role  to  ensure  the  safety  of  these  herbal  
medicines.    Thus,  in  order  to  understand  the  safe  and  effective  immunostimulatory  
activity  of   immune-­boosting  herbal  medicines,   it   is  essential   to  take  a  step  back  





The  journey  of  a  Ph.D.  student  might  be  compared  to  the  journey  of  life.  The  
road  to  receiving  the  doctoral  degree  may  be  filled  with  trials  and  tribulations,  ups  
and  downs.  However,  I  have  and  will  forever  cherish  every  one  of  these  moments,  
good  or  bad.  
First  and  foremost,  I  would  like  to  express  my  gratitude  to  my  Ph.D.  mentor,  
Prof.  Akira  Kawamura,   to  whom   I  owe  my  appreciation   for   research.   I  am   truly  
grateful  for  your  advice  and  patience  at  every  step  of  this  journey.  I  would  not  have  
had  the  greatest  experience  that  I  did,  without  your  constant  encouragement  and  
guidance.  Ralph  Waldo  Emerson  quoted  “Our  chief  want  in  life  is  somebody  who  
will  make  us  do  what  we  can”  and  you  have  been  that  person  in  my  life.  Thank  you  
for  always  believing  in  me  and  believing  that  I  could  do  it.  
I   would   also   like   to   extend   my   gratitude   to   my   wonderful   committee  
members,  Prof.  Wayne  Harding,  Prof.  Moriya  Tsuji,  Prof.  Weigang  Qiu,  and  Prof.  
Haiping   Cheng.   I   have   gained   so   much   from   all   your   valuable   feedback   and  
mentorship  during  the  committee  meetings.    
I  have  been  fortunate  to  be  part  of  a  lab  with  the  most  amazing  colleagues,  
and  especially  being  a  mentee  to  Dr.  Diego  Montenegro,  my  colleague  and  friend  
who  took  me  under  his  wing,  and  taught  me  to  do  inspiring  science.  I  am  extremely  
thankful  to  Diego  for  motivating  me  and  questioning  me  at  the  same  time;;  it  made  
me   inquisitive   about   not   just   the   “what”   and   “how”,   but   also   the   “why”   of   my  
research.  My  lab  mates,  Steven,  Christine,  Ximena,  Shen,  and  all  the  former  and  
 ix 
current  members  of  the  Kawamura  lab  have  not  only  helped  me  in  my  research  
but  also  given  me  timeless  memories  outside  of   the   lab.  You  are  all  my  friends  
before  you  are  my  lab  mates.  I  will  cherish  you  all  forever.  A  special  thank  you  to  
Dr.  Nirav  Kapadia  for  being  an  incredible  friend  and  for  being  there  to  help  me  with  
everything.  I  would  also  like  to  thank  our  external  collaborators,  Dr.  Monica  Trujillo  
and   Dr.   Revathi   Iyengar   for   their   help   in   new   projects   that   blossomed   into  
wonderful  directions.      
I   am   thankful   to   the   Chemistry   and   Biochemistry   Department   at   Hunter  
College,  especially  late  Dr.  Cliff  Sol  and  Dr.  Barney  Yoo  for  their  help  with  the  Mass  
Spectrometry   facility.   A   special   thank   you   to   the   administrative   and   teaching  
support   staff,   including   but   not   limited   to   Ms.   Mirela   Settenhofer,   Ms.   Shontel  
Houston   and   Ms.   Olena   Shport   for   their   assistance.   I   am   also   grateful   to   the  
Biochemistry  Department  at  the  Graduate  Center,  the  former  Executive  Officer,  Dr.  
Edward  Kennelly,  the  current  EO,  Dr.  Richard  Magliozzo.  Ms.  Judy  Li,  the  former  
Assistant  Program  Officer,  who  was  ready  to  answer  me  with  my  questions,  always  
with  a  smile  as  well  as  the  current  Assistant  Program  Officer,  Ms.  Denise  Charles,  
who  helped  me  with  all  paperwork.  
Last,  but  never  the  least,  the  most  grateful  I  am  to  my  parents,  Mr.  Ranjan  
Kumar  Singh  and  Mrs.  Rachna  Singh  for  giving  me  the  best  of  things  in  life  and  
encouraging  me  to  always  shoot  for  the  stars.  They  have  been  my  support  system  
when  things  didn’t  look  up,  and  been  the  proudest  at  my  every  achievement.  I  am  
also  indebted  to  my  most  wonderful  little  sister,  Dr.  Rachita  Ramya,  who  came  to  
New  York  a   few  years  after   I  did  and  who   literally  helped  me  survive  and  grow  
 x 
stronger  through  my  ups  and  downs.  She  was  always  there  to  lend  a  listening  ear  
and  to  tell  me  “it’s  okay  to  take  a  break”  and  “it’s  going  to  alright”.  She  made  sure  
I  was  eating  well,  and  cooked  for  me  when  I  couldn’t  and  when  I  came  home  late  








I  dedicate  this  thesis  to  my  parents,  their  parents  and  my  sister.  
  
  
     
 xii 
 
TABLE  OF  CONTENTS  
ABSTRACT  ......................................................................................................  iv	  
ACKNOWLEDGMENTS  ..................................................................................  viii	  
TABLE  OF  CONTENTS  ...................................................................................  xii	  
LIST  OF  FIGURES  ........................................................................................  xviii	  
LIST  OF  TABLES  ...........................................................................................  xxii	  
APPENDIX.....................................................................................................  xxiii	  
LIST  OF  ABBREVIATIONS  ..........................................................................  xxiv	  
Chapter  1  ..............................................................................................................  2	  
1.1  INTRODUCTION  .........................................................................................  2	  
1.1.1.  Traditional  Chinese  Medicine  (TCM)  ....................................................  3	  
1.1.2.  Medicinal  herbs  in  Indian  Ayurveda  .....................................................  3	  
1.1.3.  Japanese  Kampo  medicine  ..................................................................  4	  
1.1.4.  Bio-­active  compounds  isolated  from  plants  ..........................................  4	  
1.1.5.  Difficulties  in  drug  discovery  from  plants  ..............................................  7	  
1.2  SIGNIFICANCE  ...........................................................................................  8	  
1.3  REFERENCES  ..........................................................................................  10	  
Chapter  2  ............................................................................................................  13	  
2.1.  INTRODUCTION  ......................................................................................  13	  
2.1.1.  Juzen-­taiho-­to  ....................................................................................  13	  
2.1.2.  Objective  and  Hypothesis  ..................................................................  15	  
2.2.  RESULTS  .................................................................................................  18	  
2.2.1.  Biochemical  evidence  for  the  presence  of  LPS  in  JTT  .......................  18	  
 xiii 
2.2.2.  Enrichment  of  Lipid  A  from  JTT  ..........................................................  20	  
2.2.3.  Immunostimulatory  activities  of  LA-­like  fractions  from  JTT  ................  22	  
2.2.4.  Direct  chemical  evidence  of  LA  in  JTT  ...............................................  24	  
2.3.  DISCUSSION  ...........................................................................................  26	  
2.4.  MATERIALS  AND  METHODS  .................................................................  30	  
2.4.1.  Cell  Culture  ........................................................................................  30	  
2.4.2.  Endotoxin  Removal  using  Detoxi-­Gel  ................................................  30	  
2.4.3.  Cell  treatment  and  lysis  ......................................................................  31	  
2.4.4.  RNA  Purification  and  Quantification  ...................................................  31	  
2.4.5.  Reverse  Transcription  ........................................................................  32	  
2.4.6.  Quantitative  real-­time  polymerase  chain  reaction  (qRT-­PCR)  ...........  33	  
2.5.  REFERENCES  .........................................................................................  34	  
Chapter  3  ............................................................................................................  37	  
3.1.  INTRODUCTION  ......................................................................................  37	  
3.1.1.  Objective  and  Hypothesis  ..................................................................  37	  
3.2.  RESULTS  .................................................................................................  45	  
3.2.1.  A.  sinensis  contains  immune-­boosting  bacteria  .................................  45	  
3.2.2.  A.  sinensis  contains  immunostimulatory  LPS  ....................................  50	  
3.2.3.  A.  sinensis  samples  exhibit  variable  immunostimulatory  activity  .......  51	  
3.2.4.  The  first  16S  sequencing  analysis  of  A.  sinensis  ...............................  53	  
3.2.5.  Immunostimulatory  activities  of  the  four  batches  of  A.  sinensis  
samples  ........................................................................................................  58	  
3.2.6.  Selection  of  primers  for  the  second  16S  sequencing  .........................  59	  
 xiv 
3.2.7.  The  second  16S  sequencing  analysis  of  A.  sinensis  .........................  62	  
3.3.  DISCUSSION  ...........................................................................................  70	  
3.3.1.  What  are  the  “immune-­boosting”  bacteria  in  medicinal  plants?  .........  70	  
3.3.2.  What  is  the  origin  of  batch-­to-­batch  variability?  .................................  72	  
3.3.3.  Technical  challenges  in  16S  sequencing  of  plant  samples.  ...............  73	  
3.4.  MATERIALS  AND  METHODS  .................................................................  77	  
3.4.1.  Cell  Culture  ........................................................................................  77	  
3.4.2.  RNA  purification  and  RT  ....................................................................  77	  
3.4.3.  qRT-­PCR  ............................................................................................  77	  
3.4.4.  Water  Extracts  of  A.  sinensis  .............................................................  77	  
3.4.5.  DNA  Extraction  ...................................................................................  77	  
3.4.6.  DNA  Amplification  with  PCR  ..............................................................  78	  
3.4.7.  Gel  Electrophoresis  ............................................................................  82	  
3.4.8.  QIIME  Analysis  ...................................................................................  82	  
3.4.9.  Bacterial  culture  from  A.  sinensis  .......................................................  83	  
3.5.  REFERENCES  .........................................................................................  84	  
Chapter  4  ............................................................................................................  89	  
4.1.  INTRODUCTION  ......................................................................................  89	  
4.1.1.  Structure  of  LPS  .................................................................................  90	  
4.1.2.  Objective  and  Hypothesis  ..................................................................  94	  
4.2.  RESULTS  .................................................................................................  96	  
4.2.1.  Endotoxin  levels  of  R.  aquatilis  and  E.  coli  bacterial  pellets  ..............  96	  
4.2.2.  HPLC  Purification  of  R.  aquatilis  and  E.  coli  LAs  ...............................  97	  
 xv 
4.2.3.  E.  coli  LA:  Extraction,  Purification  and  Activity  .................................  100	  
4.2.4.  R.  aquatilis  LA:  Modified  Micro-­Extraction  Protocol  .........................  101	  
4.2.5.  Endotoxicity  of  R.  aquatilis  LA  ..........................................................  102	  
4.2.6.  Large-­scale  extraction  of  LA  from  R.  aquatilis  .................................  105	  
4.2.7.  Structural  characterization  of  MPL  ...................................................  107	  
4.3.  DISCUSSION  .........................................................................................  108	  
4.3.1.  Are  there  differences  between  R.  aquatilis  LA  and  endotoxic  LAs?  109	  
4.3.2.  Are  there  similarities  between  R.  aquatilis  LA  and  endotoxic  LAs?  .  110	  
4.3.2.  New  hypotheses  emerged  from  this  study  .......................................  113	  
4.4.  MATERIALS  AND  METHODS  ...............................................................  115	  
4.4.1.  Cell  Culture  ......................................................................................  115	  
4.4.2.  RNA  purification  and  RT  ..................................................................  115	  
4.4.3.  qRT-­PCR  ..........................................................................................  115	  
4.4.4.  Micro-­extraction  of  Rahnella  LA  .......................................................  115	  
4.4.5.  LAL  Assay  ........................................................................................  116	  
4.4.6.  HPLC  ................................................................................................  116	  
4.4.7.  Bacterial  Cell  Culture  .......................................................................  117	  
4.5.  REFERENCES  .......................................................................................  118	  
Chapter  5  ..........................................................................................................  122	  
5.1.  INTRODUCTION  ....................................................................................  122	  
5.1.1.  Ashwagandha  ..................................................................................  122	  
5.1.2.  Hypothesis  .......................................................................................  125	  
5.1.3.  Signaling  pathways  initiated  by  structurally  distinct  LPS/LAs  ..........  126	  
 xvi 
5.1.4.  The  need  to  establish  simple,  economical,  and  reliable  cell-­based  
assays  to  distinguish  TRIF  and  MyD88  pathways.  ....................................  129	  
5.2.  RESULTS  ...............................................................................................  132	  
5.2.1.  Immunostimulatory  Activity  of  Ashwagandha  ...................................  132	  
5.2.2.  Presence  of  LPS  in  Ashwagandha  ...................................................  133	  
5.2.3.  Enrichment  of  LA  in  Ashwagandha  ..................................................  135	  
5.2.4.  Development  of  a  cell-­based  assay  to  study  the  TRIF/MyD88  bias  .  137	  
5.2.5.  TRIF/MyD88  bias  of  the  water  extracts  of  Ashwagandha  samples  ..  141	  
5.2.6.  Evaluation  of  the  water  extracts  of  the  commercial  Ashwagandha  
supplements  ...............................................................................................  143	  
5.2.7.  The  TRIF/MyD88  bias  of  the  DMSO  Extracts  of  Ashwagandha  ......  146	  
5.3.  DISCUSSION  .........................................................................................  148	  
5.3.1.  Are  bacteria  and  their  LPS  associated  with  the  activity  of  
Ashwagandha?  ..........................................................................................  148	  
5.3.2.  How  do  plant  compounds  modulate  the  activity  of  Ashwagandha?  .  149	  
5.4.  MATERIALS  AND  METHODS  ...............................................................  153	  
5.4.1.	   Cell  Culture  ..................................................................................  153	  
5.4.2.	   RNA  Purification  and  RT  ..............................................................  153	  
5.4.3.	   Water  Extracts  of  Ashwagandha  .................................................  153	  
5.4.4.	   Endotoxin  Removal  using  Detoxi-­Gel  ..........................................  153	  
5.4.5.	   Extraction  of  LA  from  Ashwagandha  ...........................................  154	  
5.4.6.	   DMSO-­soluble  extracts  of  Ashwagandha  ....................................  154	  
5.4.7.	   Macrophage  Cell  treatment  and  lysis  ..........................................  154	  
 xvii 
5.4.8.	   PMA-­differentiation  of  THP-­1  monocytes  ....................................  155	  
5.4.9.	   qRT-­PCR  assay  for  bias  for  signaling  pathway  ...........................  155	  





LIST  OF  FIGURES  
Figure  1.1:  Some  pharmacologically  active  compounds  isolated  from  
plants.  ............................................................................................................  6	  
Figure  1.2:  Structure  of  QS-­21............................................................................  7	  
Figure  2.1.  Component  herbs  in  JTT.  ..............................................................  13	  
Figure  2.2:  Scheme  for  the  fractionation  of  immunostimulatory  activity  of  
JTT..  .............................................................................................................  15	  
Figure  2.3:  Structures  of  compounds  isolated  from  the  active  fraction  of  
JTT..  .............................................................................................................  16	  
Figure  2.4:  Biochemical  Evidence  of  LPS  in  JTT..  .........................................  19	  
Figure  2.5:  Enrichment  of  LA  in  JTT.  ...............................................................  21	  
Figure  2.6:  “LA-­like”  fractions  in  JTT.  .............................................................  22	  
Figure  2.7:  Immunostimulatory  activities  of  LAs  from  JTT..  .........................  23	  
Figure  2.8:  Mass  Spectrometric  analysis  of  LA  Fr.  3..  ...................................  24	  
Figure  2.9:  Polymyxin  B  and  LPS..  ..................................................................  28	  
Figure  3.1:  Immunostimulatory  activities  of  component  herbs  of  JTT..  ......  39	  
Figure  3.2:  Angelica  sinensis.  .  ........................................................................  40	  
Figure  3.3:  Model  demonstrating  sequencing  analysis  of  A.  sinensis.  .......  43	  
Figure  3.4:  16S  rRNA  gene..  .............................................................................  45	  
Figure  3.5:  Presence  of  bacteria  in  Angelica  sinensis..  ................................  47	  
Figure  3.6:  Presence  of  bacteria  in  Peony  lactiflora..  ....................................  48	  
Figure  3.7:  Presence  of  bacteria  in  Cinnamomum  cassia..  ...........................  49	  
Figure  3.8:  Polymyxin  B-­treatment  of  A.  sinensis..  ........................................  51	  
 xix 
Figure  3.9:  Immunostimulatory  activities  of  A.  sinensis..  .............................  52	  
Figure  3.10:  Agarose  gel  showing  PCR  amplicons  before  Illumina  MiSeq..  54	  
Figure  3.11:  First  16S  rRNA  Sequencing  analysis  of  A.  sinensis..  ...............  55	  
Figure  3.12:  First  sequencing  analysis  of  A.  sinensis..  .................................  57	  
Figure  3.13:  ICAM-­1  expression  of  four  A.  sinensis  samples  evaluated  by  
qRT-­PCR..  ....................................................................................................  59	  
Figure  3.14:  Selection  of  primer  pairs  for  second  16  sequencing  analysis..
  .....................................................................................................................  60	  
Figure  3.15:  Agarose  gel  showing  PCR  products  before  second  Illumina  
MiSeq  study..  ..............................................................................................  61	  
Figure  3.16:  Taxonomic  information  with  second  16  rRNA  Sequencing  
analysis..  .....................................................................................................  62	  
Figure  3.17:  16S  rRNA  Sequencing  analysis  of  all  four  A.  sinensis  with  
three  different  primer  pairs.  ......................................................................  63	  
Figure  3.18:  Diversity  at  the  phylum  level..  .....................................................  64	  
Figure  3.19:  Diversity  at  the  class  level.  .........................................................  65	  
Figure  3.20:  Abundance  of  Gammaproteobacteria  with  P2.  .........................  66	  
Figure  3.21:  Diversity  at  the  order  level..  ........................................................  68	  
Figure  3.22:  Diversity  at  the  genus  level.  ........................................................  69	  
Figure  4.1:  Basic  structural  backbone  of  Lipopolysaccharide..  ...................  90	  
Figure  4.2:  E.  coli  Lipid  A.  .  ...............................................................................  92	  
Figure  4.3:  Structural  variations  in  LA  in  different  bacterial  species.  ..........  93	  
Figure  4.4:  O.D.  of  E.  coli  and  R.  aquatilis  pellets.  .........................................  97	  
 xx 
Figure  4.5:  HPLC  Profile  of  crude  R.  aquatilis  LA.  .........................................  98	  
Figure  4.6:  HPLC  Profile  of  crude  E.  coli  LA..  .................................................  99	  
Figure  4.7:  Immunostimulatory  activity  of  the  E.  coli  LA  fractions..  ..........  100	  
Figure  4.8:  Immunostimulatory  activity  of  R.  aquatilis  LA  fractions..  ........  102	  
Figure  4.9:  Standard  Curve  for  LAL  Assay.  ..................................................  103	  
Figure  4.10:  Endotoxin  levels  of  R.  aquatilis  LA  fractions.  .........................  105	  
Figure  4.11:  Immunostimulatory  activities  of  LA  fractions  obtained  by  large-­
scale  extraction.  I.  ....................................................................................  107	  
Figure  4.12:  Comparison  of  ICAM-­1  immunostimulatory  activity  (blue)  and  
the  endotoxicity  (red)  of  the  R.  aquatilis  LA  fractions  (R_LA1-­6).  .......  112	  
Figure  5.1:  Ashwagandha  root  and  plant  ......................................................  123	  
Figure  5.2:  Withanolides  from  Ashwagandha..  .............................................  124	  
Figure  5.3:  Cytokines  activated  by  LPS-­TLR4  binding..  ..............................  127	  
Figure  5.4:  Structurally  distinct  LAs  activate  different  pathways..  ............  129	  
Figure  5.5:  Differentiation  of  THP-­1  cells.  .....................................................  131	  
Figure  5.6:  Immunostimulatory  activities  of  Ashwagandha.  .  .....................  133	  
Figure  5.7:  Presence  of  LPS  in  Ashwagandha.  ............................................  134	  
Figure  5.8:  Immunostimulatory  activities  of  LA  fractions  isolated  from  
Ashwagandha..  .........................................................................................  136	  
Figure  5.9:  Scheme  for  THP-­1  differentiation  into  macrophages..  .............  138	  
Figure  5.10:  Structurally  distinct  LAs  lead  to  activation  of  different  
signaling  pathways.  .................................................................................  140	  
 xxi 
Figure  5.11:  Immunomodulatory  activity  of  water  extracts  of  O.A.  and  
N.O.A..  .......................................................................................................  142	  
Figure  5.12:  Immunomodulatory  activities  of  water  extracts  of  OIA..  ........  144	  
Figure  5.13:  Immunomodulatory  activities  of  DMSO-­soluble  extracts  of  OIA.




LIST  OF  TABLES  
Table  2.1  :  Preparation  of  JTT..  ........................................................................  14	  
Table  2.2:  MS  data  for  the  analysis  of  Cpd1  and  Cpd2..  ................................  25	  
Table  3.1:  PCR  Reaction  Mixture.  ....................................................................  79	  
Table  3.2:  Primers  for  Illumina  sequencing..  ..................................................  80	  
Table  3.3:  Comparison  between  First  and  Second  16S  rRNA  sequencing  
studies..  .......................................................................................................  81	  
Table  3.4:  PCR  conditions  for  first  sequencing  study..  .................................  81	  
Table  3.5:  PCR  conditions  for  second  sequencing  study..  ...........................  82	  
Table  4.1:  O.D.  and  Endotoxin  Levels  of  LAs..  .............................................  104	  
 
 
     
 xxiii 
APPENDIX  
Appendix  A:  Abundance  of  Gammaproteobacteria  with  P1  and  P3..  .........  160	  
Appendix  B:  Gammaproteobacteria  amplification  by  primer  region..........  161	  
Appendix  C:  Background  O.D.  from  E.  coli  and  R.  aquatilis  bacterial  
pellets..  ......................................................................................................  162	  
Appendix  D:  TLC  profile  of  E.  coli  and  R.  aquatilis  crude  LA  samples..  ....  163	  
Appendix  E:  R.  aquatilis  colonies  on  agar  plates..  ......................................  164	  
Appendix  F:  ESI-­MS  (positive  mode)  analysis  of  MPL..  ...............................  165	  
Appendix  G:  Culturable  microbes  from  A.  sinensis.  ...................................  166	  
Appendix  H:  Structurally  distinct  LAs  activate  different  cytokines..  .........  167	  
Appendix  I:  ICAM-­1  expression  of  dose-­dependent  water  extracts  of  OIA..
  ...................................................................................................................  168	  
Appendix  J:  Immunomodulatory  effects  of  dose-­dependent  water  extracts  
of  KSM-­66  Ashwagandha.  .......................................................................  169	  
Appendix  K:  ICAM-­1  expression  of  dose-­dependent  water  extracts  of  KSM-­
66  Ashwagandha..  ....................................................................................  170	  
Appendix  L:  Immunomodulatory  effects  of  dose-­dependent  DMSO-­soluble  
extracts  of  KSM-­66  Ashwagandha..  .......................................................  171	  
     
 xxiv 
LIST  OF  ABBREVIATIONS  
 
AS   Angelica  sinensis    
APC   antigen-­presenting  cells  
Ashw   Ashwagandha  
B.C.   Before  Christ  
bp     base  pairs  
BSSG   β-­sitosteryl-­b-­D-­glucoside  
C   Carbon  
CA1   Chinese  Angelica  1  
CA2   Chinese  Angelica  2  
CAM   Complementary  and  Alternative  medicine  
CCL5   C-­C  Motif  Chemokine  Ligand  5  (RANTES)  
CD14   cluster  of  differentiation  14  
cDNA   complementary  DNA  
CH2Cl2   dichloromethane  
CHCl3   chloroform  
CNS   central  nervous  system  
CO2   carbon  dioxide  
COX-­2   Cyclooxygenase-­2  
Cpd     compound    
CT   cycle  threshold  
Da   Daltons  
 xxv 
DCs   Dendritic  cells  
ddCT  (DDCT)   delta  delta  CT  
DEPC   diethylpyrocarbonate  
DGDG   digalactosyldiacylglycerol  
DMSO   dimethylsulfoxide  
DNA   deoxyribonucleic  acid  
dNTP   deoxyribonucleotide  triphosphate  
DPL   di-­phosphorylated  Lipid  A  
EC   Escherichia  coli  
ELSD   evaporative  light  scattering  detector  
EMP   Earth  Microbiome  Project  
ESI-­MS   electrospray  ionization  mass  spectrometry  
EU   Endotoxin  Units  
FDA   Food  and  Drug  Administration  
Fr.   Fraction  
g   gram  
GAPDH   Glyceraldehyde  3-­phosphate  dehydrogenase  
H   hydrogen  
H2O   water  
HEPES   (4-­(2-­hydroxyethyl)-­1-­piperazineethanesulfonic  acid)  
HIV   Human  Immunodeficiency  Virus  
HPLC   High  Performance  Liquid  Chromatography  
HRESIMS   high-­resolution  electrospray  ionization  mass  spectrometry  
 xxvi 
HTS   high-­throughput  screening  
ICAM-­1   intercellular  adhesion  molecule  1  
IFN-­g   interferon-­g  
IKKb   Inhibitor  of  NF-­kappa-­B  kinase  
IL-­12   Interleukin  12  
IL-­6   Interleukin  6  
JA1   Japanese  Angelica  1  
JA2   Japanese  Angelica  2  
JTT   Juzen-­taiho-­to  
KDO   3-­Deoxy-­D-­manno-­oct-­2-­ulosonic  acid  
KSM   KSM-­66  Ashwagandha  supplement  
L   liter    
LA   Lipid  A  
LAL   limulus  amebocyte  lysate  
LAL   Limulus  amebocyte  lysate  
LBP   LPS  binding  protein  
LPS   Lipopolysaccharide  
LTA   lipotechoic  acid  
m/z   mass  to  charge  ratio  
MALDI   Matrix  assisted  laser  desorption/ionization  
MAMP   microbe-­associated  molecular  pattern  
MeOH   methanol  
Mf   macrophages  
 xxvii 
mg   milligram  
MGDG     monogalactosyldiacylglycerol  
mL   milliliter  
mM   milli  molar  
MPL   monophosphorylated  lipid  A  
Mr   relative  molecular  mass  
mRNA   messenger  ribonucleic  acid  
MS   mass  spectroscopy  
MyD88   myeloid  differentiation  primary  response  gene  88  
N   nitrogen  
N.O.A.   Non-­organic  Ashwagandha  
NCCIH   National  Center  for  Complementary  and  Integrative  Health  
NEMO   NF-­kappa-­B  essential  modulator  
NF-­kB   nuclear  factor  kappa-­chain-­enhancer  of  activated  B  cells  
ng   nanogram  
NGS   next  generation  sequencing  
NH4OH   ammonium  hydroxide  
nm   nanometer  
NMR   Nuclear  magnetic  resonance  
O   oxygen  
O.A.   Organic  Ashwagandha  
O.D.   Optical  density  
ºC   degree  Celsius  
 xxviii 
OIA   Organic  India  Ashwagandha  supplement  
OPS   O-­polysaccharide  
OTU   Operational  Taxonomical  Unit  
P   phosphorous  
P1   Primer  pair  1  
P2   Primer  pair  2  
P3   Primer  pair  3  
PAMP   Pathogen-­associated  molecular  pattern  
PCR   polymerase  chain  reaction  
PDA   photodiode  array  detector  
PMA   Phorbol-­12-­myristate-­13-­acetate  
PmxB/PB   Polymyxin  B  
PNA   peptide  nucleic  acid  
PRR   pattern-­recognition  receptors  
PSB   phosphate  solubizing  bacterium  
QC   Quality  control  
QIIME   Quantitative  Insights  Into  Microbial  Ecology  
qPCR   quantitative  polymerase  chain  reaction  
qRT-­PCR   quantitative  real-­time  polymerase  chain  reaction  
QS   Quillaja  saponaria  
QSE   quality,  safety  and  efficacy  
R_LA   R.  aquatilis  LA  
RA   Rahnella  aquatilis  
 xxix 
RANTES   regulated  on  activation,  normal  T  cell  expressed  and  secreted  
rDNA   ribosomal  DNA  
Rf   retention  factor  
RNA   ribonucleic  acid  
rpm   revolutions  per  minute  
RPMI   Roswell  Park  Memorial  Institute  medium  
RQ   relative  quantification  
rRNA   Ribosomal  ribonucleic  acid  
RT   Reverse  transcription  
SDS   sodium  dodecyl  sulfate  
sec   second  
TCM   Traditional  Chinese  Medicine  
TLC   thin  layer  chromatography  
TLR   toll  like  receptor  
TNF-­α   tumor  necrosis  factor  alpha  
TPA   12-­O-­tetradecanoylphorbol-­13-­acetate  
TRAM   TRIF-­related  adaptor  molecule  
TRIF   TIR-­domain-­containing  adapter-­inducing  interferon-­β    
USDA   United  States  Department  of  Agriculture  
UV   ultraviolet  
v   volume  
V     variable  section  on  16S  locus  
WA   Withaferin  A  
 xxx 
µg   microgram  























“Nature  itself  is  the  best  medicine”    
-­Hippocrates     
 2 
 
Chapter  1    
1.1  INTRODUCTION  
Medicinal  herbs  have  been  around  since  the  beginning  of  life  on  Earth.  They  have  
been  a  part  of  mythological  stories;;  they  have  been  an  important  part  of  all  cultures  and  
traditions  around  the  world;;  and  they  have  also  been  a  part  of  modern  medicine.  It  is  no  
wonder  then  that  herbal  medicine  has  been  a  prime  topic  in  research.    
The   timeless   Hindu   mythological   story   of   Ramayana   told   over   generations,  
mentions  a  wonder  herb,  “Sanjeevani  booti”  that  brought  back  Lord  Rama’s  wounded  and  
unconscious  brother,  Lakshmana  back  to  life  and  full  of  vigor.  For  this  reason,  it  has  come  
to  be  known  as  a  “life-­giving  herb”  or  a  “resurrecting  plant”.  However,  this  mythological  
medicinal  plant   is  not   just  part  of  a  story,  but   it  has  also  been  the  focus  of  research  in  
many   studies   [1,   2].   The   original   Sanjeevani   booti   possessed   the   property   of  
bioluminescence   for   its   easy   identification   [2].   The   scientific   question,   however,   was  
whether  such  a   life-­giving  herb  exists   in   the   Indian  Himalayas,  with  similar  properties.  
From  being  a  small,  yet  in  no  way  trivial,  part  of  a  mythological  story,  to  being  discovered  
as  a  medicinal  plant  of  scientific  importance,  Sanjeevani  booti  has  come  a  long  way.  It  
was  in  fact  discovered  that  an  herb  in  the  Himalayas  with  diverse  medicinal  properties  as  
well  as  drought  resistance  comes  close  to  becoming  a  substitute  for  the  Sanjeevani  booti.  
Scientifically   known   as   Selaginella   bryopteris,   this   medicinal   plant   also   has  
bioluminescent  properties  [1].  
 3 
This   story   is   not   a   singular   instance   in   any   way.   Medicinal   plants   played   an  
important  role  in  nearly  all  ancient  civilizations.  Herbal  medicine  has  truly  become  a  part  
of  all  cultures  around  the  world.    
1.1.1.  Traditional  Chinese  Medicine  (TCM)  
TCM   was   introduced   to   the   Chinese   civilization   around   2800   B.C.   by   the  
mythological  Emperor,  Shen  Nung   (translated   “God  Farmer”),  who   is  credited   to  have  
tasted  hundreds  of  herbs,  even  poisons  to  identify  their  medicinal  value  [3].  The  earliest  
known  publication  on  TCM,  Shen-­nung  Pen-­tsao  Ching  (The  Herbal  Classic  of  the  Divine  
Plowman),  is  a  compilation  of  the  herbs  and  their  uses  discovered  by  Shen  Nung  [4].  This  
book   is   regarded  as   the   first  Chinese  Pharmacopeia.  Since   then,  several  other  books  
have  been  added  to  the  world  of  TCM,  listing  thousands  of  medicinal  herbs.  Medicinal  
herbs  such  as  ginseng,  cinnamon,  peony  and  licorice  root  were  all  part  of  the  first  edition  
of  the  book  and  have  still  been  around  all  these  years,  not  just  as  medicinal  herbs,  but  
also  as  culinary  herbs.    
1.1.2.  Medicinal  herbs  in  Indian  Ayurveda    
The  earliest  mention  of  medicinal  herb  usage  in  Indian  civilization  is  in  one  of  the  
oldest  books  in  Indian  history,  Rigveda,  written  between  4500  to  1600  B.C.  [5].  However,  
it  is  in  another  book  known  as  the  Ayurveda  that  gives  the  detailed  description  of  not  only  
medicinal  herbs  and  their  uses,  but  also  how  they  impact  human  health.  Ayurveda  formed  
the   first   Indian   materia   medica,   and   eventually   became   a   great   influence   to   other  
civilizations  in  their  journey  to  modern  medicine.          
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1.1.3.  Japanese  Kampo  medicine    
Developed  about  1500  years  ago,  Japanese  traditional  medicine  known  as  Kampo  
includes   herbal   medicine   and   alternative   and   complementary   practices   such   as  
acupuncture  and  acupressure.  Kampo  medicine  originated  from  TCM  but  was  adapted  to  
Japanese   culture,   and   has   now   even   been   incorporated   into   the  modern   health-­care  
system  in  Japan  [6].  Most  Kampo  medicine  are  used  as  formulations  of  different  herbs  in  
specific  ratios  to  treat  ailments  of  the  whole  human  body  [7].  After  being  adopted  from  
TCM,  Kampo  medicine  have  been  optimized  over  time  and  therefore,  are  considered  one  
of  the  safest  and  effective  medicinal  practices  with  few  adverse  effects.  
1.1.4.  Bio-­active  compounds  isolated  from  plants  
Herbal  medicine  around  the  world  have  been  a  constant  focal  point  of  research.  
Plants  are  among  the  greatest  sources  of  natural  products  and  drugs.  Many  compounds  
and  metabolites  have  been  isolated  from  different  medicinal  plants  and  their  biological  
activities  evaluated  to  identify  the  active  factors  in  them.  Some  of  these  plant  compounds  
have  in  fact,  shown  great  therapeutic  potential  and  made  it  to  clinical  trials  and  even  been  
given  FDA  approval.  The  following  compounds  have  all  been   isolated  from  plants  and  
exhibit  promising  biological  properties.  
Taxol   (Paclitaxel)  was   first   isolated   from   the   stem  bark   of   the  Pacific   yew   tree  
(Taxus  brevifolia)  [8].  It  is  one  of  the  most  well-­known  anti-­tumor  agents  and  have  been  
shown   to   be   effective   against   leukemia,   breast,   lung   and   other   forms   of   cancer   [9].  
Artemisinin  is  another  widely-­used  plant-­derived  therapeutic  drug  that  is  used  as  an  anti-­
malarial  agent.  It  is  the  second  drug  after  quinine  to  gain  such  popularity  for  the  treatment  
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of  the  malarial  parasite,  Plasmodium  falciparum  [10].  Like  quinine,  an  alkaloid,  which  was  
extracted   from   the   bark   of   the   Cinchona   tree,   Artemisinin   is   another   plant-­derived  
peroxide  from  a  medicinal  weed  from  China,  known  as  qing  hao  [10].  Pilocarpine   is  a  
medication  used  to  treat  dry  eyes  and  dry  mouth.  It  has  been  as  an  ophthalmological  drug  
to   increase   eye   pressure.   It   was   first   isolated   from   the   South   American   plant   genus,  
Pilocarpus   [11,  12].   It  has  been  mentioned  on   the  World  Health  Organization’s  List  of  
Essential  Medicines,  which  suggests   that  Pilocarpine   is  a  safe  and  effective  medicine  
[13].  Morphine  and  Codeine  are  both  plant-­derived  compounds  belonging  to  the  class  
of  opioid  alkaloids.  Morphine  was  in  fact  is  considered  the  first  pharmacologically  active  
natural  product  isolated  from  a  plant.  Both  morphine  and  codeine  were  first  isolated  from  
the  same  plant  species:  opium  produced  by  poppy  seeds,  Papaver  somniferum  [14].  They  




Figure  1.1:  Some  pharmacologically  active  compounds  isolated  from  
plants.  
  
Plant   extracts   are   also   useful   for   the   isolation   of   potential   candidates   for  
immunologically  important  natural  products.  A  purified  plant  extract,  QS-­21  (Figure  1.2)  
is  a  saponin  that  is  derived  from  the  bark  of  the  soap  tree,  Quillaja  saponaria,  native  to  
Chile,  South  America.  Its  ability  to  enhance  the  functions  of  the  immune  system  has  made  
it  a  good  candidate  for  an  immunological  vaccine  adjuvant  [15,  16].  Immuno-­adjuvants  
are  additives  that  can  boost  the  immune  response  of  the  body  to  a  vaccine  antigen.  QS-­
21  is  currently  undergoing  clinical  trials  as  an  adjuvant  for  the  treatment  of  diseases  such  








































Figure  1.2:  Structure  of  QS-­21.  QS-­21   is  an   immuno-­adjuvant  currently  
under  clinical  trials.  
  
1.1.5.  Difficulties  in  drug  discovery  from  plants  
There  are  numerous  other  pharmacologically  active  compounds  that  have  been  
isolated  from  plants.  Recently,  however,  the  discovery  of  natural  products  from  plants  has  
reached  a  saturation  point.  Screening  of  natural  products  for  their  biological  activities  is  a  
painstakingly  long  process.  This  industry  that  initially  revolutionized  the  field  of  modern  
medicine  has  declined  substantially  in  the  past  15-­20  years  [20].  Novel  alternatives  were  







































The  focus  of  our  research  has  been  Japanese  Kampo  medicine,  and  particularly  
identifying   and   characterizing   the   active   factors   from  medicinal   herbs.   Chapter   2   will  
describe  our  efforts  in  this  direction.  A  surprising  discovery  suggesting  that  plant-­derived  
compounds  might  not  be  the  most  biologically  active  factor  in  medicinal  herbs  shifted  our  
research   to   exploring   alternative   methods   to   study   these   other   “immune-­boosting”  
compounds.      
1.2  SIGNIFICANCE    
Herbal  medicine  is  a  multi-­billion-­dollar  industry  with  an  estimated  global  market  
share   for   herbal   supplements   reaching   $115   billion   by   2020.   In   the   United   States,  
approximately  4  in  every  10  people  use  Complementary  and  Alternative  medicine  (CAM)  
according  to  the  2008  statistics  presented  by  the  National  Center  for  Complementary  and  
Integrative   Health   (NCCIH)   and   the   National   Center   for   Health   Statistics   (part   of   the  
Centers  for  Disease  Control  and  Prevention).  Moreover,  among  the  most  preferred  CAM  
approaches,  the  use  of  natural  products  is  the  most  predominant  with  about  18%  people  
opting  for  it  over  other  therapies.  
Herbal   formulations   face   a   major   challenge   with   regard   to   batch-­to-­batch  
variability.  Variability  of  an  herbal  sample  could  arise  from  variability  of  its  components,  
either  therapeutic  or  toxic.  If  a  therapeutic  component  varies,  it  could  affect  efficacy;;  if  a  
toxic  component  varies,   it  could  affect  safety.  For  this  reason,  variation  in  quality   is  an  
important   problem.   One   solution   to   this   important   issue   is   to   characterize   the   active  
constituents   from  medicinal  herbs.  To  address   this   issue,  most   typical  Quality  Control  
(QC)   methodologies,   thus   far,   have   utilized   a   chemical   approach   by   evaluating   the  
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chemical  constituents  of  these  herbs.  Traditional  approach  utilizes  chromatographic  and  
electrophoretic   techniques  such  as  High  Performance  Liquid  Chromatography   (HPLC)  
and  DNA  fingerprinting  [21,  22].  However,  this  traditional  approach  has  some  limitations.  
First,   although,   the   chemical   constituents   studied   in   this   approach   are   the   major  
ingredients  of  herbal  medicines;;  they  are  not  necessarily  the  most  active.  Second,  higher  
quantity  of  sample  is  required  for  the  QC  analysis  of  chemical  constituents.    
On  one  hand,  the  use  of  TCM  has  been  becoming  increasingly  popular  in  Western  
medicine.   Still,   there   have   been   concerns   regarding   quality   of   the   crude   Chinese  
medicinal  herbs  and  the  stability  of  the  preparations  [23].  The  lack  of  knowledge  about  
the  mode  of  action  and  bioactive  compounds  of  most  herbal  formulation  also  produces  
uncertainty   about   their   quality,   safety   and   efficacy   (QSE)   [23].   Furthermore,   literature  
suggests  pathogenic  bacteria  are  associated  with  medicinal  herbs,  either  by  adhering  to  
the  plant  parts,  or  by  incorporation  during  herbal  preparations  [24].  Genome  structures  of  
many  plant  pathogenic  bacteria  have  also  been  elucidated   [25,  26].  However,  most  of  
these  studies  do  not  account   for   the  symbiotic  bacteria  associated  with   the  medicinal  
herbs.  There  have  been  considerations  that  the  bacterial  communities,  both  pathogenic  
and   symbiotic,   associated   with   these   herbs   influence   the   reproducibility   of   herbal  
medications.   All   these   factors   point   to   a   pressing   need   to   develop   methods   of  
authentication   to   ensure   proper   QSE   of   these   herbal   medicines.   One   solution   to  
understanding   the   contribution   of   bacteria   in   variability   of   medicinal   herbs   is   by  
characterizing  the  associated  bacterial  population.  Analysis  of  the  bacterial  communities  
associated  with  medicinal  herbs,  therefore,   is   important  not  just  because  it   is  not  fully  
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Chapter  2    
2.1.  INTRODUCTION  
2.1.1.  Juzen-­taiho-­to  
Juzen-­taiho-­to  (JTT)  or  Shi  Quan  Da  Bu  Tang  is  an  immune-­boosting  formulation,  
widely  used  in  Traditional  Chinese  Medicine  (TCM)  and  Japanese  Kampo  medicine.   It  
consists  of  ten  different  herbs,  namely  Panax  ginseng  (Ginseng),  Angelica  sinensis  (Dong  
quai),  Paeonia  lactiflora  (Peony),  Atractylodes  macrocephala  (Atractylodes),  Poria  cocos  
(Hoelen),   Cinnamomum   cassia   (Cinnamon),   Astragalus   membranaceus   (Astragulus),  
Liqusticum  wallichii  (Cnidium),  Glycyrrhiza  uralensis  (Licorice),  and  Rehmannia  glutinosa  
(Rehmannia)  [1]  (Figure  2.1).  
  
Figure  2.1.  Component  herbs  in  JTT.  The  herbal  mixture  of  JTT  contains  
ten  component  herbs,  which  include  six  roots,   two  stems,  a  cortex  and  a  
fungus.  
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JTT  is  generally  prepared  as  a  mixture  of  the  ten  herbs  in  the  following  ratios  [2]:  
Crude  Drug   Botanical  Origin  (Family  name)   Ratio  
Astragali  radix   Astragalus  membranaceus  Bunge  or  A.  
monongholicus  Bunge  (Leguminosae)  
1.5  
Cinnamomi  cortex   Cinnamomum  cassia  Blume  (Lauraceae)   3.0  
Angelicae  radix   Angelica  acutiloba  Kitagawa  (Umbelliferae)   3.0  
Paeoniae  radix   Paeonia  lactiflora  Pallas  (Paeoniaceae)   3.0  
Cnidii  rhizoma   Cnidium  officinale  Makino  (Umbelliferae)   3.0  
Rehmanniae  radix  
  
Rehmannia  glutinosa  Liboschitz  var.  purpurea  
Makino  or  R.  glutinosa  Liboschitz  
(Scrophulariaceae)  
3.0  
Ginseng  radix    Panax  ginseng  C.A.  Meyer  (Araliaceae)   3.0  
Atractylodis  Lanceae  
rhizoma  
Atractlylodes  lancea  De  Candolle  or  A.  
chinensis  Koidzumi  (Compositae)  
3.0  
Poria    The  scletrotium  of  Poria  cocos  Wolf  
(Polyporaceae)  
3.0  
Glycyrrhizae  radix   Glycyrrhiza  uralensis  Fischier  or  G.  glabra  
Linne  ́  (Leguminosae)  
3.0  
  
Table   2.1   :   Preparation   of   JTT.   Botanical   origins   and   ratios   of   the   ten  
component  herbs  of  JTT.    
JTT  is  used  for  boosting  the  immune  system  after  surgeries,  chemotherapy,  ear  
infections  (otitis),  fatigue  [3-­7].  JTT  does  not  have  any  severe  adverse  side-­effects  and  
therefore,  is  considered  safe  to  consume,  and  for  this  reason,  it  has  been  prescribed  by  
medical  practitioners  and  doctors  as  an  immune-­booster  for  centuries  [1].  
JTT   has   been   shown   to   activate   immune   cells   in   the   body   known   as   antigen-­
presenting  cells  (APCs).  APCs  form  the  first  line  of  defense  of  the  immune  system,  and  
include  monocytes,  as  well  as  specialized  cells  like  macrophages  (Mf)  and  dendritic  cells  
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(DCs)  [8-­10].  Furthermore,  JTT  also  enhances  natural  killer  cell-­inducing  activity  and  the  
production  of  antibodies  in  the  liver  [7].    
2.1.2.  Objective  and  Hypothesis    
JTT,  which  is  prepared  with  dried  herbs,  shows  highly  potent  immunostimulatory  
activity.  The  search  of  identifying  the  active  component  in  JTT  has  driven  research  by  our  
lab  and  other  groups  [7,  11-­14].  Previous  research  done  by  our  lab  led  to  the  isolation  
and  purification  of  several  plant  compounds  in  JTT  [13].  The  fractionation  was  followed  
guided  by  the  immunostimulatory  activity  as  determined  by  the  induction  of  biomarkers  
associated  with  monocyte   activation   (Figure   2.2).   This  was   termed   “biomarker-­guided  
screening”  and  the  activity  was  followed  using  ICAM-­1  (intercellular  adhesion  molecule  
1)  mRNA   induction,   as  measured  by   quantitative   real-­time  polymerase   chain   reaction  
(qRT-­PCR)  [13].  ICAM-­1  is  a  biomarker  for  immunostimulation.  
 
Figure  2.2:  Scheme  for  the  fractionation  of  immunostimulatory  activity  
of  JTT.  The  activity  of  JTT  was  followed  by  the  ICAM-­1  mRNA  expression  
of  THP-­1  monocytes,  measured  by  qRT-­PCR.    
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The  protocol   led   to   the  purification  of  an  active  methanol   (MeOH)   fraction.  The  
active   fraction,   thus   obtained,   was   further   purified   by   HPLC   and   the   structural  
characterization  was  performed  using  mass  spectrometry  and  NMR.  This  revealed  the  
presence  of  several  glycolipids  and  phytosterols,  compounds  generally  found  in  plants  
(Figure   2.3).   The   major   compound   isolated   was   β-­sitosteryl   β-­D-­glucoside   (BSSG),  
whereas  other   isolated  plant-­based  compounds   included  monogalactosyldiacylglycerol  
(MGDG)  and  digalactosyldiacylglycerol  (DGDG)  [13].    
  
Figure  2.3:  Structures  of  compounds  isolated  from  the  active  fraction  
of  JTT.  The  following  compounds  were  isolated  from  JTT:  (1)  β-­sitosteryl  
β-­D-­glucoside  (BSSG);;  (2)  stigmasteryl  β-­D-­glucoside;;  (3)  campesteryl  β-­  
D-­glucoside;;   (4)   24-­epicampesteryl   β-­D-­glucoside;;   (5   and   6)   β-­







































However,   when   these   compounds   were   individually   analyzed   for   their  
immunostimulatory   activities,   they   failed   to   fully   explain   the   potent   activity   of   JTT.  
Therefore,  we  hypothesized  that  there  may  be  additional  compounds,  structurally  
similar  to  glycolipids,  that  contribute  to  the  immune-­boosting  activity  of  the  herbal  
mixture,   JTT.   Since   these   compounds   were   not   detected   in   the   active   fractions  
mentioned  above,  this  suggested  that  they  might  be  in  miniscule  quantities  and  buried  
within  the  major  plant  compounds  that  were  structurally  characterized.  Additionally,  this  
also   suggested   that,   although   these   glycolipid-­like   compounds   existed   in   minuscule  
quantities,   they  might  be  very  potent   to  explain   the  potency  of  JTT.  This   led  us   to  our  
central   hypothesis   that  bacteria   associated  with   the   component   herbs   of   JTT   could  
contribute  to  the  immune-­boosting  activity  of  JTT.  The  rationale  behind  this  hypothesis  
is  two-­fold.  First,  six  of  the  component  herbs  of  JTT  are  roots  and  roots  being  underground  
are  exposed  to  different  bacterial  communities.  Second,  some  bacterial  glycolipids  such  
as  Gram-­negative  lipopolysaccharide  (LPS)  are  well-­known  immunostimulants.    
However,  since  it  was  not  clear  whether  the  activity  of  JTT  was  due  to  the  bacteria  
associated  with  its  component  herbs,  we  conducted  preliminary  studies  to  test  our  central  
hypothesis.  Our  preliminary  studies  in  fact  suggested  that  some,  if  not  all,  of  JTT’s  activity  
came   from   bacterial   sources,   such   as   LPS.   This   chapter   will   present   chemical,  
biochemical,   and   immunological   studies   that   collectively   indicate   the   presence   and  




2.2.1.  Biochemical  evidence  for  the  presence  of  LPS  in  JTT  
Although,  JTT  is  known  for  its  potent  immunostimulatory  activity,  the  cause  for  this  
is   yet   unknown.   To   examine   the   possibility   of   bacterial   LPS   contribution   in   JTT,   we  
conducted  a  series  of  biochemical  and  chemical   tests.  To  test   the  presence  of  LPS  in  
JTT,  our  preliminary  study  used  an  affinity-­resin  with  immobilized  polymyxin-­B  (PmxB),  
an   antibiotic   used   to   reduce   LPS   contamination   [15,   16].   The   rationale   behind   this  
experiment  was  that,  if  the  immunostimulatory  activity  was  in  fact  coming  from  bacterial  
LPSs,  it  would  be  diminished  by  the  PmxB  treatment.      
JTT  was  subjected  to  PmxB  treatment  (JTT  PB),  as  well  as  Streptavidin  agarose  
resin   treatment   (JTT   Mock)   as   a   control   to   test   for   non-­specific   binding.   The  
immunostimulatory  activity  was  analyzed  by  the  qRT-­PCR  of  ICAM-­1  mRNA  expression  
in  THP-­1  monocytes   (Figure  2.4).  JTT  Mock  as  well  as  untreated  JTT  positive  control  
showed   approximately   30-­fold   ICAM-­1   induction   compared   to   the   vehicle   DMSO-­
treatment.  The  JTT  PB  sample,  exhibiting  12-­fold  ICAM-­1  induction  compared  to  DMSO-­
treatment,  led  to  a  substantial  decrease  in  immunostimulatory  activity  of  JTT  (Figure  2.4).  
The  ICAM-­1  induction  is  relative  to  that  of  DMSO,  which  was  used  as  a  vehicle  control.  
The  significant  decrease  in  immune-­boosting  activity  of  JTT  after  LPS  removal  suggested  
the  presence  of  LPS  and  consequently,  Gram-­negative  bacteria,  associated  with  our  JTT  
sample.    
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Figure   2.4:   Biochemical   Evidence   of   LPS   in   JTT.   Immunostimulatory  
activity  of  JTT,  as  measured  by  ICAM-­1  mRNA  expression  using  qRT-­PCR,  
is  significantly  lowered  by  subjecting  it  to  polymyxin  B-­agarose  resin  (JTT-­
PB)  when  compared  to  the  mock  treatment  (JTT-­Mock)  and  untreated  JTT.  
The  mock  treatment  did  not  significantly  alter  the  activity  compared  to  the  
untreated  JTT  sample.  THP-­1  cells  were  treated  with  samples  (100  µg/mL)  
for   4   hours.   The   bars   represent   fold   change   as   measured   by   Relative  
Quantification  (RQ),  with  the  gene  expression  of  the  samples  being  relative  






2.2.2.  Enrichment  of  Lipid  A  from  JTT  
The  preliminary  experiment  with  PmxB-­treatment  of  JTT  suggested  the  presence  
of  bacterial  LPS  in  the  immunostimulatory  activity  of  the  herbal  formulation.  Therefore,  
JTT  was  subjected  to  a  purification  protocol  to  enrich  Lipid  A  (LA).  LA  is  the  endotoxic  
component   of   LPS   and   is   responsible   for  most   of   its  monocyte   activity   [17,   18].   The  
purification  protocol  was  based  on  an  established  scheme  for  the  purification  of  LA  from  
bacterial  cultures  [19].  However,  it  was  modified  to  enrich  LA  from  the  herbal  sample  as  
shown  in  Figure  2.5.  JTT  powder  was  first  extracted  in  hot  water.  An  organic  extraction  
with   1:1   Chloroform/Methanol   (CHCl3/MeOH)   was   performed,   which   acts   as   a   de-­
lipidation  step,  leading  to  most  lipids  being  extracted  in  the  organic  or  hydrophobic  layer.  
LPS,  at  this  stage  being  more  hydrophilic  due  to  the  presence  of  a  large  polysaccharide  
moiety,  separates  into  the  aqueous  layer.  Next,  the  sugar  moieties  from  the  O-­antigen  
and  core  polysaccharides  were  cleaved  off  from  the  LA  by  hydrolyzing  the  aqueous  layer  
with   acetic   acid   at   slightly   acidic   pH.   A   second   organic   extraction   separates   the  
hydrophilic  sugars   in  LPS  from  the  cleaved  hydrophobic  LA.  This  enriched  LA  sample  
was   further   purified   using   preparative   thin-­layer   chromatography   (Prep   TLC)   and  
fractionated  by  silica  gel  column  chromatography.  The  fractions  obtained  were  analyzed  
by   thin   layer  chromatography   (TLC)   (Figure  2.6).  LAs   typically  appear   in   the  Rf   range  
between  0.2  and  0.6   in   this   condition   (CHCl3/MeOH/H2O/  NH4OH,  40:25:4:2   (v/v/v/v))  




Figure   2.5:  Enrichment  of   LA   in   JTT.  Scheme   for   the   enrichment   and  




Figure   2.6:   “LA-­like”   fractions   in   JTT.   TLC   showing   Rf   values   of   all  
extracted  LA  fractions  in  the  range  between  0.2-­0.6,  consistent  with  those  
of   naturally   occurring   LAs.   The   condition   used   was   (CHCl3/MeOH/H2O/  
NH4OH,  40:25:4:2  (v/v/v/v)).  
  
2.2.3.  Immunostimulatory  activities  of  LA-­like  fractions  from  JTT  
The   immunostimulatory   activities   of   the   LA   fractions   enriched   from   JTT   were  
assayed  by  qRT-­PCR  using  the  ICAM-­1  mRNA  induction  of  THP-­1  monocytes  (Figure  
2.7).  The  activity  profile  of  the  purified  fractions  was  consistent  with  LAs,  which  are  known  
to  be  potent  immunostimulants.  Most  fractions  (Fr.  2-­Fr.  5a)  stimulated  significant  immune  
response   in   the  monocytes.  DMSO  was  used  as   the  vehicle  control  whereas  JTT  and  
LPS  were  the  two  positive  controls.    
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Figure   2.7:   Immunostimulatory   activities   of   LAs   from   JTT.  
Immunostimulatory   activities   of   the   LA   fractions   enriched   in   JTT,   were  
measured  by   ICAM-­1  mRNA  expression   in  THP-­1  cells  using  qRT-­PCR.  
DMSO  was  used  as  the  negative  control  whereas  JTT  (100µg/mL)  and  LPS  
(100ng/mL)  were  both  positive  controls.  LA  fractions  at  5µg/mL  were  used  
for  cell  treatment.  Fractions  Fr.  2-­Fr.  5a  show  significant  immunostimulatory  





2.2.4.  Direct  chemical  evidence  of  LA  in  JTT  
The  most  potent  LA  fraction,  Fr.  3,  was  analyzed  with  high-­resolution  electrospray  
ionization   mass   spectrometry   (HRESIMS)   (Figure   2.8   and   Table   2.2).   The   analysis  
revealed  a  series  of  singly  and  doubly  charged  ions,  which  corresponded  to  the  molecular  
formulas   of   C83H145N2O23P   and   C120H217N4O38P.      These   molecular   formulas   were  
consistent  with  the  structural  backbone  of  typical  LAs,  which  contain  phosphorylated  di-­
glucosamine   with   multiple   acyl   chains.   The   large   number   of   carbons   and   hydrogens  
indicates  the  presence  of  multiple  long  fatty  acyl  chains.  Moreover,  like  the  known  LAs,  
these   compounds   comprised   of   one   phosphorus   atom   (suggesting   the   presence   of  
monophosphate)  and  2-­4  nitrogen  atoms.  Furthermore,  the  m/z  ratios  of  both  singly  and  
doubly  charged  ions  in  both  compounds  were  consistent  with  the  molecular  weights  of  
known  LA  species,  which  generally  range  between  1500-­2500  Daltons  (Da).  Therefore,  
this  MS  analysis  provided  the  direct  molecular  evidence  of  LPS  in  JTT.  
 
  
Figure  2.8:  Mass  Spectrometric  analysis  of  LA  Fr.  3.    The  MS  analysis  
of  the  most  potent  fraction,  Fr.  3  revealed  the  presence  of  two  compounds,  







Table  2.2:  MS  data  for  the  analysis  of  Cpd1  and  Cpd2.  The  m/z  ratios  
and   the  molecular   formulas   for  all   the   ions   identified   in  both  compounds  
Cpd1  and  Cpd2  are  consistent  with  those  of  general  LAs.  These  formulas  
were  however,  different  from  those  of  known  LAs  indicating  the  presence  of  
novel  and  unidentified  LA-­like  factors  in  JTT. 
Taken   together,   all   these   results   suggest   the   presence   of   LPS/LA-­like   factors  
associated  with  the  herbal  formulation,  JTT.    However,  the  obtained  molecular  formulas  
did   not   have  exact  matches   to   known  LAs   in   the  Sci-­Finder   database.  This   led  us   to  
believe   that   the   purified   factors   could   be   structural   variants   of   known   LAs.   To   our  
knowledge   the   current   study  was   the   first   to   obtain   direct  molecular   evidence  of   LPS  
variants  in  immune-­boosting  herbs.    
  
m/z z Cal$m/z Formula Ion
776.5027 +2 776.5008 C83H145N2O23P [M+2H-
2H2O]+2
785.5160 +2 785.5061 C83H145N2O23P [M+2H]+2
Cpd1 807.4878 +2 807.4880 C83H145N2O23P [M+2Na]+2
1551.9923 +1 1551.9943 C83H145N2O23P [M+H-H2O]+1
1570.0047 +1 1570.0049 C83H145N2O23P [M+H]+1
1591.9842 +1 1591.9868 C83H145N2O23P [M+Na]+1
1168.7488 +2 1168.7474 C120H217N4O38P [M+2H-
2H2O]+2
Cpd2 1177.7553 +2 1177.7527 C120H217N4O38P [M+2H]+2
1186.2612 +2 1186.2756 C120H217N4O38P [M+2H-
2H2O]+2
1199.7364 +2 1199.7346 C120H217N4O38P [M+2Na]+2
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2.3.  DISCUSSION  
Plant-­bacteria  associations,  both  pathogenic  and  symbiotic,  have  been  the  focus  
of  many   scientific   studies   [20,   21].  Some  studies   suggest   the  presence  of   bacteria   in  
association  with  medicinal  herbs  [22,  23].  However,  until  recently,  the  impact  that  these  
herb-­colonizing  bacteria  may  have  on  the  medicinal  plants  or  humans  that  consume  them  
was  unknown.    
A  new  hypothesis  emerged  with  the  results  presented   in  this  chapter:   immune-­
boosting  bacteria  are  enriched  in  medicinal  plants.  The  main  active  factors  in  JTT,  
characterized  thus  far,  were  mainly  polysaccharides  and  glucocerebrosides.  However,  in  
this  study,  the  main  immunostimulatory  agent  in  the  herbal  concoction  was  observed  to  
be  bacterial  LPS.  An  important  question  that  arises  with  this  observation  is  why  was  LPS  
not   found   in   JTT   prior   to   this   study.   The   active   factors   of   many   herbs   are   poorly  
characterized  and  it  is  generally  difficult  to  characterize  them.  If  these  active  factors  are  
in   fact   LPS   variants   from   plant-­colonizing   bacteria,   they   are   present   in   minuscule  
quantities   and   are   buried   in   the   large   amounts   of   plant-­derived   compounds,   such   as  
glycolipids   and   carbohydrates.   In   addition,   LPS   variants   in   plants   are   heterogeneous  
mixtures  from  various  plant-­colonizing  bacteria.  For  these  reasons,  it  may  be  difficult  to  
identify  these  bacterial  lipids.  The  most  abundant  compounds  in  plants  are  generally  not  
the  most  active  compounds,  as  was  seen  in  the  case  of  BSSG  [13].  
A  study  by  Pasco  and  co-­workers  successfully  demonstrated  that  bacteria  are  not  
only  present  in  Echinacea  purpurea,  a  popular  medicinal  herb  for  common  cold  treatment,  
but   also   are   correlated   with   the   immune-­boosting   activity   of   the   herb   [24].   Despite  
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decades  of  research  on  Echinacea,  the  active  immunomodulatory  ingredients  in  the  herb  
remained  unclear,  with  mostly   the  plant  alkylamides  being   indicated  as  the  major  anti-­
inflammatory  components.  Pasco’s  work  was  the  first  to  attribute  the  immune-­boosting  
activity  of  Echinacea  to  bacterial  components,  such  as  LPS  and  lipoprotein.  This  study  
evaluated  the  contribution  of  bacterial  LPS  using  both  biochemical  and  cell-­based  assays.  
The   group   used   the   endotoxin   detection   assay,   Limulus   amebocyte   lysate   (LAL),   to  
estimate  the  amount  of  LPS  in  the  plant  material.  Furthermore,  they  developed  a  PCR-­
based  assay  to  extract  and  quantify  the  bacterial  load  in  Echinacea.    The  bacterial  load  
within   the  plant  sample  was  eventually  correlated  with   the   in  vitro  NF-­kB  activation   in  
THP-­1  cells  [24].  The  results  of  the  study  provided  further  evidence  that  bacteria  within  
medicinal  herbs  are  responsible  for  the  immune-­boosting  activity  of  the  herb.  
Independently,   around   the   same   time,   our   study   investigated   the   presence   of  
bacterial  LPS   in  JTT  and  suggested   the  contribution  of  LPS   in   the   immunostimulatory  
activity  of  JTT  [25].  The  molecular  evidence  of  LPS  in  JTT  was  provided  by  subjecting  
JTT  to  the  antibiotic  PmxB,  and  comparing  the  activity  of  the  treated  sample  with  that  of  
mock  treated  JTT  with  Streptavidin.  Our  study  presented,  for  the  first  time,  direct  mass  
spectrometric  evidence  of  LPS  variants  being  present   in   immune-­boosting  herbs.  This  
important  finding  may  pave  the  way  to  uncovering  new  roles  of  beneficial  bacteria,  which  
we   call   as   “herbal   probiotics”   in   JTT   and   other   herbs.   The   presence   of   previously  
uncharacterized   “LA-­like”   factors   in   JTT   indicate   that   the   bacteria   associated  with   the  
herbs  of  JTT  may  present  novel  or  unique  structures  of  LA  [25].    
Polymyxin  is  a  class  of  nonribosomal  cyclic  lipopeptide  antibiotics,  with  Polymyxin  
B   (PmxB)   and   E   being   the   most   researched   members   [26,   27].   PmxB   binds   to   the  
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negatively-­charged  groups  in  LPS  in  the  bacterial  cell  membrane  as  shown  in  Figure  2.9  
and   disrupts   the   outer   membrane   permeability,   thereby,   resulting   in   cell   death   [27].  
However,  PmxB  leads  to  the  elimination  of  some,  but  not  all,  Gram-­negative  bacteria  [28].  
This  could  be  the  reason  for  some  of  the  immunostimulatory  activity  remaining  in  the  JTT  
sample  treated  with  PmxB  (JTT-­PB).    
 
Figure  2.9:  Polymyxin  B  and  LPS.    The  antibiotic,  polymyxin  B  binds  to  
the   negatively   charged   groups   in   LPS   (highlighted   in   red)   and   removes  
Gram-­negative  bacteria.  
  
A  more  recent  study  by  Cech’s  group  studied  Echinacea  and  showed  that  when  
grown  under  germ-­free  conditions,  it  did  not  exhibit  immunostimulatory  activity.  This  was  




































































conditions   [29].  This  study  also  corroborated   the  hypothesis   that   the   immune-­boosting  
activity  of  medicinal  herbs  may  be  attributed  to  the  presence  of  bacteria  associated  with  
the  herb. 
Taken  together,  all  these  studies  suggest  the  presence  and  contribution  of  bacteria  
in   the   immune-­boosting   activity   of   medicinal   herbs.   However,   the   identities   of   these  
immune-­boosting   bacteria   or   “herbal   probiotics”   was   still   unknown   by   the   time   of   our  
study.  To  this  end,  some  of  these  immune-­boosting  bacteria  in  JTT  were  identified.  This  




2.4.  MATERIALS  AND  METHODS  
2.4.1.  Cell  Culture  
THP-­1  monocytes  were  purchased  from  ATCC  and  cultured  in  RPMI-­1640  medium  
containing  25  mM  HEPES  and  L-­glutamine  (HyClone)  and  supplemented  with  10%(v/v)  
fetal  bovine  serum  (Fisher),  1%(v/v)  penicillin,  streptomycin  and  amphotericin  B  mixture  
(VWR)  and  0.005  mM  β-­mercaptoethanol. The  cells  were  maintained  at  37ºC  in  a  5%  
CO2  incubator.    
2.4.2.  Endotoxin  Removal  using  Detoxi-­Gel  
10  mg  of  JTT  powder  was  dissolved  in  2  mL  of  Millipore  water  to  prepare  a  stock  
solution  of  concentration  5  mg/mL.  Equal  amounts  (0.5  ml)  of  Streptavidin  Agarose  Resin  
(Thermo  Scientific,  Prod.  #  20349)  and  Detoxi-­Gel™  Endotoxin  Removing  Resin  (Thermo  
Scientific,   Prod.   #   20339)  were   taken   in   separate  Eppendorf®   tubes.   The   tubes  were  
centrifuged  at  >10,000  rpm  for  1  minute  to  remove  preservative  solution  from  the  gels.  
The  gels  were  washed  3  times  by  adding  700  µL  of  Millipore  water  and  centrifuging  at  
>10,000  rpm  for  1  minute  to  remove  residual  preservative  solutions  from  the  gels.  0.5  ml  
(~2.5  mg)  of  JTT  stock  solution  was  added  to  Avidin  and  Detoxi  gels.  0.5  ml  (~2.5  mg)  of  
JTT  stock  solution  was  taken  in  a  fresh  Eppendorf®  tube  to  serve  as  a  positive  control  for  
the  experiment.  0.5  mL  of  Millipore  water  was  used  as  a  negative  control.  The  experiment  
was  performed  in  duplicate.  The  Eppendorf®  tubes  were  placed  in  a  tube  rotator  overnight  
at  4°C.  The  tubes  were  centrifuged  at  >10,000  rpm  for  1  minute  the  following  day.  400  µL  
(~2  mg)  of  the  supernatants  of  each  of  the  samples  was  filtered  through  a  5  mL  syringe  
filter   into   pre-­weighed   eppendorf   tubes.   The   tubes   were   dried   in   the   Eppendorf®  
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Vacufuge,   and   weighed   again.   The   samples   were   dissolved   in   DMSO   to   achieve   a  
concentration  of  0.02  µg/µL  for  THP-­1  cell  treatment.  Final  concentration  of  samples  in  
media  used  for  treatment  was  0.1  µg/mL.  
2.4.3.  Cell  treatment  and  lysis  
THP-­1  cells  were  plated  at  a  concentration  of  500,000  cells/2mL  in  a  12-­well  plate.  
The  following  day,  cells  were  treated  with  the  LA  fractions/samples  dissolved  in  DMSO  to  
achieve   a   concentration   of   5µg/mL),   positive   control   (JTT   at   100µg/mL   and   LPS   at  
0.2ng/mL),  DMSO  as  the  vehicle  or  negative  control  for  4  hours  in  a  37ºC  incubator  and  
5%  CO2.  After  4  hours  of  incubation,  cells  were  transferred  to  a  15mL  Falcon  tube  and  
centrifuged  at  1300rpm  for  5  minutes  at  room  temperature.  The  medium  was  aspirated,  
without  disturbing  the  pellet.  The  pellet  containing  the  cells  was  lysed  with  350µL  TRK  
Lysis  Buffer   containing   2%  b-­mercaptoethanol.   The   pellets   re-­suspended   in   the   Lysis  
buffer   were   transferred   to   Omega®   Homogenizer   columns   (Omega   Bio-­Tek)   and  
centrifuged  for  2  minutes  at  maximum  speed  (approximately  13,000rpm)  in  a  centrifuge.  
The  homogenized  lysate  was  either  stored  at  -­80ºC  or  immediately  processed  for  RNA  
purification.  
2.4.4.  RNA  Purification  and  Quantification  
The  cell   lysate  was  washed  with  350/700µL  of  freshly  prepared  70%  ethanol  by  
gentle  pipetting.  The  E.Z.N.A.  Total  RNA  Kit  I  (Omega  Bio-­Tek)  was  used  for  purifying  
the  RNA  from  the  cell   lysates.  The  lysate-­ethanol  mixture  was  loaded  onto  the  Hi-­bind  
RNA  mini  column,  placed  inside  a  2mL  collection  tube.  The  contents  were  centrifuged  for  
1  minute  at  13,000rpm,  and  the  flow-­through  was  discarded.  RNA  Wash  Buffer  I  (500µL)  
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was  added  to  the  columns  and  they  were  centrifuged  for  1  minute  at  13,000rpm.  The  flow-­
through  was  discarded  following,  which  two  washes  each  with  500µL  of  RNA  Wash  Buffer  
II  were  performed.  The  contents  were  centrifuged   for  1  minute  at  13,000rpm,  and   the  
flow-­through  was  discarded  after  each  wash.  The  columns  were  placed  in  fresh  collection  
tubes  and  centrifuged  for  2  minutes  at  13,000rpm  to  completely  dry  any  residual  liquid.  
The   columns   were   transferred   to   fresh   2mL   Eppendorf®   tubes   and   the   25µL   DEPC  
(Nuclease-­free)  water  was  added  to  the  column  membrane  and  they  were  incubated  at  
room  temperature  for  2  minutes.  Purified  RNA  was  finally  eluted  in  the  Eppendorf®  tubes  
by  centrifuging  for  1  minute  at  13,000rpm.  The  resulting  RNA  samples  were  quantified  
using  a  Thermo  Scientific  NanoDrop  1000  Spectrophotometer  by  reading  the  absorbance  
at  260nm.  Samples  showing  ratios  between  1.8-­2.2  for  the  260nm/280nm  were  used  for  
cDNA  synthesis.  
2.4.5.  Reverse  Transcription  
The  purified  RNA  samples  were  synthesized  to  cDNA  by  reverse  transcription.  The  
total  RNA  concentration  for  each  sample  was  adjusted  to  the  lowest  concentration  of  RNA  
obtained  for  the  samples  (approximately  more  than  150ng/µL).  The  samples  were  diluted  
with   DEPC  water   to   a   volume   of   13µL   to   reach   the   desired   concentration.   For   each  
reaction,  1µL  of  a  10mM  dNTP  Mix  (Promega)  and  2µL  of  Random  primers  (0.3  µg/µL,  
Invitrogen)  was  added.  The  mixture  was  placed  in  a  PCR  thermocycler  for  3  minutes  at  
70ºC  and  then  cooled  to  4ºC  for  1  minute.  To  each  of  the  reaction  tubes,  4µL  of  5X  RT  
Buffer  and  0.5µL  of  200U/µL  M-­MLV  Reverse  Transcriptase  (Promega)  was  added.  The  
resulting   mixture   was   incubated   at   42ºC   for   1   hour   and   then   heated   to   95ºC   for   10  
minutes.   Finally,   the  mixture  was   incubated   at   37ºC   for   20  minutes.   The   synthesized  
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cDNA  was  either  used  immediately  for  quantitative  real-­time  PCR  (qRT-­PCR)  analysis  or  
stored  at  -­20ºC  until  required.  
2.4.6.  Quantitative  real-­time  polymerase  chain  reaction  (qRT-­PCR)  
The   synthesized   cDNA  samples  were   diluted  with  DEPC  water   to   the   required  
concentration  of  0.025µg/µL  for  qRT-­PCR  analysis.  Taqman®  Gene  Expression  assays  
(Applied  Biosystems)  were  used  for  the  quantification  of  mRNA  induction  using  specific  
probes   for   different   genes   of   interest.   GAPDH   was   the   endogenous   gene   used   for  
normalization  of  mRNA.  For  each  assay,  10µL  of  Taqman®  Gene  Expression  Master  Mix  
was  mixed  with  1  µL  of   the  probe  (GAPDH  or  any  gene  of   interest)  depending  on   the  
number  of  samples.  From  each  of  the  probe  mixtures,  34.5µL  was  transferred  to  a  PCR  
tube  and  28µL  of  the  cDNA  mixture  was  added  to  prepare  the  final  mixture  for  qRT-­PCR.  
Triplicates  were  prepared   for  each  sample   to  be   tested  by  adding  20µL   from   the   final  
mixture   into   MicroAmp®   Optical   Tube   Strips   (Applied   Biosystems).   The   tubes   were  
placed   in   the   7500   Real-­Time   PCR   system   (Applied   Biosystems)   and   the   following  
reaction  was  carried  out  for  the  selected  genes:    
Temperature   Time   Cycles  
50ºC   2  minutes   1  
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Chapter  3    
3.1.  INTRODUCTION  
Being  ubiquitous  in  nature,  bacteria  are  found  anywhere  and  everywhere;;  from  the  
depths  of  the  ocean,  and  core  of  the  Earth’s  crust,  to  the  inside  of  the  human  gut,  and  
even   the   food   we   consume   [1-­4].   It   is   well   known   that   bacteria   are   not   just   harmful  
microorganisms  but  also  beneficial  as  well,  by  existing   in  both  parasitic  and  symbiotic  
relationships  with  other  organisms,  including  plants  and  humans.  
In  Chapter  2,  we  discovered  bacterial  lipids  contributing  to  the  immune-­boosting  
activity  of  Juzen-­taiho-­to  (JTT).  The  presence  of  bacterial  LPS  in  JTT  and  its  contribution  
to  the  immunostimulatory  activity  of  the  herbal  mixture  was  a  consequential  discovery.  
However,   this   discovery   is   not   isolated.   Other   research   groups   have   reported   similar  
studies   in   other   medicinal   plants.   Recently,   Pasco   and   co-­workers,   successfully  
demonstrated  not  just  bacteria  being  present  in  an  herb,  Echinacea  purpurea,  used  for  
common  cold  treatment,  but  also  correlated  its  total  bacterial  load  with  its  immune  system  
enhancing  activity  [5,  6].  
3.1.1.  Objective  and  Hypothesis  
The  presence  of  bacterial   lipids   in  JTT  and  other  medicinal  plants  suggests   the  
presence  of   “immune-­boosting”  bacteria   that  could  safely  and  effectively  stimulate   the  
immune  system  when  consumed.  However,  the  identities  of  these  immune-­boosting  
bacteria  in  JTT  and  other  medicinal  plants  are  not  known.  This  lack  of  knowledge  is  
an  important  problem  because  the  bacteria  hold  important  clues  to  understanding  the  
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immunostimulatory  effects  of  JTT,  which  have  been  used  safely  and  effectively  for  various  
ailments  in  East  Asia.  As  such,  the  primary  objective  of  the  study  presented  in  this  chapter  
was  the  identification  of  immune-­boosting  bacteria  in  JTT.    
Identification  of  immune-­boosting  bacteria  in  JTT  also  provides  new  insights  into  
the   issue  of  batch-­to-­batch  variability  of  herbal  medicine.  Herbal  medicines  encounter  
several  challenges  regarding  their  quality  and  standardization  due  to  variability  between  
different  batches  of  the  same  herb  [7,  8].  Although  the  issue  could  arise  from  the  variability  
in   harvest   conditions   and   manufacturing   methods   of   the   herbal   formulations   [9],   the  
batch-­to-­batch  variability  of  bacterial  populations  associated  with  the  herb  has  not  
been  studied.  This  gap  in  knowledge  is  important  because  by  determining  the  variability  
of  bacterial  communities  and  their  contribution  to  immune-­boosting  activity  of  the  herb,  it  
would  become  possible  not  only  to  gain  new  insights  into  the  variability  issue  but  also  to  
improve  the  standardization  of  JTT  and  possibly  other  immune-­boosting  herbs.  Thus,  the  
secondary  objective  of  the  study  presented  in  this  chapter  was  to  characterize  how  the  
bacterial  community  in  JTT  is  associated  with  the  immunological  activity.  
Our  attempt  to  characterize  the  immune-­boosting  bacteria  in  JTT,  however,  raised  
a  question  of  whether  to  characterize  all  component  herbs  in  JTT.  This  is  an  important  
question  because  JTT   is   a   complex  mixture  of   ten  different   herbs.  This  question  was  
partly   addressed   by   a   study   conducted   previously   in   our   laboratory,   in   which   the  
immunostimulatory   activity   of   ten   component   herbs   were   separately   characterized.  
Among  the  ten  component  herbs,  three  showed  significant  immunostimulatory  activity  as  
determined  by  ICAM-­1  mRNA  induction  in  THP-­1  monocytes  (Figure  3.1).  These  were  
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Angelica  sinensis  (A.  sinensis),  Paeonia  lactiflora  (P.  lactiflora),  and  Cinnamomum  cassia  
(C.  cassia)  [10,  11].    
 
 
Figure  3.1:  Immunostimulatory  activities  of  component  herbs  of  JTT.  
The   immunostimulatory   activities   of   the   ten   component   herbs   were  
measured  by   their   ICAM-­1  expression  on  THP-­1  monocytes,  using  qRT-­
PCR.  DMSO  and  JTT  (100µg/mL)  were  the  negative  and  positive  controls,  
respectively.  The  component  herbs  were  extracted  with  boiling  water,  dried  
and  reconstituted  in  DMSO  and  treated  at  a  final  concentration  of  10µg/mL.    
 
The  question,  however,   remained  as   to  whether  any  or  all   three  of   these  herbs  
contain   immune-­boosting   bacteria.   To   address   this   question,   all   three   herbs   were  
subjected  to  preliminary  PCR  analyses  to  detect  bacterial  specific  gene  (16S  ribosomal  
RNA)   in   them.  As  presented   in   the  Results   section   of   this   chapter,   the  PCR  analysis  
reproducibly  detected  bacteria  only  in  A.  sinensis.  As  such,  the  study  presented  in  this  












A.   sinensis   (Dong  Quai)   is   a  potent   immunostimulatory  herb,   generally   used   in  
combination   with   other   herbs   to   prepare   different   herbal   concoctions   [12].   Among   its  
several  uses,  some  of   the  more  common  ones   includes  promotion  of  blood  circulation  
and  treatment  of  women’s  health  issues,  such  as  menstrual  disorders  like  dysmenorrhea  
[13,  14].  For  this  reason,  it  is  popularly  also  known  as  “female  ginseng”.  It  is  also  used  as  
an  anti-­oxidant  and  for  anti-­inflammatory  properties  [15].  
 
Figure  3.2:  Angelica  sinensis.  The  plant  and  flowers  of  A.  sinensis  (on  the  
left)  and  the  dried  roots  of  the  herb  (on  the  right)  are  shown.  
 
The  dried  roots  of  the  plant,  also  known  as  Angelica  sinensis  Radix  is  used  both  
on  its  own  as  well  as  in  different  herbal  formulations  in  both  Traditional  Chinese  Medicine  
(TCM)  and  Japanese  Kampo  medicine  (Figure  3.2).  Immunological  activity  of  Angelica  
sinensis  has  been  studied  extensively  [13,  15-­17].  It  is  one  of  the  component  herbs  of  the  
ten-­herb  formulation,  Juzen-­taiho-­to  (JTT),  which  is  used  to  enhance  the  properties  of  the  
immune  system  in  cases  of  chemotherapies,  tumor  surgeries,  Hepatitis  C,  otitis  among  
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others   [18-­21].  A.   sinensis   is   also   regarded   as   an   immunostimulant   and   an   immune-­
booster  in  vitro  as  it  promotes  the  production  of  several  cytokines  such  as  interleukin-­6  
(IL-­6)  and   interferon-­g   (IFN-­g)   by  activated  macrophages  and  other   cells  of   the   innate  
immune  system  [22].    
Several  chemical  constituents  have  been  extracted  and  purified  from  the  water-­
soluble   or   organic   extracts   of  A.   sinensis,   which   include   many   carbohydrates,   lipids,  
phenolic   compounds,   organic   acids,   and   others   [23].   Some   of   these,   such   as   certain  
polysaccharides  and  organic  acids,  have  been  shown  to  possess  biological  activities  [14,  
23].    
Our  previous  research  has  suggested  bacterial  LPS,  and  not  plant  compounds,  to  
be  the  active  factors  in  JTT.    Among  the  ten  herbs  in  JTT,  A.  sinensis  was  likely  to  contain  
the  immune-­boosting  bacteria.  Thus,  the  working  hypothesis  investigated  here  is  that  
the  symbiotic  bacteria  associating  with  A.  sinensis  are  Gram-­negative   in  nature,  
and   therefore,   produce   LPSs,   which   consequently   contribute   to   some   of   the  
immunostimulatory  activity  of  the  herb.  
Another   technical   question   raised   at   the   onset   of   this   study   was   how   to  
characterize  the  bacterial  community  in  A.  sinensis.    In  retrospect,  we  were  at  the  right  
time   to  conduct   this  study.   It  was   the   time  when  powerful  next-­generation  sequencing  
(NGS)  technology  was  becoming  widely  available.  The  field  of  metagenomics  research  
was  rapidly  emerging.  
Metagenomics   sequencing   has   been   defined   as   “the   functional   and   sequence-­
based  analysis  of  the  collective  microbial  genomes  contained  in  an  environmental  sample  
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of  uncultured  organisms”  [24].  The  identification  of  bacteria  in  environmental  samples  is  
greatly  impeded  by  the  non-­culturable  nature  of  most  microorganisms  [25].  To  overcome  
this  limitation,  a  metagenomics  or  sequencing-­based  approach  is  utilized.    The  advent  of  
16S   rRNA   survey   has  made   the  metagenomics   analysis   of   both   culturable   and   non-­
culturable   microorganisms   an   affordable   and   faster   approach   to   study   host-­microbe  
relationships,   thereby   providing   an   insight   into   beneficial  microbes,   their   isolation   and  
characterization  [26].  
Several  techniques  and  tools  are  utilized  for  the  sequencing  of  microorganisms  in  
environmental   samples.   The   tool   employed   for   identifying   bacterial   communities  
associated   with  A.   sinensis   was   Illumina   sequencing.   Illumina   sequencing   introduced  
paired-­end   sequencing   platforms   catering   to   different   needs   including   HiSeq   2000  
platform,  MiSeq  genome  analyzer,  and  RNASeq  to  diverse  metagenomics  data  [27].    
To   test  our  hypothesis  of  presence  and  contribution  of  bacteria   in   the   immune-­
boosting   activity   of   A.   sinensis,   16S   survey   of   different   batches   of   A.   sinensis   was  
performed  to  identify  the  bacteria  associated  with  the  dried  roots  of  the  herb.  The  dried  
root   powder   was   used   to   extract   DNA.   The   DNA   samples   were   subjected   to   PCR  
amplification  of  bacteria  specific  16S  rRNA  gene.  Illumina  MiSeq  genome  analyzer  was  
used  to  sequence  the  amplified  16S  rRNA  from  the  A.  sinensis  samples  (Figure  3.3).  The  
data  obtained  was  finally  analyzed  using  a  bioinformatics  pipeline  (QIIME:  Quantitative  
Insights  Into  Microbial  Ecology)  to  gain  knowledge  about  the  bacteria  associated  with  the  




Figure  3.3:  Model  demonstrating  sequencing  analysis  of  A.  sinensis.  
DNA   is   extracted   from   the   dried   roots   of  A.   sinensis   first,   which   is   then  
subjected   to  PCR  amplification  using  bacteria-­specific  primers.  The  PCR  
amplicons  are  sequenced  and  the  data  obtained  is  analyzed  to  identify  the  
microbial  communities  associated  with  the  herb.  
 
16S  ribosomal  RNA  (rRNA)  subunit   is  a  component  of   the  30S  small   ribosomal  
unit  in  prokaryotes  (bacteria  and  Archaea).  The  gene  encoding  for  the  16S  rRNA  subunit  
is  known  as  the  16S  rRNA  gene  or  16S  rDNA.  The  16S  rRNA  gene  is  highly  conserved  
in   prokaryotes   but   contains   hypervariable   regions   that   are   different   from  bacterium   to  
bacterium.   Therefore,   16S   rRNA   is   widely   used   as   a   phylogenetic   marker   for   the  
identification  of  bacteria  [28].  
This  chapter  describes  two  different  16S  rRNA  sequencing  studies  performed  on  
multiple  batches  of  A.  sinensis  to  assess  variability  of  bacterial  communities  associated  
within   different   batches   of   the   same   herb.   The   first   study  was   performed   using   three  
batches  of  A.  sinensis  obtained   from  different  sources.  This   first  analysis  provided  an  
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insight  into  the  identities  of  bacteria  associated  with  the  herb,  as  well  as  explained  the  
batch-­to-­batch  variability  in  terms  of  the  immune-­boosting  activities  of  the  herb.  However,  
some   primer   pairs   used   in   the   first   sequencing   study   co-­amplified   plant   DNA   (see  
Results).   In   an   attempt   to   overcome   this   problem,   the   second   sequencing   study  was  
carried  out  with  newly  designed  primer  pairs.  Additionally,  the  sample  size  of  the  second  
sequencing   study   was   increased   to   four   A.   sinensis   batches   and   a   better   PCR  
amplification  protocol  was  adopted  (see  Discussion).       
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3.2.  RESULTS  
3.2.1.  A.  sinensis  contains  immune-­boosting  bacteria  
Although  JTT   is  a  decoction  of   ten  different  herbs,  our  previous  study   indicated  
that   the   immunostimulatory   activity   of   JTT   arises   from   three   herbs,   namely,  Angelica  
sinensis,  Paeonia   lactiflora,   and  Cinnamomum  cassia   (Figure  3.1).  Therefore,  we   first  
examined  the  presence  of  bacterial  DNA  in  these  three  herbs  by  PCR.  
  
  
Figure   3.4:   16S   rRNA   gene.   16S   rRNA   gene   is   a   1500bp   gene   with  
conserved  and  hypervariable  regions.    
 
PCR   was   performed   using   primer   pairs   that   amplify   different   regions   of   the  
hypervariable  regions  of  16S  rDNA.  The  16S  rRNA  gene  is  1500  base-­pair  (bp)  in  size  
and  consists  of  two  types  of  regions:  conserved  and  variable  regions  (  
Figure   3.4).   Conserved   regions   are   consistently   present   in   most   bacteria   and  
Archaea.    
The  PCR  analysis  was  first  carried  out  for  A.  sinensis,  which  was  the  most  potent  
herb  among  all  the  ten  component  herbs  of  JTT.  The  primer  pairs  used  in  the  analysis  
were  fM1/rC5,  799f/1392r,  906f/1392r,  and  1114f/1392r.  These  primer  pairs  have  been  
previously   used   in   other   16S   survey   studies,   where   bacteria   were   amplified   in   the  
presence   of   plant   samples.   The   primer   pair,   fM1/rC5   is   a   universal   primer   pair   [29],  
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whereas  799f/1392r  was  used  in  another  study  for  bacterial  amplification  from  another  
medicinal   herb,   Echinacea   purpurea   [5].   The   other   two   primer   pairs   were   used   for  
identification  of  bacteria  associated  with  the  model  plant,  Arabidopsis  thaliana  [30].  
  The  presence  of  bacterial  DNA  was  confirmed  with  the  bands  on  the  gel  for  primer  
pair   fM1/rC5   (~400bp),   799f/1492r   (~735bp),   926f/1392r   (~466bp)   and   1114f/1392r  
(~308bp)  [5,  29-­31].  The  primer  pair,  804f/1392r  did  not  produce  any  bands,  therefore,  it  
was  not  used  for  further  analysis.  Primer  pair,  799f/1492r  was  also  excluded  from  future  
studies,   since,   the   PCR   amplicon   for   Illumina   sequencing   should   be   approximately  
~400bp  in  size  (Figure  3.5).  This  initial  study  was  a  proof  of  principle  for  the  presence  of  





Figure  3.5:  Presence  of  bacteria  in  Angelica  sinensis.  PCR  amplicons  
of   DNA   extracted   from   A.   sinensis   were   analyzed   with   agarose   gel  
electrophoresis.  The  bands  for  bacterial  DNA  were  observed  with  most  of  
the  primer  pairs  used  for  amplification  and  are  marked  with  an  arrow.  
  
Peony  lactiflora  was  also  subjected  to  the  PCR  analyses  to  detect  bacterial  16S  
rRNA  gene.  However,  as  Figure  3.6  shows,  no  bands  were  observed  on  agarose  gel  for  
the   PCR   amplicons.   Furthermore,   when  DNA  was   extracted   from  P.   lactiflora,   it   was  
observed  to  be  present  in  extremely  low  concentration.  Therefore,  when  this  DNA  was  
amplified,   it   led   to  no  detection  of  bacterial  bands  on  agarose  gel.  On  the  other  hand,  
bands  with  sizes  less  than  100bp  for  primer  dimers  were  observed.  Although,  this  does  

















quantity  of  bacterial  DNA  was  minuscule.  It  is  important  to  acknowledge  that  most  herbs  
are  in  fact  dried,  and  this  may  be  another  reason  for  some  herbs  not  harboring  sufficient  
bacteria   [32].   This   result,   or   the   lack   of   bands   for   bacterial   DNA,   was   consistently  




Figure  3.6:  Presence  of  bacteria  in  Peony  lactiflora.  PCR  amplicons  of  
DNA  extracted  from  Peony  were  analyzed  with  agarose  gel  electrophoresis.  
No   bands   for   bacterial   DNA  were   observed.   Bands  with   sizes   less   than  
100bp  indicate  primer  dimers.  
 
Another   one   of   the   three  most   potent   herbs   in   JTT  was  Cinnamomum   cassia.  
Similar   to   the   preliminary   study   for   Peony,   DNA   was   extracted   and   amplified   from  
Cinnamon  using  the  same  primer  pairs.  The  PCR  amplicons  were  analyzed  by  agarose  
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gel  electrophoresis.  However,  no  bands  for  bacterial  DNA  amplification  were  observed  
on  the  gel  (Figure  3.7).    
The  lack  of  bacterial  DNA  amplification  in  C.  cassia  may  be  attributed  to  the  fact  
that  Cinnamon  is  a  bark.  For  this  reason,  C.  cassia  might  not  harbor  as  much  endophytes  
and  epiphytes  as  other  herbs  derived  from  plant  roots,  which  tend  to  harbor  multifarious  
bacteria  in  the  rhizosphere.  
 
Figure   3.7:   Presence   of   bacteria   in   Cinnamomum   cassia.   PCR  
amplicons  of  DNA  extracted  from  Cinnamon  were  analyzed  with  agarose  
gel  electrophoresis.  No  bands  for  bacterial  DNA  were  observed  with  any  of  














Collectively,  the  PCR  analyses  of  A.  sinensis,  P.  lactiflora,  and  C.  cassia  indicated  
that  the  immune-­boosting  bacteria  in  JTT  were  from  A.  sinensis.  Therefore,  we  decided  
to  focus  our  further  study  on  A.  sinensis.    
3.2.2.  A.  sinensis  contains  immunostimulatory  LPS  
Prior  to  the  16S  survey  of  A.  sinensis,  we  investigated  the  presence  of  LPS  in  this  
herb.  The  Detoxi-­gel  experiment  with  Polymyxin  B  treatment,  as  shown  in  Chapter  2  for  
JTT,  was  performed  for  one  of  the  batches  of  A.  sinensis,  namely  Japanese  Angelica  1  
(JA1).   Polymyxin   B-­treated   JA1   (JA1_PB)   showed   reduction   in   immunostimulatory  
activity   when   compared   to   the   mock   treatment,   JA1   treated   with   Streptavidin   resin  
(JA1_A).   JA_PB   induced   approximately   3.5-­fold   ICAM-­1  mRNA   induction,   which   was  
nearly  half  of  that  of  JA_A  (7-­fold),  when  compared  with  the  negative  control,  DMSO.  This  
loss  of  activity  of  JA1_PB  as  shown  in  Figure  3.8  suggested  the  contribution  of  LPS  in  the  






Figure  3.8:  Polymyxin  B-­treatment  of  A.  sinensis.   Immunostimulatory  
activities   of  Mock   and   Polymyxin   B-­treated  A.   sinensis   as  measured   by  
ICAM-­1  expression  using  qRT-­PCR  suggest  the  contribution  of  LPS  in  the  
herb’s  activity.  THP-­1  monocytes  were   treated  with  5µg/mL  of  JA_A  and  
JA_PB.  DMSO  was  used  as  the  negative  control.  The  bars  represent  fold  
change   as   measured   by   Relative   Quantification   (RQ),   with   the   gene  
expression  of  the  samples  being  relative  to  that  of  DMSO  treatment.  
  
3.2.3.  A.  sinensis  samples  exhibit  variable  immunostimulatory  activity  
To   test   for   the   batch-­to-­batch   variation   in   the   immune-­boosting   activity,   we  
evaluated  the  immune-­boosting  activities  of  the  three  A.  sinensis  samples,  from  different  
sources/vendors.  THP-­1  monocytes  were  treated  with  the  water  extracts  of  the  three  A.  
sinensis  samples  and  the  ICAM-­1  induction  was  measured  from  their  cDNA  using  qRT-­
PCR   (Figure   3.9).   Although,   immunostimulatory   activity   was   observed   for   all   three  
batches  of  A.  sinensis,   they  stimulated   the  monocytes  differently.  Chinese  Angelica  1  
(CA1)   was   shown   to   be   the   least   potent,   whereas   the   Japanese   Angelicas   were  
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comparatively  more  potent,  with  Japanese  Angelica  2  (JA2)  being  the  most  active.  This  
further  corroborates  with  our  hypothesis   that  different  batches  of   the  same  herb  could  
possess  differential  immunostimulatory  activities.  This  may  be  due  to  the  difference  in  the  
type  and  abundance  of  bacterial  communities  colonizing  the  herbs,  which  underscored  




Figure  3.9:   Immunostimulatory  activities  of  A.  sinensis.   The   ICAM-­1  
expression  of  the  three  A.  sinensis  samples,  Chinese  Angelica  (CA1)  and  
Japanese  Angelicas  1  and  2  (JA1  and  JA2)  were  evaluated  by  qRT-­PCR.  
THP-­1  monocytes  were   treated  with   the  samples  at  5µg/mL.  DMSO  was  
used  as  the  negative  control  whereas  JTT  (100µg/mL)  and  LPS  (0.2ng/mL)  
were  the  positive  controls.  
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3.2.4.  The  first  16S  sequencing  analysis  of  A.  sinensis  
The  Detoxi  gel  experiment  and  immunological  assays  of  three  A.  sinensis  samples  
set   the  stage   for   the  16S  sequencing  study   to   identify   the  bacteria  associated  with  A.  
sinensis.  The  preliminary  PCR  analysis  with  the  different  primer  pairs  to  amplify  bacterial  
16S   rRNA   gene,   aided   in   the   selection   of   the  most   suitable   primer   pairs   for   our   first  
Illumina  sequencing  analysis  (Figure  3.5).  The  16S  sequencing  study   incorporated  the  
three  A.  sinensis  samples,  JA1,  JA2  and  CA1,  whose  DNA  was  extracted  and  amplified  
with  the  following  primer  pairs:  fM1/rC5;;  926f/1392r;;  1114f/1392r.  The  PCR  amplicons  
were  finally  analyzed  on  agarose  gel  before  subjecting  them  to  sequencing  using  Illumina  
MiSeq  (Figure  3.10).   It  was  observed  that   two  bands  were  present  on  agarose  gel   for  
PCR   products   amplified   with   P2.   The   band   at   ∼850bp   corresponded   to   host   DNA,  
whereas   bacterial   DNA   generated   a   ∼550bp   amplicon   [33].   The   bacterial   DNA   can  
however,  be  separated  from  the  plant  DNA  on  the  agarose  gel  because  of  this  variation  
in  their  sizes.  
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Figure   3.10:   Agarose   gel   showing   PCR   amplicons   before   Illumina  
MiSeq.  The  gel   image  shows   the  PCR  amplicons   from   three  A.  sinensis  
samples,  JA1,  JA2  and  CA1  using  the  selected  the  primer  pairs  for  the  first  
sequencing  study.  The  bands  at  ~450bp   (fM1/rC5),  ~550bp   (906f/1392r)  
and  ~400bp  (1114f/1392r)  represent  bacterial  DNA.  
 
Libraries   of   16S   rDNA   amplicon   were   constructed   and   quantified   at   Genome  
Technology  Center  of  New  York  University  Langone  Medical  Center.  The  purified  PCR  
amplicons   were   then   sequenced   using   an   instrument   for   performing   Next-­Generation  
Sequencing   (NGS)   called   Illumina   MiSeq,   which   is   generally   used   for   bacterial   16S  
amplicon  sequencing  [27].  QIIME,  a  bioinformatics  pipeline,  was  employed  to  obtain  the  
























communities   were   identified   by   assignment   of   taxonomical   identities   as   Operational  
Taxonomical  Units  (OTUs)  to  different  bacteria  [34].  
The  results  from  our  first  16S  rRNA  sequencing  study  revealed  several  different  
communities  of  bacteria  associated  with   the  roots  of  A.  sinensis.   It  was  also  observed  
that   the  bacterial  population  varied  depending  on   the  A.  sinensis  sample.  This   further  
strengthens   our   hypothesis   that   there   exists   a   batch-­to-­batch   variation   with   herbal  
samples  with  regard  to  their  bacterial  populations.    
 
Figure   3.11:   First   16S   rRNA   Sequencing   analysis   of   A.   sinensis.  
Proteobacteria   and   Cyanobacteria   (chloroplast)   were   the   two   most  
abundant  phyla  revealed  in  A.  sinensis.  
 
The  most   predominant   phylum   of   bacteria  was   observed   to   be  Proteobacteria.  




co-­amplification   of   chloroplast   or   plant  DNA.   Figure   3.11   shows   both   these   abundant  
phyla  observed  as  a  result  of  sequencing  A.  sinensis.  The  figure  also  demonstrates  the  
batch-­to-­batch   variability   between   JA1,   JA2   and   CA1,   with   JA1   showing   the   most  
abundance  of  Proteobacteria  followed  by  JA2  and  CA1,  respectively.    
In  addition  to  batch-­to-­batch  variability,  there  was  also  variation  in  the  amplification  
of  bacteria  with  the  three  different  primer  pairs.  The  third  primer  pair  (P3),  1114f/1392r,  
produced  the  most  Proteobacterial  amplification.  All   three  batches  of  A.  sinensis,  JA1,  
JA2  and  CA1,  showed  better  bacterial  DNA  amplification  with  P3  (Figure  3.11).  
QIIME  analysis  of  the  16S  rRNA  sequencing  data  revealed  519  different  genera  of  
bacteria  associated  with  the  dried  roots  of  A.  sinensis.  On  closer  evaluation  of  all  these  
genera,   one   genus   seemed   significant.   This  was   the  Gram-­negative   genus  Rahnella,  
which  was  associated  with   the   roots  of  all   three  A.  sinensis  samples.   It  was   the  most  
predominant  bacterial  genus   in  all   the  samples.  Moreover,   the  abundance  of  Rahnella  
seemed  to  correlate  with  the  immune-­boosting  activity  of  the  three  samples,  suggesting  
that  Rahnella  contributes  to  the  activity  of  A.  sinensis.  Here,  AS1,  AS2  and  AS3  represent  
CA1,  JA1  and  JA2,  respectively  (Figure  3.12).  
All  reads  obtained  with  Illumina  sequencing  denote  one  Operational  Taxonomical  
Unit   (OTU).  OTU   reads   for   the  different  genera  could   indicate   the  number  of  different  
species  within  a  genus.  All  Illumina  reads  for  the  genus  Rahnella,  belonged  to  a  single  




Figure   3.12:   First   sequencing   analysis   of   A.   sinensis.   (a)   Illumina  
sequencing  revealed  519  genera  of  bacteria  associated  with   the   roots  of  
dried  A.  sinensis;;  (b)  Rahnella  was  found  to  be  the  most  predominant  genus  
in  all  three  batches  of  A.  sinensis;;  (c)  The  abundance  of  Rahnella  seemed  
to  be  associated  with  the  immune-­boosting  activity  of  all  three  samples  of  
A.  sinensis.  
  
Our   first   sequencing   analysis   provided   an   insight   into   some   of   the   bacteria  
associated   with   the   roots   of   A.   sinensis   [10].   However,   the   primer   pairs   for   16S  
amplification,   used   in   our   initial   study,   P1   (fM1/rC5),   P2   (926f/1392r),   and   P3  
(1114f/1392r)  induced  co-­amplification  of  the  plant  mitochondria  and  chloroplast  (Figure  
3.11).  The  first  study,  being  the  first  of  its  kind,  needed  to  be  further  verified.  To  this  end,  
we  planned  a  second  16S  sequencing  study  of  A.  sinensis,  which  involved  different  primer  
pairs  that  reduce  potential  co-­amplification  of  mitochondria  and  chloroplast  DNA  because  
of  base-­pair  differences  between  them.  Furthermore,  we  decided  to  increase  the  sample  
size   by   incorporating   another   batch   of  A.   sinensis,   thereby,   testing   a   total   of   four  A.  






















sample,   we   decided   to   include   another   batch   of   Chinese   Angelica   for   the   second  
sequencing  study.   
3.2.5.  Immunostimulatory  activities  of  the  four  batches  of  A.  sinensis  samples  
Since   one   A.   sinensis   sample   was   added   to   our   study,   we   examined   the  
immunostimulatory   activity   of   the   four   samples.   Water   extracts   of   the   four   different  
batches   of  A.   sinensis   were   used   to   treat   THP-­1  monocytes.   The   immunostimulatory  
activities  of  the  samples  were  evaluated  by  ICAM-­1  expression  using  qRT-­PCR.  ICAM-­1  
is  a  marker  for  immunostimulation.    
Figure   3.13   shows   the   immunostimulatory   activities   of   the   four   A.   sinensis  
samples.  The  four  samples  of  dried  roots  of  A.  sinensis  were  commercially  bought  from  
different   sources/vendors:   Japanese   Angelica   1   and   2   (JA1   and   JA2)   and   Chinese  
Angelicas  1  and  2  (CA1  and  CA2).  DMSO  was  used  as  a  vehicle  control,  and  Escherichia  
coli  LPS  at  a  low  concentration  of  0.2ng/mL  and  JTT  at  100µg/mL  were  used  as  positive  
controls.   E.   coli   LPS   is   a   well-­known   potent   immunostimulant,   and   even   at   low  
concentrations,   it  can  generate  an   immune  response   [35,  36].  There  was  a  significant  
variation  in  the  immunostimulatory  activities  of  A.  sinensis  in  terms  of  their  origin.  The  two  
Japanese   Angelicas,   JA1   (77-­fold)   and   JA2   (128-­fold),   seemed   to   stimulate   THP-­1  
monocytes   significantly   higher   than   the   two   Chinese   Angelicas,   CA1   and   CA2,  




Figure  3.13:  ICAM-­1  expression  of  four  A.  sinensis  samples  evaluated  
by  qRT-­PCR.  THP-­1  cells  were  treated  with  A.  sinensis  samples  (5μg/mL),  
LPS   (0.2ng/mL)   and   JTT   (100µg/mL)   for   four   hours.   JAs   showed  
significantly  higher  immunostimulatory  activities  with  JA1  (77-­fold)  and  JA2  
(128-­fold)  than  CAs  at  nearly  12-­fold  as  compared  to  DMSO.  
 
3.2.6.  Selection  of  primers  for  the  second  16S  sequencing  
The   first   16S   sequencing   study   observed   the   co-­amplification   of   plant  
mitochondrial  and  chloroplast  18S  DNA,  even  though  the  study  used  primer  pairs   that  
had  been  previously  employed  to  amplify  bacterial  16S  rRNA  gene   in   the  presence  of  
plant  DNA.  To   reduce  potential   co-­amplification  of  plant  mitochondrial  and  chloroplast  
18S  DNA,  the  second  16S  sequencing  study  employed  different  primer  pairs.  The  primer  
pairs  were  designed  based  on  the  reported  base-­pair  differences  between  the  plant  DNA  
(i.e.,  mitochondrial  and  chloroplast    DNA)  and  the  bacterial  16S  rRNA  (Figure  3.14)  [37].  
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The   primer   pairs,   27F/338R   (P1),   799F/1114R   (P2)   and   1114F/1392R   (P3)   were  
selected.  Among  these,  P3  was  also  used  in  the  first  sequencing  study  [10].  In  particular,  
P2   contains   the   maximum   number   of   base-­pair   differences   between   the   bacteria  
sequence  to  be  amplified  by  the  primers  and  the  chloroplast  and  mitochondria  sequences.      
  
Figure   3.14:   Selection   of   primer   pairs   for   second   16   sequencing  
analysis.  The  first  two  primer  pairs  (shown  by  red  and  green  boxes)  reduce  
the   co-­amplification   of   mitochondria   and   chloroplast   due   to   base-­pair  
differences   with   the   primer   and   bacterial   sequences,   whereas   the   third  
primer  pair  (shown  in  turquoise  blue  box)  was  used  in  the  first  sequencing  
study  as  P3.  It  was  selected  again  as  a  reference  for  the  second  sequencing  
study.  
  
The  new  primer  pairs  were  used  to  amplify  bacterial  DNA  from  the  four  A.  sinensis  
samples  and  the  PCR  amplicons  were  analyzed  on  agarose  gel  to  test  the  suitability  of  
the  new  primer  pairs  to  detect  bacterial  DNA  (  
Figure  3.15).  The  presence  of  bacterial  DNA  was  confirmed  with  the  bands  on  the  




Figure   3.15:   Agarose   gel   showing   PCR   products   before   second  
Illumina  MiSeq  study.  The  gel  image  shows  the  PCR  amplicons  from  four  
A.   sinensis   samples,   JA1,   JA2,  CA1  and  CA2  using   the   selected  primer  
pairs   for   the  second  sequencing  study.  The  bands  at  ~310bp   (27f/338r),  





































3.2.7.  The  second  16S  sequencing  analysis  of  A.  sinensis  
The  second  16S  sequencing  analysis  of  A.  sinensis   generated  a  much  greater  
wealth  of  information  as  compared  to  the  first  study.  The  study  revealed  31  different  phyla  
associated  with  the  dried  roots  of  the  herb,  as  well  as  approximately  850  different  genera  
of  microorganisms  (Figure  3.16).  In  the  subsequent  sections  (3.2.7.1  -­  3.2.7.4),  observed  
microbial  communities  are  analyzed  at  different  taxonomical  levels.  
  
  
Figure  3.16:  Taxonomic  information  with  second  16  rRNA  Sequencing  
analysis.  HTS  with  Illumina  MiSeq  revealed  859  genera  of  different  bacteria  





3.2.7.1.  Diversity  of  bacteria  in  A.  sinensis  at  the  phylum  level  
The  second  sequencing  study,  similar   to   that   for   the  first  study,  gave  an   insight  
about  the  two  most  abundant  phyla,  Proteobacteria  and  Cyanobacteria  (chloroplast)  as  
shown  in  Figure  3.17.      
  
Figure  3.17:  16S  rRNA  Sequencing  analysis  of  all  four  A.  sinensis  with  
three  different  primer  pairs.  The  most  abundance  of  Proteobacteria  was  
observed  by  P2  amplification  (799f/1114r)  for  all  four  A.  sinensis  samples.  
 
However,  since  there  still  was  chloroplast  co-­amplification  with  bacterial  DNA,  to  
obtain   the  most   informative  results,   first,  we  removed  cyanobacteria   (chloroplast)   from  
the  phyla  classification.  Next,  the  top  phyla  obtained  in  this  study  were  compared.  Figure  
3.18  demonstrates  the  predominance  of  Proteobacteria  in  all  four  A.  sinensis  samples.  
Additionally,  among   the  other  phyla,   the  Chinese  Angelicas  also  enrich  Actinobacteria  
and  Firmicutes.  Since,  for  the  second  sequencing  study,  P2  (799f/1114r)  amplified  the  




Figure  3.18:  Diversity  at  the  phylum  level.  The  most  relative  abundant  
phylum  was  Proteobacteria,   after   removing  chloroplast  and  mitochondria  
from  the  data.  
 
3.2.7.2.  Diversity  of  bacteria  in  A.  sinensis  at  the  class  level  
The   first   sequencing   study   had   identified   a   Proteobacterial   species   as   being  
predominantly  enriched  in  A.  sinensis  [10].  We,  therefore,  looked  closely  at  all  classes  of  
Proteobacteria,   since   it   was   the   most   abundant   phylum   in   this   study   as   well.  
Alphaproteobacteria  was  observed  to  be  enriched  the  most  in  all  four  samples,  however,  
on  careful  examination,  it  was  observed  that  the  Alphaproteobacteria  corresponded  to  the  
Rickettsia  mitochondria  at   the   family   level.  Therefore,  we   looked  at   the  class  diversity  




Figure   3.19:   Diversity   at   the   class   level.   The   class   level   diversity   of  
bacteria  showed  the  predominance  of  Gammaproteobacteria  in  all  four  A.  
sinensis   samples.   Alphaproteobacteria   was   excluded   from   this   graph  
because  of  mostly  Cyanobacterial  predominance  in  the  class.  
 
The  most   abundant   class   was   observed   to   be   Gammaproteobacteria,   and   the  
relative  abundance   indicates  a  correlation  with   the   immunostimulatory  activities  of   the  
four  A.  sinensis  samples  (Figure  3.13).  To  this  end,  we  looked  at  Gammaproteobacteria  
closely  with  all  three  primer  pairs.  P2  showed  a  significant  difference  in  the  abundance  of  
Gammaproteobacteria   identified   in   JA1   and   JA2,   when   compared   to   CA1   and   CA2  
(Figure  3.20).  A  similar  trend  was  also  seen  with  the  other  two  primer  pairs,  P1  and  P3,  
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however,  the  abundance  of  Gammaproteobacteria  identified  with  them  was  notably  lower  




Figure   3.20:   Abundance   of   Gammaproteobacteria   with   P2.   The  
abundance  or  total  count  of  Gammaproteobacteria  amplified  with  P2  for  all  
four  A.   sinensis   samples  was  higher   for   the   two   Japanese  Angelicas  as  






3.2.7.3.  Diversity  of  bacteria  in  A.  sinensis  at  the  order  level  
At  the  next  taxonomical  level,  or  the  order  level,  we  observed  the  predominance  
of   Rickettsiales,   which   falls   under   the   class   Alphaproteobacteria.   This   order   mostly  
incorporates  mitochondria.  However,  moving  to  the  next  most  relative  abundant  order,  for  
the   two   Japanese   Angelicas,   Enterobacteriales   and   Psuedomonadales   (under   class  
Gammaproteobacteria),  and  for  the  two  Chinese  Angelicas,  Burkholderiales  (under  class  




Figure   3.21:   Diversity   at   the   order   level.   The   top   ten   orders   were  
categorized   for  all   four  A.  sinensis  samples.  Chinese  Angelicas  enriched  
mostly   Burkholderiales   whereas   the   Japanese   Angelicas   enriched   the  
orders,  Enterobacteriales  and  Psuedomonadales.  
  
3.2.7.4.  Diversity  of  bacteria  in  A.  sinensis  at  the  genus  level  
The  first  Illumina  sequencing  study  identified  Rahnella  as  the  most  predominant  
genus  associated  with   the  dried   roots  of  A.  sinensis   (Figure  3.12).  An  examination  of  
some   of   the  most   relative   abundant   genera   in   the   second   sequencing   analysis   of  A.  
sinensis   revealed  Pseudomonas   along   with  Rahnella   in   all   four   batches   of   the   herb.  
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Another   genus,   Paenibacillus   was   also   observed   to   be   relative   abundant   in   the   two  
Chinese  Angelicas,  CA1  and  CA2  (Figure  3.22).    
The   second   sequencing   study   identified   Pseudomonas   as   another   group   of  
bacteria   associated   with   immune-­boosting   effects.   However,   since   the   genus  
Pseudomonas  incorporates  numerous  species  within  this  genus,  it  was  easier  to  focus  
on  R.  aquatilis.  
 
  
Figure  3.22:  Diversity  at  the  genus  level.  The  top  genera  observed  in  all  
four  A.  sinensis  batches.  Rahnella  and  Pseudomonas  were  among  the  most  
relative  abundant  genera.  
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3.3.  DISCUSSION  
Plants  harbor  diverse  microbial  communities  within  themselves  (endophytes),  on  
their   surface   (epiphytes)   or   in   the   soil   where   they   grow   (rhizosphere).   Plant-­microbe  
interactions   have   been   studied   extensively   for   several   reasons.   Most   studies   have  
focused  on  microbes  that  are  pathogenic  to  their  host  plants,  while  others  have  been  on  
microbes  with  plant  growth-­promoting  properties  that  help  the  host  plant  against  infections  
from  other  microbes  [38].  Yet  some  other  studies  have  shown  that  microbes  may  provide  
benefits  not   just   to  the  plants  they  inhabit,  but  also  to  human  beings  and  animals  who  
consume   these   plants.   However,   interactions   of   microbes   with   medicinal   herbs   is   a  
relatively  newer  field  of  research  that  has  garnered  interest  over  the  last  few  years.    
Prior  to  this  research,  and  research  by  other  groups,  pharmacological  studies  on  
medicinal  plants  mostly  focused  on  secondary  metabolites  or  other  compounds  derived  
from  plants.  However,  with  the  knowledge  of  bacteria  associated  with  medicinal  plants  as  
the  contributors  of  active  factors  that  stimulate  the  immune  system,  the  course  of  natural  
products  research  has  shifted  from  plants  to  bacterial  metabolites.  Such  immune-­boosting  
bacteria  or  herbal  probiotics  were  shown  to  contribute  to  the  immunostimulatory  activity  
of  the  component  herb  of  JTT,  and  consequently  JTT  itself.    
3.3.1.  What  are  the  “immune-­boosting”  bacteria  in  medicinal  plants?    
The   identities   of   these   immune-­boosting   bacteria   were   not   known   prior   to   our  
research.  The  most  exciting  outcome  of  this  study  was  the   identification  of  potential  
immune-­boosting  bacteria.  The  16S  surveys  of  the  bacteria  associated  with  the  herb,  
A.   sinensis,   for   the   first   time   identified   a   bacterial   species   that   is   associated  with   the  
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activity  of  the  medicinal  herb.  Our  study,  to  our  knowledge,  was  the  first  to  characterize  
and   identify   the  potential   immune-­boosting  bacterial   populations   in   a  medicinal  
plant.    
Even  with  different  primer  pairs  used  in  the  two  sequencing  studies,  there  were  
some   certain   bacterial   genera   that   were   consistently   observed   associated   with   A.  
sinensis.  With  both   first   and  second  sequencing  studies,  Rahnella   and  Pseudomonas  
remained  the  most  predominant  genera.  Although,  these  two  were  the  most  predominant,  
we  cannot  ignore  the  presence  of  other  genera.  The  presence  of  other  genera  such  as  
Bacillus,   Erwinia,   Paenibacillus   and   Agrobacterium   was   consistently   shown   in   both  
studies.  While  most  of  these  belonged  to  the  class  Gammaproteobacteria,  some  genera  
such   as  Bacillus  and  Paenibacillus   represent  Gram-­positive   bacteria.  Paenibacillus   is  
known  to  be  plant-­growth  promoting  while  also  being  a  producer  of  siderophores  and  of  
medicinal  value.  It  might  be  worthwhile  to  explore  some  of  these  other  genera.  However,  
as  they  include  more  than  one  species,  we  decided  to  focus  on  just  Rahnella  aquatilis  for  
now,  since  it  was  the  only  OTU  obtained  from  this  genus  (Figure  3.12).  
Like   LPS   of   Gram-­negative   bacteria,   Gram-­positive   bacteria   also   present  
glycolipids  on   their   surface.  Gram-­positive  bacteria   possess   lipotechoic  acid   (LTA)  on  
their  cell  membrane  that  serves  as  an  anchor  to  the  peptidoglycan  layer.  LTA  is  known  to  
elicit  an  immunostimulatory  response  by  the  induction  of  cytokines  such  as  TNF-­a  and  
IL-­12  [39,  40].  It  generates  an  immune  response  by  activating  immune  cells  through  the  
Toll-­like  receptor-­2  (TLR-­2)  [41,  42].  
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R.  aquatilis  was  observed  as  the  most  predominant  species  in  all  three  samples  of  
A.   sinensis   in   the   first   sequencing   study.   R.   aquatilis   is   a   Gram-­negative  
Gammaproteobacteria  belonging  to  the  Enterobacteriaceae  family.  The  abundance  of  R.  
aquatilis  observed  in  the  three  batches  of  A.  sinensis  seemed  to  be  associated  with  the  
immune-­boosting  activities  of  the  three  samples  as  well,  indicating  that  the  bacteria  could  
be  an  “immune-­boosting”  species  itself.  Our  efforts  in  characterizing  the  LPS/LA  from  R.  
aquatilis  will  be  discussed  in  the  next  chapter.    
The   relative   abundance   of   Pseudomonas   and   Rahnella,   taken   together   may  
account  for  the  immune-­boosting  activities  of  the  four  A.  sinensis  samples  (Figure  3.13  
and   Figure   3.22).   The   presence   of   Gammaproteobacteria   has   been   shown   in   other  
medicinal  herbs  like  Echinacea  and  medicinal  mushrooms.  In  addition  to  that,  the  total  
bacterial   load   present   in   Echinacea   has   been   correlated   with   its   immune-­boosting  
activities  [5,  43,  44].  
3.3.2.  What  is  the  origin  of  batch-­to-­batch  variability?    
Another  objective  of   the  sequencing  studies  was   to  assess   the  batch-­to-­batch  
variability  of  A.  sinensis.  In  both  studies,  a  substantial  variation  in  bacterial  populations  
was   observed   from   sample   to   sample   even  with   the   same   herb.   It   was   therefore,   no  
wonder  that  the  immune-­boosting  activities  varied  significantly  for  the  different  batches  of  
A.  sinensis.  Microbial  populations  of   the  same  species  could  be   influenced  by  several  
factors  like  location  of  the  herb  due  to  environmental  factors  such  as  growing  conditions,  
pH  and  moisture  content  of  the  soil,  temperature,  time  or  season  of  harvest,  and  other  
such  parameters  [43].  The  batch-­to-­batch  variability  in  terms  of  the  bacterial  communities  
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they  harbored,  thus  further  strengthened  our  hypothesis  that  bacteria  might  be  associated  
with  the  immune-­boosting  activities  of  medicinal  plants.  
As  mentioned   previously,   batch-­to-­batch   variability   within   the   same   herb   is   an  
important  concern  associated  with  herbal  medicine.  In  this  regard,  the  variability  could  
be  used  to  address  standardization  issues  of  medicinal  herbs.  The  standardization  
of  herbal  medicine  was  previously  done  with  the  most  abundant  chemical  derived  from  
the  plants.  Now  that  we  know  what  kind  of   immune-­boosting   taxa  are  associated  with  
medicinal  plants,  it  may  be  possible  to  predict  the  immune-­boosting  effects  of  herbs  using  
qPCR   assays   targeting   the   specific   taxa.   Such   an   assay   to   target   and   quantify   the  
immune-­boosting  bacterial  taxa  will  open  the  possibility  of  standardizing  medicinal  herbs  
in  a  better  and  effective  manner.    
3.3.3.  Technical  challenges  in  16S  sequencing  of  plant  samples.    
3.3.3.1.  Primer  Design  
Even   with   all   the   information   the   studies   generated,   they   also   opened   new  
questions  that  we  could  attempt  to  answer  in  the  future.  The  primers  used  in  this  study  
were  meant   to   target   the  amplification  of  bacterial  DNA.  However,  some  of   the  primer  
pairs  used  in  the  two  sequencing  studies  failed  to  amplify  bacterial  DNA,  and  instead  led  
to  a  co-­amplification  of  plant  mitochondria  and  chloroplast  DNA.  As  mentioned  previously,  
the  challenge  to  isolate  and  sequence  bacterial  DNA  in  the  presence  of  plant  DNA  is  a  
very  real  and  important  problem.  Plant  DNA,  being  more  abundant  in  such  samples,  may  
overpower  the  smaller  quantities  of  bacterial  DNA  present  in  these  plants.  To  overcome  
this  technical  problem,  designing  better  primer  pairs  that  reduce  co-­amplification  of  plant  
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DNA   may   be   better   suitable   for   gaining   more   information   about   the   plant-­colonizing  
bacteria.  
Primer   region  also  needs   to  be   taken   into  consideration  when  designing  primer  
pairs   for   sequencing   analysis   of   bacteria   from   environmental   and   plant   samples.  
Amplification   of   V4-­V6   variable   regions   of   the   16S   rRNA   gene   provides   the   most  
consistent  results  by  amplifying  predominantly  almost  all   the  Proteobacteria  (Appendix  
B).    
Metagenomics   analysis   from   environmental   and   plant   samples   still   poses   a  
challenge.  Characterization  of  bacteria  associated  with  plant  samples  is  greatly  hindered  
by   the   amplification   of   mitochondrial   and   chloroplast   DNA   of   the   host   plant.   The   co-­
amplification   of   plant   mitochondria   and   chloroplast   DNA   posed   a   significant   problem  
during  both  the  sequencing  studies.  To  this  end,  we  developed  a  novel  primer  pair,  P2  
(799f/1114r)  in  our  second  sequencing  study,  which  gave  much  better  amplification  of  
diverse  bacteria  like  Proteobacteria  and  other  classes,  while  minimizing  the  chloroplast  
and  mitochondrial  contamination  from  the  plants.  The  novel  primer  pair  proved  to  be  a  
much  superior  choice  than  the  existing  primer  pairs  used  in  the  study.  
To  overcome   the  problem  of  co-­amplification  of  host  DNA  entirely,  several  new  
directions  may  be   taken   for   future  sequencing  studies  with  A.  sinensis  or  other  herbs.  
First,  with   sequence   information   on   hand,   better   primers  may   be   designed   that   could  
selectively   amplify   the   region   that   is   unique   to   the   target   of   interest.   This   has   been  
previously  shown  for  other  bacteria  such  as  to  target  and  amplify  Pseudomonas  [45,  46].  
Several  software  can  now  help  design  primer  pairs  based  on  base-­pair  uniqueness  to  the  
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bacteria   that   need   to   be   amplified   or   identified   in   environmental   samples.   Multiple  
sequence  alignment  of  the  sequences  of  the  primer  pairs,  chloroplast  and/or  mitochondria  
and  those  of  the  target  bacteria  could  identify  selected  regions  where  the  primers  would  
anneal  to  the  bacteria  but  not  host  DNA.  MultiAlign,  NCBI  Primer-­BLAST  and  Primer  Map  
are  some  of  the  many  available  free  software  for  designing  or  testing  the  effectiveness  of  
primers   [47,   48].  Second,   chloroplast   and  mitochondria   co-­amplification   could  also  be  
eliminated  using  peptide  nucleic  acid  (PNA)  during  PCR  [31].  PNA  are  synthetic  clamps  
that   bind   to   host   DNA,   and   thereby   block   both   mitochondria   (mPNA)   and  
chloroplast/plastid  (pPNA)  from  interfering  with  bacterial  amplification.  
3.3.3.2.  Annealing  temperature  for  PCR  amplification  
Since  P3  worked  the  best  for  us  in  the  first  16S  sequencing  study,  there  must  be  
a  reason  for  it  not  working  as  well  for  the  second  study.  One  major  difference  between  
the  two  Illumina  MiSeq  runs  was  in  the  procedure  adopted  for  PCR  amplification  of  16S  
rRNA  gene.  A  different  annealing  temperature  was  used  in  both  studies  during  the  PCR  
amplification  step  of  bacterial  DNA  (Table  3.3).  The  first  study  made  use  of  a  gradient  
PCR,  in  which  the  temperature  gradually  increased  during  the  annealing  step  at  a  rate  of  
0.2ºC/sec.  This  allowed  the  three  different  primer  pairs  to  anneal  at  different  temperatures  
that  were  suitable  to  each  of  them  individually.    
The  second  sequencing  study  utilized  a  standard  protocol  for  amplification  of  16S  
rDNA   from   environmental   samples   was   used,   which   included   specific   annealing  
temperatures  as  specified  by  the  Earth  Microbiome  Project  (EMP)  [49].  This  might  have  
been  the  reason  for  P3  not  working  as  well  as  the  first  sequencing  study,  since  it  was  
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different   from   the   standard   default   primers   specified   for   such   amplifications.   This  
temperature  difference  can  lead  to  primers  not  annealing  to  the  bacterial  16S  rRNA  gene  
and  therefore,  leading  to  non-­amplification  of  bacteria.  This  is  seen  in  Error!  Reference  
source  not  found.  where  most  of  the  amplification  seen  by  P3  is  that  of  host  chloroplast  
DNA,   and   not   Proteobacteria.   Under   the   conditions   used   for   the   second   sequencing  
study,  P2  gave  the  best  results  with  most  Proteobacteria  and  least  plant  chloroplast  DNA  
being  amplified.  This  suggests  that  in  standard  PCR  conditions,  this  new  primer  pair  may  
amplify  bacterial  16S  rDNA,  and  thus,  could  be  used  as  a  novel  primer  pair  for  bacterial  
amplification  and  identification.    
In   conclusion,   the   sequencing   of   A.   sinensis   led   to   the   discovery   of   potential  
immune-­boosting  bacteria  such  as  R.  aquatilis.  The  next  chapter  will  therefore,  describe  
the  isolation  and  immunological  characterization  of  active  fraction  from  this  bacterium.      
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3.4.  MATERIALS  AND  METHODS  
3.4.1.  Cell  Culture  
Refer  to  Chapter  2  (page  50)  
3.4.2.  RNA  purification  and  RT  
Refer  to  Chapter  2  (page  51)  
3.4.3.  qRT-­PCR  
Refer  to  Chapter  2  (page  53)  
3.4.4.  Water  Extracts  of  A.  sinensis      
The   immune-­boosting  activities  of   the   four  A.   sinensis  samples  were  assessed  
using   THP-­1   cell   line.   THP-­1   cells   (500,000   cells/   2mL)   were   treated   with   the   water  
extracts  of  each  of  the  four  herb  samples  along  with  DMSO  (negative  control)  and  LPS  
at  0.2ng/mL  and  JTT  at  100µg/mL  as  the  positive  controls.  The  cells  were  lysed  after  four  
hours  of   incubation  at  37ºC  and  5%  CO2.  RNA  was  purified   from   the  cell   lysates  and  
converted  to  cDNA  with  Reverse  Transcription  (RT).  The  cDNA  samples  were  subjected  
to   Quantitative   Real-­Time   Polymerase   Chain   reaction   (qRT-­PCR)   to   quantify   ICAM-­1  
expression.  ICAM-­1  is  a  marker  for  immunostimulation.    
3.4.5.  DNA  Extraction  
A.  sinensis  samples  purchased   from  different  vendors  were  used   for   the  study.  
The  dried   roots  were  ground   into  a  powder  containing  2-­5mm  particles  using  a  coffee  
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bean  grinder.  DNA  was  extracted  from  the  herbal  samples  using  the  MoBio  PowerLyzer®  
PowerSoil®  DNA  Isolation  Kit  following  the  instructions  of  the  kit  with  a  few  modifications.  
Following   the   protocol,   DNA   was   finally   eluted   in   50µL   of   Solution   6   (Elution   Buffer  
provided  in  the  Kit),  and  further  quantified  using  Nanodrop®  to  obtain  approximately  1.2-­
1.6µg  of  DNA  per  sample.  DNA  extraction  was  carried  out  in  three  independent  replicates  
for  each  of  the  A.  sinensis  samples.  
3.4.6.  DNA  Amplification  with  PCR  
DNA  was  amplified  using  primer  pairs  that  selectively  amplify  the  16S  rRNA  gene  
in  bacteria.  16S  rRNA  gene  is  a  phylogenetic  marker  for   identification  of  bacteria.  The  
first  sequencing  study  examined  three  different  primer  pairs,  namely,  P1  (fM1/rC5),  P2  
(926f/1392r)  and  P3   (1114f/1392r).  Primer  sequences  are  given  below.  Primer  design  
also   included   overhangs   for   Illumina   sequencing   for   each   of   the   forward   and   reverse  
primers.  The  overhang  sequences  are  also  shown  in  the  table  below.  PCR  reactions  were  
performed  with  100ng  of  extracted  DNA.  The  PCR  reaction  mix  incorporated  the  following  
components   for   a   25µL   reaction:   12.5µL  KAPA  HiFi   HotStart   Ready  Mix   (2X)   (KAPA  
Biosystems;;  Catalog  #  KR0370),  1µL  forward  primer,  1µL  reverse  primer,  100ng  template  




Component   Volume  
KAPA  HiFi  HotStart  Ready  Mix  (2X)   12.5  µL  
Forward  primer   1  µL  
Reverse  primer   1  µL  
Template  DNA   Required  volume  for  100ng  
Nuclease  free  water   Adjusted  to  make  25µL  mixture    
Table   3.1:  PCR  Reaction  Mixture.   The   components   were   combined   to  






Primer   Sequence  
Overhang  for  Forward  primer   5’-­tcgtcggcagcgtcagatgtgtataagagacag-­3  
Overhang  for  Reverse  primer   5’-­gtctcgtgggctcggagatgtgtataagagacag-­3’  
926f   5’-­aaactyaaakgaattgacgg-­3’  
1114f   5’-­gcaacgagcgcaaccc-­3’  
1392r   5’-­acgggcggtgtgtrc-­3’  
fM1   5’-­ccgcgtgnrbgahgaaggyyyt-­3’  
rC5   5’-­taatcctgtttgctccccac-­3’  
27f   5’-­agagtttgatcntggctcag-­3’  
338r   5’-­catgctgcctcccgtaggagt-­3’  
799f   5’-­aacmggattagataccckg-­3’  
1114r   5’-­  gggttgcgctcgttgc-­3’  
1492R   5’-­ggntaccttgttacgactt-­3’  
Table   3.2:   Primers   for   Illumina   sequencing.   The   forward   and   reverse  
primers   used   for   both   16S   rRNA   sequencing   studies   along   with   the  
overhangs  are  listed  in  the  table.  
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The  following  table  lists  all  the  differences  between  the  two  Illumina  sequencing  
studies:  
First  Study   Second  Study  
A.  sinensis  samples:  3   A.  sinensis  samples:  4  
Samples:  CA1,  CA2,  JA1   Samples:  CA1,  CA2,  JA1,  JA2  
Primer  pairs:  3   Primer  pairs:  3  
Primer  pairs:    fm1/rc5;;  
926F/1392R;;  1114F/1392R  
Primer  pairs:    27F/338R;;  
799F/1114R;;  1114F/1392R  
PCR  Conditions:  Annealing  
temperature  gradient  
PCR  Conditions:  Standard  
Annealing  temperature  fixed  
Table   3.3:   Comparison   between   First   and   Second   16S   rRNA  
sequencing  studies.   The   two   sequencing   studies   incorporated  different  
samples,  different  primers  and  variation  in  the  PCR  conditions  for  bacterial  
amplification.  
  
3.4.6.1.  PCR  Conditions  (first  sequencing  study)  
Step   Temperature   Time   Cycles  
Initial  denaturation   95ºC   3  minutes   -­  
Denaturation   95ºC   30  seconds   30  
Annealing  Ramp   50-­58ºC  
(0.2ºC/second)  
45  seconds   30  
Extension   72ºC   1  minute   30  
Final  extension   72ºC   10  minutes   -­  
Table   3.4:   PCR   conditions   for   first   sequencing   study.   The   PCR  
conditions  included  a  temperature  ramp/gradient  for  the  annealing  step.  
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3.4.6.2.  PCR  Conditions  (second  study):  As  specified  by  Earth  Microbiome  Project  
Step   Temperature   Time   Cycles  
Initial  denaturation   94ºC   3  minutes   -­  
Denaturation   94ºC   45  seconds   35  
Annealing  Ramp   50ºC     60  seconds   35  
Extension   72ºC   90  seconds   35  
Final  extension   72ºC   10  minutes   -­  
Hold   4ºC        
Table   3.5:   PCR   conditions   for   second   sequencing   study.   The   PCR  
conditions  included  a  constant  temperature  for  the  annealing  step.  
  
3.4.7.  Gel  Electrophoresis  
The  PCR  amplicons  were  analyzed  by  agarose  gel  electrophoresis  using  a  2%  
agarose  gel.    
3.4.8.  QIIME  Analysis  
The  software  package  Quantitative   Insights   Into  Microbial  Ecology  (QIIME)  was  
employed   for   analysis   of   the  NGS  data   from   Illumina  MiSeq.  Amazon  BaseSpace   for  
Illumina   was   used   to   access   the   data   and   the   codes/scripts   were   written   using   the  
programming   language,   Python   to   analyze   the   data.   Microbial   communities   were  
identified   by   assignment   of   taxonomical   identities   as   Operational   Taxonomical   Units  
(OTUs)  to  different  bacterial  families.  The  database  GREENGENES  was  used  to  assign  
OTUs  to  the  microorganisms  identified  by  Illumina.  Certain  parameters  such  as  sampling  
depths  were  modified  during  the  data  analysis  for  the  second  sequencing  study  to  obtain  
the  most  information  from  the  sequencing  data.    
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3.4.9.  Bacterial  culture  from  A.  sinensis  
Bacteria  were  isolated  from  A.  sinensis  to  study  the  culturable  bacterial  species.  
A.  sinensis  was  soaked  in  Difco  Nutrient  Broth  and  different  amounts  of  this  medium  were  
used   for  spreading  on  agar  plates  prepared  with  Difco  Nutrient  Agar.  The  plates  were  
incubated  at  room  temperature  for  48-­72  hours.  Diverse  bacterial  species  appeared  on  
the  agar  plates  with  35  µL  of  A.  sinensis-­medium  (Appendix  G).    
Using  autoclaved   toothpicks  pure  colonies  were  picked  and   inoculated   in   liquid  
medium   in   a   96-­well   plate   and   incubated   at   room   temperature   for   48-­72   hours.   3mL  
cultures  were  then  prepared  from  the  cultures  grown  in  the  96-­well  plate,  and  incubated  
in  a  shaker  incubator  at  room  temperature  with  constant  agitation  at  400rpm  or  revolutions  
per  minute.  After  incubation  period  of  48  hours,  the  3mL  cultures  were  used  to  prepare  
glycerol   stocks   with   50%  Glycerol   and   stored   at   -­80°C.   These   glycerol   stocks   of   the  
diverse  bacteria  cultured  from  A.  sinensis  will  later  be  used  for  sequencing  using  specific  
primers  to  determine  the  bacterial  species  isolated  from  the  herb.   
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“It  is  not  the  strongest  of  the  species  that  survives,  nor  the  most  intelligent  that  






Chapter  4    
4.1.  INTRODUCTION  
Pathogen-­associated   molecular   patterns   (PAMPs)   are   structurally   conserved  
molecular  motifs  produced  by  pathogenic  microbes.  PAMPs  are  recognized  by  pattern-­
recognition  receptors  (PRRs)  of  immune  cells  in  a  highly  sensitive  manner.  Recognition  
of   PAMPs   by   PRRs   triggers   rapid   immunological   responses   to   prevent   infection.  
Lipopolysaccharides  (LPSs)  of  Gram-­negative  pathogens  are  well-­known  PAMPs,  as  well  
as  a  potent  immunostimulants.  Lipid  A  (LA)  is  the  endotoxin  portion  of  LPS,  and  is  mainly  
responsible  for  the  bioactivity  and  endotoxicity  of  LPS.  
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Figure   4.1:   Basic   structural   backbone   of   Lipopolysaccharide.   LPS  
consists  of  three  components:  O-­Antigen,  core  polysaccharide  and  the  Lipid  
A  region.  LA  is  the  component  mostly  responsible  for  the  activity  of  LPS.  
 
The  basic  backbone  of  LPS  is  highly  conserved  among  different  Gram-­negative  
bacteria  as  shown  in  Figure  4.1:  
1.   Core  polysaccharide.  The  core  region  of  LPS  consists  of  two  regions:  the  
inner  core  and  the  outer  core.  The  inner  core  region  in  most  Gram-­negative  
bacterial  LPS  is  composed  of  a  sugar  moiety  known  as  3-­Deoxy-­D-­manno-­
oct-­2-­ulosonic  acid  (KDO)  and  1-­glycero-­d-­manno-­heptose  residues  linked  
to  LA  at  the  5’  position  [1].  The  outer  core  region  is  made  up  of  repeating  
variable  hexose  residues  and  aids  in  the  attachment  to  the  O-­antigen  [2].  
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2.   O-­Antigen.   The   O-­Antigen   or   O-­polysaccharide   (OPS)   are   made   up   of  
repeating  disaccharide  subunits,  with   their  monosaccharides  attached  by  
single   glycosidic   linkages   [3].   Complex   O-­antigens   may   contain  
homopolysaccharide   or   heteropolysaccharide   units   linked   by   glycosidic  
linkages   or   a   combination   of   sugar   or   non-­saccharide  moieties   such   as  
amino  acids,  respectively  [1].  Due  to  the  complexity  of  the  polysaccharide  
portion,  the  O-­antigen  or  OPS  is  a  highly  variable  region.    
3.   Lipid  A  (LA).  LA  is  known  as  the  endotoxin  portion  of  LPS,  and  is  thereby  
responsible  for  most  of  the  activity  exerted  by  the  entire  LPS  molecule  [4,  
5].  The  structure  of  LA  is  highly  conserved  in  most  Gram-­negative  bacteria,  
with  minor  structural  modifications  present  within  different  bacterial  species.  
These   structural   modifications   may   lead   to   different   activities   of   the  
molecule  as  well  as  different  fates  of  LA.    
LA  is  a  di-­glucosamine  phospholipid  typically  containing  1-­2  phosphate  moieties  
and   2-­4   nitrogens.   In   addition   to   these,   there   are   a   large   number   of   carbons   and  
hydrogens  due  to  the  presence  of  3-­7  fatty  acyl  chains  attached  to  the  di-­glucosamine  
backbone  [6,  7].  The  length  and  number  of  the  fatty  acyl  chains  could  vary  in  different  
bacterial  species.  The  general  structure  of  endotoxic  LA  is  shown  below  (Figure  4.2).  The  
molecule  is  generally  1500-­2500  Da  in  size  and  has  a  molecular  formula  similar  to  that  of  
E.  coli  LA,  C94H178N2O25P2  [8].  
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Figure  4.2:  E.  coli  Lipid  A.  The  LA  of  the  pathogenic  bacteria  consists  of  
a  di-­glucosamine  backbone  with  two  phosphates  and  six  acyl  chains.  
 
The   function  of  LA   for   the  bacteria   is  structural  attachment  and  protection.  The  
hydrophobic  fatty  acyl  chains  behave  as  anchor  to  attach  LPS  to  the  outer  membrane  of  
Gram-­negative  bacteria  [9].  It  also  acts  as  a  signaling  molecule  in  the  human  body  and  
may  be  sensed  by  the  immune  system  in  the  case  of  a  bacterial  infection.  Although  LPS  
is  generally  considered  an  endotoxin  and  could  lead  to  a  septic  shock  or  even  death,  in  
smaller  amounts  it  is  considered  of  interest  as  an  immunomodulatory  agent  [10,  11].  
The   LA   structure   is   generally   conserved   in   most   bacteria;;   however,   it   may  
incorporate   small   variations   leading   to   different   immunological   characteristics.   Some  
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common   LA   structures   of   different   bacteria   are   shown   below   (Figure   4.3).   The  most  
variations   are   observed   in   the   length   and   number   of   fatty   acyl   chains   as  well   as   the  
number   of   phosphate   groups   present   [12].   Like  E.   coli,  Salmonella   minnesota   R595  
species  possesses  a  LA,  which  is  endotoxic  in  nature.  This  LA  structure,  when  modified  
by  removing  an  acyl  chain  and  a  phosphate  moiety  leads  to  a  detoxified  version,  known  
as  monophosphorylated  LA  (MPL).  The  absence  of  phosphates  in  the  LA  of  Rhizobium  
etli,  a  nitrogen-­fixing  bacterium,  leads  to  no  toxicity  or  even  endotoxic  antagonism  [13].  
 
Figure  4.3:  Structural  variations   in  LA   in  different  bacterial  species.  
Modifications   to   the  structure  of  LA  such  as  number  of  phosphates,  and  
length  and  number  of  acyl  chains  lead  to  different  activities/endotoxicities.  
Salmonella  minnesota  R595  is  a  pathogenic  bacterium  with  a  potent  and  
endotoxic   LA.   Modification   to   this   LA   leads   to   a   detoxified  
monophosphorylated  LA  (MPL).  Rhizobium  species  possess  non-­toxic  LA  
structures.  
 
While   the   structures   and   immunological   effects   of   endotoxic   LAs   have   been  











































































































scientific  community.  As  a  result,  little  is  currently  known  about  LA  variants  produced  by  
herb-­colonizing   bacteria.   This   problem   is   significant   because   the   knowledge   of   LA  
variants   of   herb-­colonizing   bacteria   will   lead   to   a   better   understanding   of   immune-­
boosting  herbal  medicines  that  have  long  been  used  throughout  the  world.  
4.1.2.  Objective  and  Hypothesis  
  The  16S  rRNA  sequencing  study  in  Chapter  3  not  just  identified  Rahnella  aquatilis  
as  the  most  predominant  bacterium  in  the  dried  roots  of  A.  sinensis  but  also  showed  a  
correlation  between  the  abundance  of  R.  aquatilis  and  the   immune-­boosting  activity  of  
the  herb  [14].    
R.   aquatilis   is   a   Gram-­negative   Gamma-­Proteobacterium   belonging   to   the  
Enterobacteriaceae  family.  It  has  been  previously  isolated  from  different  natural  sources,  
such  as  soil,  water  and  plants.  R.  aquatilis  has  been  isolated  from  fruits  like  apples  as  
well  as  the  rhizosphere  of  plants  such  as  soybean,  wheat  and  maize  [15-­17].  R.  aquatilis  
is   researched   for   its   plant   growth-­promoting   properties   such   as   atmospheric   nitrogen  
fixation   [15].   It   is   a   phosphate   solubizing   bacterium   (PSB)   and   can   also   solubilize  
hydroxyapatite  [17,  18].  Furthermore,  R.  aquatilis  has  been  shown  as  a  pest  control  agent  
and   a   good   alternative   for   pesticides.   It   was   demonstrated   to   be   effective   against  
postharvest  spoilage  caused  by  Penicillium  expansum  and  Botrytis  cinerea  in  apples  [16].  
Bacterial   spot   of   tomato   fruits   caused   by   the   bacterium  Xanthomonas   campestris   pv.  
vesicatoria  was  also  biologically  controlled  using  R.  aquatilis  [19].    
There   is  not  much  known  about   the  LPS   that  R.  aquatilis  presents  on   its  outer  
membrane.  Several   strains  of   the  bacterium  have  been   isolated   from   freshwater,   soil,  
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plants  and  even  patients  and  their  LPS  subjected  to  chemical  characterization  [20].  The  
O-­antigen  is  the  most  researched  region  of  R.  aquatilis  LPS  [21-­23].  The  OPS  has  been  
shown  to  predominantly  consist  of  repeating  units  of  rhamnose  and  mannose  units  [24].  
In   other   cases,   the   O-­Antigen   comprises   of   hetero-­polysaccharides.   The   O-­specific  
polysaccharide  region  of  several  strains  of  R.  aquatilis,  including  strains  33071,  1-­95,  2-­
95,  2-­87  and  3-­95,  have  been  characterized  [25].  However,  the  structure  of  the  R.  aquatilis  
LA  has  not  been  characterized  as  yet.  
The  objective  of  the  study  presented  in  this  chapter  is  to  characterize  the  LA  of  R.  
aquatilis  chemically  and   immunologically.     Our  working  hypothesis   is   that  R.  aquatilis  
produces   unique   structural   variants   of   LA   that   give   rise   to   safe   and   effective  




4.2.  RESULTS    
4.2.1.  Endotoxin  levels  of  R.  aquatilis  and  E.  coli  bacterial  pellets  
Bacterial  cultures  for  E.  coli  and  R.  aquatilis  were  centrifuged  to  obtain  cell  pellets.  
The  endotoxin   levels  of   the  cell  pellets  were  assessed  with  Limulus  amebocyte   lysate  
(LAL)  assay,  an  endotoxin  detection  assay.  The  assay  uses  a  chromogenic  substrate  and  
LAL  to  estimate  endotoxin  levels  of  biological  samples.  In  this  assay,  LA  (LPS)  initiates  
the  activation  of  coagulation  enzymes  (proteases),  which  results   in   the  hydrolysis  of  a  
colorless  substrate  into  a  UV-­absorbing  chromophore.    
The  bacterial  pellets  are  extremely  crude  samples  that  contain  all  components  of  
the  cells,  including  proteins,  DNA,  lipids  and  LPS/LA.  The  pellets  were  evaluated  at  two  
different   concentrations   (1   ng/µL   and   10   ng/µL)   for   both  E.   coli   and  R.   aquatilis.   The  
graphs  were  extrapolated  to  0  ng/µL  for  each  sample  and  compared  after  subtracting  the  
background  (Appendix  C).  The  graph  below  (Figure  4.4)  shows  that  the  endotoxin  levels  
for  both  E.  coli  and  R.  aquatilis  pellets  are  different  with  E.  coli  showing  higher  O.D.  values  
at  each  concentration,  indicating  higher  endotoxin  levels  than  R.  aquatilis.  
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Figure  4.4:  O.D.  of  E.  coli  and  R.  aquatilis  pellets.  The  bacterial  pellets  
E.  coli  and  R.  aquatilis  were  evaluated  for  their  endotoxin  levels  using  LAL  
Assay.   E.   coli   exhibited   higher   O.D.   values   indicating   higher   endotoxin  
content  as  compared  to  R.  aquatilis.  
  
4.2.2.  HPLC  Purification  of  R.  aquatilis  and  E.  coli  LAs    
Bacterial   LA  was   enriched   from  E.   coli   and  R.   aquatilis   cell   lysates   as   per   the  
scheme  described  in  Figure  2.5  [14].  The  crude  E.  coli  and  R.  aquatilis  LAs  obtained  after  
extraction  of  the  hydrophobic  layer  (before  the  preparative  TLC  step)  were  further  purified  
by  HPLC  and  TLC.  The  HPLC  method  used  was  modified  from  an  established  protocol  
for  the  purification  of  lipid  A  for  structural  analysis  [26].  The  TLC  profiles  of  E.  coli  and  R.  
aquatilis  crude  LA  samples  were  consistent  with   the  HPLC  profiles,   indicating   the  LAs  
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The  crude  R.  aquatilis  LA  sample  was  found  to  be  of  higher  purity  than  that  of  E.  
coli  LA.  They  were  followed  using  both  the  UV  and  ELSD  detectors.  The  ELSD  detector  
showed  a  significant  peak  for  the  R.  aquatilis  crude  LA  at  the  retention  time  of  around  
12.5  minutes  (Figure  4.5),  whereas  a  significant  peak  at  retention  time  of  20.9  minutes  
(Figure  4.6)  was  observed  for   the  E.  coli  crude  LA  sample.  The  retention   time  of  20.9  
minutes   observed   for  E.   coli   LA  has   been  previously   reported   [27].   This   difference   in  
retention  times  between  the  two  LA  samples  suggested  that   they  might  be  structurally  
different.    
 
Figure   4.5:   HPLC   Profile   of   crude   R.   aquatilis   LA.   An   HPLC  
chromatogram  of   extracted  R.   aquatilis   LA.  Conditions:  Alltech  Reverse-­
Phase   C18   (Analytical   column).   The   column   was   operated   at   room  
temperature.   Solvent   gradient:   Solvent   A:   MeOH/CHCl3/H2O   (57:12:31,  
v/v/v)   containing   10mM   ammonium   acetate   to   Solvent   B:   CHCl3/MeOH  
(70:30,   v/v)   containing   50mM   ammonium   acetate.   The   flow   rate   was  
*  12.5  min 
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maintained   at   3mL/min.   The   run   was   followed   using   ELSD   detector.   A  
significant   peak   (shown   by   the   *)   was   detected   by   ELSD   (blue)   at   12.5  
minutes.  
 
Figure  4.6:  HPLC  Profile  of  crude  E.  coli  LA.  An  HPLC  chromatogram  of  
extracted   E.   coli   LA.   Conditions:   Alltech   Reverse-­Phase   C18   (Analytical  
column).  The  column  was  operated  at  room  temperature.  Solvent  gradient:  
Solvent  A:  MeOH/CHCl3/H2O  (57:12:31,  v/v/v)  containing  10mM  ammonium  
acetate   to   Solvent   B:   CHCl3/MeOH   (70:30,   v/v)   containing   50mM  
ammonium  acetate.  The  flow  rate  was  maintained  at  3mL/min.  The  run  was  
followed   using   ELSD   detector.   A   significant   peak   (shown   by   the   *)   was  
detected  by  ELSD  (blue)  at  20.9  minutes.  
 
LA-­enriched  fractions  were  obtained  from  R.  aquatilis  bacterial  cultures  using  the  
purification  protocol  established  before  and  presented  in  Chapter  2  [14,  28].  In  addition  
to  R.  aquatilis,  we  also  characterized  the  LA  isolated  from  E.  coli  as  a  reference.  
*  20.9  min 
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4.2.3.  E.  coli  LA:  Extraction,  Purification  and  Activity  
The  crude  LA   from  E.  coli  was  subjected   to   further  purification  with  preparative  
TLC  to  obtain  five  fractions  (EC_LA  1-­5).  Among  the  five  E.  coli  LA  fractions  tested,  four  
showed   immunostimulatory   activity   as   determined   by   the   ICAM-­1  mRNA   induction   in  
THP-­1  monocytes.  EC_LA2  showed  16-­fold  change  activity  compared  to  DMSO,  whereas  
the  positive  control,  LPS  at  a  low  concentration  of  0.2ng/mL  showed  nearly  4.5-­fold  ICAM-­
1  mRNA  induction  (Figure  4.7).    
 
Figure  4.7:  Immunostimulatory  activity  of  the  E.  coli  LA  fractions.  The  
immunostimulatory  activity  of  E.  coli  LA  fractions  (EC_LA  1-­5)  at  5µg/mL  
measured   by   ICAM-­1   expression   using   qRT-­PCR.   DMSO   and   LPS   at  




















4.2.4.  R.  aquatilis  LA:  Modified  Micro-­Extraction  Protocol  
R.  aquatilis  ATCC  33991  was   inoculated  on  agar   (Appendix  E)  and   the  culture  
transferred   to   liquid   medium.   LA   was   extracted   from   the   bacterial   cultures   using   a  
modified  version  of  the  protocols  published  [14,  29].  The  established  protocol  has  been  
previously  shown  to  obtain  LA  suitable  for  MS  analysis  using  a  micro-­extraction  protocol.  
Preparative   TLC   led   to   the   purification   of   six   fractions   (RA_LA   1-­6).   The  
immunostimulatory  activity  was  tested  for  all  six  fractions  by  qRT-­PCR.  Five  of  the  six  LA  
fractions   showed   immunostimulatory   activities   (Figure   4.8).   The   activities   varied   from  
nearly   18-­fold   ICAM-­1   mRNA   induction   for   R_LA6   to   1.5-­fold   induction   for   R_LA5  





Figure  4.8:  Immunostimulatory  activity  of  R.  aquatilis  LA  fractions.  The  
immunostimulatory   activity   of   R.   aquatilis   LA   fractions   at   5µg/mL   each  
(R_LA  1-­6)  measured  by  ICAM-­1  expression  using  qRT-­PCR.  DMSO  and  
LPS  at  0.2ng/mL  were  the  negative  and  positive  controls,  respectively.  
  
4.2.5.  Endotoxicity  of  R.  aquatilis  LA  
The  LA  fractions  from  R.  aquatilis  exhibit  immunostimulatory  activity.  However,  the  
presence  of  R.  aquatilis  was   revealed   in   the  medicinal   herb,  A.   sinensis  as   shown   in  
Figure   3.12   (Chapter   3).   Our   working   hypothesis   states   that   A.   sinensis   enrich  
immune-­boosting  bacteria  that  have  safe  LAs.  To  test  this  hypothesis,  we  evaluated  
the  endotoxicity  levels  of  the  LAs  extracted  from  R.  aquatilis.    The  endotoxin  content  of  
LA  fractions  (R_LA1  to  R_LA6)  was  estimated  using  an  endotoxin  detection  assay.    
A  standard  curve  was  generated  with  the  endotoxin  E.  coli  LA  standards  provided  



















4.9.  This  showed  an   increase   in   the  endotoxin   level  measured  by  Endotoxin  Units/mL  
(EU/mL)  as  the  concentration  of  E.  coli  LA  increased.  
 
Figure  4.9:  Standard  Curve  for  LAL  Assay.  A  standard  curve  using  the  
E.   coli   LA   standards   was   constructed   using   the   LAL   Assay   Kit.   The  
absorbance  read  at  410nm  estimated  the  endotoxin  levels  (EU/mL)  for  each  
standard.  
 
The  optical  density  (O.D.)  of  the  R.  aquatilis  LA  fractions  were  also  read  at  410nm  
using  a  spectrophotometer  and  their  respective  endotoxin  levels  were  estimated  (Table  
4.1).  The  table  shows  the  O.D.  of  the  standards,  R_LA1-­6  as  well  as  the  controls,  DMSO  
and   LPS   (0.2ng/mL).   The   intensity   of   the   colors   for   each   sample   corresponds   to   the  
amount  of  endotoxin  present  in  the  sample.  R_LA6  shows  an  O.D.  reading  similar  to  the  
highest  concentration  of   standard  E.  coli   LA   indicating   that   it   has   the  most  amount  of  




























EU/mL& Net&O.D&at&410nm& Sample& EU/mL& Net&O.D&at&410nm&
0" 0" DMSO" 0" 0.038"
0.1" 0.034" R_LA1" 0.058187864" 0.052"
0.25" 0.079" R_LA2" 0.078969244" 0.057"
0.5" 0.128" R_LA3" 0.42394015" 0.14"









Table  4.1:  O.D.  and  Endotoxin  Levels  of  LAs.  The  O.D.  of  standard  E.  
coli   LAs   and  R.   aquatilis   LAs   were   read   at   410nm.   The   corresponding  
endotoxin  levels  (EU/mL)  were  calculated.  The  intensity  of  colors  denotes  
the  level  of  endotoxin  present  in  the  well.  
 
The  range  of  endotoxin  levels  for  the  R_LAs  varied  from  0.058  EU/mL  for  R_LA1  
to  0.94  EU/mL  for  R_LA6.  The  R.  aquatilis  LA  samples  did  not  exhibit  very  high  endotoxin  
levels.   The   respective   spectrophotometric   readings   of   all   samples   (R_LA1-­6)   were  
observed  to  fall  within  the  range  of  the  standard  curve  (Figure  4.10).    
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Figure  4.10:  Endotoxin  levels  of  R.  aquatilis  LA  fractions.  The  endotoxin  
levels  of  R_LA1-­6  were  estimated  using  the  LAL  Assay  along  the  controls,  
DMSO  and  LPS   (0.2ng/mL)  and  plotted  with   the  standard  curve.  The  R.  
aquatilis   LA   fractions   showed   lower   or   similar   endotoxin   levels   when  
compared  to  the  standard  E.  coli  LAs.  
 
4.2.6.  Large-­scale  extraction  of  LA  from  R.  aquatilis  
The  micro-­extraction  purification  of  R.  aquatilis  LA  led  to  six  LA  fractions,  some  of  
which  exhibited   immunostimulatory  activities   (Figure  4.8),   however,   it   did  not   produce  
sufficient   sample   for   structural   characterization.   Therefore,   a   large-­scale   extraction  





























from   the   bacterial   culture   grown   in   10L   cultures   [30].   LA   was   obtained   using   acid  
hydrolysis  of  the  crude  LPS  extract  with  acetic  acid.  This  protocol  yielded  seven  fractions.  
The  immunostimulatory  activities  of  the  LA  fractions  were  consistent  with  the  LA  fractions  
obtained  using  the  micro-­extraction  procedure  (Figure  4.11)  [29].  This  protocol  led  to  the  
accumulation  of  nearly  50  mg  of  LA  samples,  which  will  be  further  purified  by  HPLC  and  
subjected   to   structural   analyses   using   MS   and   NMR.   However,   the   structural  
characterization  of  LA  from  R.  aquatilis  is  a  problem  since  the  LA  obtained  by  the  large-­
scale  extraction  was  not  pure.  This  protocol  requires  the  use  of  sodium  dodecyl  sulfate  
(SDS),  which  was  needed  to  solubilize  the  large  amounts  of  LAs.  The  residual  SDS  was  




Figure  4.11:  Immunostimulatory  activities  of  LA  fractions  obtained  by  
large-­scale   extraction.   ICAM-­1   expression   of   R.   aquatilis   LA   fractions  
extracted   using   Trizol   reagent.   The   less   polar   fractions   (R_LA1-­R_LA4)  
exhibit  higher  immunostimulatory  activities  as  compared  to  the  more  polar  
fractions  (R_LA5-­R_LA7).  
  
4.2.7.  Structural  characterization  of  MPL  
R.   aquatilis   LA   structure   is   yet   to   be   characterized.   To   aid   the   chemical  
characterization  of  R.  aquatilis  LA,  MPL  was  used  as  a  reference  sample  for  structure  
elucidation   using  MS.  Positive  mode   Ion-­Trap  ESI-­MS  was  performed   to   characterize  
MPL.  Using  MS  and  tandem  MS  experiments,  a  protocol  was  optimized  that  is  suitable  
for   the   characterization   of   LA   from   bacteria.  MS   revealed   different   LA   species   in   the  



















molecular  weight  of  1718,  however   it   is  commercially  available  as  a  mixture  of  hepta-­,  
hexa-­   and  penta-­acylated  analogs   isolated   from  Salmonella  minnesota  Re595  mutant  
[31].  The  peak  at  1978.7  (Mr  =  1954;;  1978-­23  =  1955)  showed  the  presence  of  the  hepta-­
acylated  MPL  species  with  a  sodium  adduct  (Mr  =  23).  The  presence  of  the  sodium  adduct  
was  also  observed  for  hexa-­acylated  MPL  at  1740.5  (Mr  =  1717;;  1740-­23  =  1717).  The  
penta-­acylated  MPL  species  observed  at  1529.3,  also  with  the  sodium  adduct  (Mr  =  1507;;  
1529.7-­23  =  1507)  (Appendix  F).    
MPL  was  also  characterized  using  MS/MS  using  MALDI.  The  protocols  have  now  
been  optimized  using  both  these  MS  techniques.  The  structural  characterization  of  MPL  
obtained   using   both   ESI-­MS   and   MALDI   would   serve   as   a   reference   for   the  
characterization  of  LA  species  for  R.  aquatilis.    
 
4.3.  DISCUSSION  
Gram-­negative  bacterial  LPSs  are  potent  immunostimulants.  The  potency  of  LPS  
is  conferred  to  it  by  its  endotoxic  component,  LA.  As  established  previously,  this  potency  
may  be  modulated  by  structural  modifications  to  the  LA  moiety.    
Plant-­colonizing  bacteria  possess  structurally  distinct  LAs  that  exhibit   little   to  no  
inflammatory   response,   as   in   the   case   of  R.   etli   LA   (Figure   4.3).   In   this   regard,   our  
hypothesis  was  that  bacteria  associated  with  medicinal  plants  may  also  elicit  similar  
attenuated  immune  responses  due  to  their  structurally  distinct  LA  species.  
Attenuation  of  the  endotoxicity  of  LA  may  lead  to  a  safe  and  effective  therapeutic  
agent,  as  in  the  case  of  MPL,  the  detoxified  form  of  Salmonella  minnesota  R595  LA.  MPL  
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is  the  first  available  FDA-­approved  vaccine  immuno-­adjuvant  in  80  years  [32].  It  is  used  
as  an  adjuvant  for  the  human  papilloma  virus  vaccine  [33].  This  has  led  to  an  entire  new  
area   of   research   related   to   modifying   the   structure   of   LA   of   pathogenic   bacteria   to  
generate  safe-­to-­use  LAs  with  similar  therapeutic  properties.  
The  structure  of  R.  aquatilis  LA  is  yet   to  be  characterized.  Even  so,   the  studies  
undertaken  in  this  direction  presented  certain  physicochemical  clues  as  to  how  different  
or  similar  R.  aquatilis  LA  might  be  to  endotoxic  LAs.  
4.3.1.  Are  there  differences  between  R.  aquatilis  LA  and  endotoxic  LAs?    
The  first  difference  observed  between  R.  aquatilis  and  endotoxic  bacteria  was  the  
endotoxin  content  present  in  the  cell  pellets.  The  endotoxin  levels  of  bacterial  pellets  from  
E.  coli  were  clearly  different   from   those  of  R.  aquatilis.  E.  coli  was  shown   to  possess  
higher  endotoxin  content  as  compared  to  R.  aquatilis  at  the  same  concentration  (Figure  
4.4).  This  indicated  that  their  endotoxin  component,  LAs  may  be  different  from  each  other.  
The   LAs  when   extracted   from   both  R.   aquatilis  and   endotoxic   bacteria,  E.   coli  
exhibited  quite  different  HPLC  profiles,  when  run  using  the  same  conditions  (Figure  4.5  
and  Figure  4.6).  The  retention  times  observed  for  both  again  suggested  that  the  LAs  may  
be  structurally  different.    
Since  HPLC  was  performed  with  rather  crude  samples,  the  LAs  from  both  bacteria  
were   subjected   to   further   fractionation  using  preparative  TLC.  The   immunostimulatory  
activities  of  the  LA  fractions  obtained  from  both  R.  aquatilis  and  E.  coli  crude  samples  
showed  striking  variation.  The   less  polar   fractions  of  E.  coli  LAs   like  EC_LA2  (16-­fold)  
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exhibited  significantly  higher  ICAM-­1  mRNA  induction  than  the  more  polar  fractions  like  
EC_LA5  (3-­fold)  (Figure  4.7).  In  contrast,  the  more  polar  fractions  of  R.  aquatilis  LA  like  
R_LA6  showed  potent  immunostimulatory  response  (18-­fold)  than  the  less  polar  fractions  
like  R_LA2  (6-­fold)  (Figure  4.8).  The  more  polar  fractions  of  R.  aquatilis  LA  may  possess  
hydrophilic  groups  such  as  phosphate  groups.  In  any  case,  the  different  gene  expression  
profiles   for   LAs   from  both  bacteria   suggests   that  R.  aquatilis  LA  might   be   structurally  
distinct  from  that  of  endotoxic  LAs.    
Based  on  the  literature,  the  toxicity  of  R.  aquatilis  LPS  has  also  been  shown  to  be  
different  from  that  of  endotoxic  LPS  [34].  The  study  compared  the  toxicity  and  pyrogenicity  
of  R.  aquatilis  LPS  to  that  of  endotoxic  E.  coli  LPS  in  vivo.  It  was  shown  that  R.  aquatilis  
LPS  was  less  toxic  to  the  mice  as  compared  to  the  positive  control,  endotoxic  LPS.  This  
difference  was  attributed   to  structural  components  of  LPS.  To  determine   the  chemical  
source  of   the  endotoxicity,   these  researchers  modified   the  structure  of   the  R.  aquatilis  
LPS  to  make   it  de-­phosphorylated  or  N,O-­deacylated,  which   led   to  a  complete   loss  of  
toxicity  and  pyrogenicity.  This  indicated  that  the  phosphate  groups  and  acyl  chains  are  
essential  for  both  toxicity  and  pyrogenicity  of  R.  aquatilis  LPS  in  vivo  [34].  
4.3.2.  Are  there  similarities  between  R.  aquatilis  LA  and  endotoxic  LAs?    
Even  though,  there  were  some  structural  and  immunological  differences  between  
R.  aquatilis  LA,  we  wondered  if  there  might  any  similarities  between  them.  In  fact,  based  
on  the  literature  and  some  results  from  our  study,  it  seems  that  R.  aquatilis  LA  might  even  
have  structural  and  immunological  similarities  with  endotoxic  LAs.  
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The  micro-­extraction  of  LA  from  R.  aquatilis  culture  led  to  the  fractionation  of  six  
LA-­like   species.   Some   of   these   LA   species   induced   immunostimulatory   activities  
measured  by  ICAM-­1  mRNA  expression  (Figure  4.8).  However,  R.  aquatilis  LA  is  not  just  
known  for  its  immunostimulatory  activity.  There  have  been  studies  investigating  toxicity  
associated  with  the  LA  of  R.  aquatilis.  Although,  R.  aquatilis  is  not  a  human  pathogen  per  
se,  there  have  been  reports  of  its  isolation  from  blood  or  wounds  of  patients  with  leukemia  
or  bronchial  diseases  [35-­39].  This  may  suggest  that  R.  aquatilis  act  as  an  opportunistic  
pathogen  in  immunocompromised  patients.    
Another   similarity   between   R.   aquatilis   LA   and   endotoxic   LA   may   be   the  
endotoxicity.  Although,  as  mentioned  before,  the  toxicity  of  LPS  of  both  R.  aquatilis  and  
E.  coli  may  be  different,  there  remains  some  toxicity  associated  with  R.  aquatilis  LPS  [34].        
Therefore,   in   addition   to   the   immunostimulatory   activity,   our   study   also   evaluated   the  
endotoxicity  of  R.  aquatilis  LA  fractions  using  the  LAL  Assay  (Figure  4.10).  A  comparison  
of   the   immunostimulatory   and   endotoxic   activities   of   the   LA   fractions   obtained   by   the  
micro-­extraction  revealed  that  not  all  LA  fractions  exhibit  the  same  type  of  activity  (Figure  
4.12).  R_LA6,  the  most  polar  fraction  obtained  from  R.  aquatilis  showed  higher  levels  of  
endotoxin,  indicating  that  it  might  possess  similar  chemical  structure  as  that  of  endotoxic  
LAs.  Like  endotoxic  LAs,  R.  aquatilis  LA  may  contain  removable  phosphate  moieties  that  
might   cleave   off   and   separate   after   hydrolysis.   Therefore,   R_LA6   might   be   a   di-­
phosphorylated  LA  species,  since  they  are  known  not  only  for  their  potency  but  also  for  
their   toxicity.  The   less  polar   fractions  such  as  R_LA2  and  R_LA4  might  be  hydrolysis  
products   that   are   mono-­phosphorylated   like   MPL,   and   consequently   exhibit   lower  
toxicities.    
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Figure  4.12   is  a  visual   representation  comparing   the   immunostimulatory  activity  
and  endotoxicity  of   the  R.  aquatilis  LA  fractions.   It   is  a  comparison  of   the  ratios  of   the  
immunostimulatory  activity   (ICAM-­1  mRNA  expression)  as  well   as   the  endotoxin   level  
(EU/mL)  of  all  R_LA  samples,  DMSO  and  LPS,  with  the  highest  reading  for  each  set  to  
1.  R_LA6  exhibited  the  highest  immunostimulatory  activity  (Figure  4.8)  along  with  having  
the  highest  level  of  endotoxin  (Figure  4.10  and  Table  4.1),  therefore,  its  value  has  been  
set  to  1.  The  other  samples  and  controls  have  been  estimated  as  ratios  to  the  ICAM-­1  
expression  or  endotoxicity  of  R_LA6.  
 
 
Figure  4.12:  Comparison  of  ICAM-­1  immunostimulatory  activity  (blue)  
and  the  endotoxicity  (red)  of  the  R.  aquatilis  LA  fractions  (R_LA1-­6).  
Both  variables  for  the  sample  with  the  highest  values  were  set  to  maximum  
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4.3.2.  New  hypotheses  emerged  from  this  study    
Based  on  the  data  presented  here,  a  new  hypothesis  that  emerged  from  this  study  
is   that   certain   immune-­boosting  LA   fractions   from   the  same  bacterial   species  may  be  
different   from   those   exhibiting   higher   endotoxin   levels.   The   rationale   behind   this  
hypothesis   is   that   the  crude  LA  sample  obtained  from  R.  aquatilis  after  hydrolysis  and  
separation  of  the  hydrophilic  layer  would  be  a  mixture  of  structurally  distinct  LA  species.  
This  novel  finding  suggested  that  R.  aquatilis  may  enrich  certain  LA  species  that  could  
not  only  attenuate  the  negative  inflammatory  response  of  LA  but  also  stimulate  the  innate  
immune  system.    
Further   research   to   characterize   the   structure   of   these   immune-­boosting   LA  
species  is  required  for  a  better  understanding  of  safe  LAs  that  may  be  effectively  used  as  
potential  therapeutic  agents.    
Regardless  of  the  structure  of  R.  aquatilis  LA  not  being  characterized,  this  research  
strengthened   our   central   hypothesis   that   medicinal   herbs   enrich   immune-­boosting  
bacteria.  R.   aquatilis   LA   species   that   possess   non-­polar   character   may   be   potential  
candidates   for   therapeutic   immune-­adjuvant   with   lower   toxicity,   while   generating   an  
innate  immune  response.    
It  was  shown  however,  that  R.  aquatilis  is  not  completely  devoid  of  all  endotoxicity  
and   some   variants   of   the   LA   from   the   bacteria   might   even   be   structurally   similar   to  
endotoxic  LAs.  The  important  question  now  is  how  is  it  that  R.  aquatilis  safely  exists  in  
herbal   medicine   such   as  A.   sinensis,   without   causing   any   endotoxic   or   inflammatory  
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effects.  To  address  this  question,  Chapter  5  will  evaluate  the  effect  of  the  medicinal  plants  
themselves  in  modulating  the  endotoxicity  of  bacterial  LPS.  
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4.4.  MATERIALS  AND  METHODS  
4.4.1.  Cell  Culture  
Refer  to  Chapter  2  (page  50).  
4.4.2.  RNA  purification  and  RT  
Refer  to  Chapter  2  (page  51).  
4.4.3.  qRT-­PCR  
Refer  to  Chapter  2  (page  53).  
4.4.4.  Micro-­extraction  of  Rahnella  LA  
The  cell  pellet  was  washed  twice  with  1:2  v/v  chloroform:methanol  (CHCl3:MeOH)  
and  a   final  wash  with  3:2:0.25  v/v  chloroform:methanol:water   (CHCl3:MeOH:H2O)  was  
done.  The  cell  pellet  was  re-­suspended  in  water  to  form  an  aqueous  single-­phase  mixture.  
The  rest  of   the  protocol  was  similar  to  the  one  used  for  E.  coli,  however   it  was  scaled  
down   for   the  micro-­extraction   (Scheme   showed   in   Figure   2.5).   The   hydrophobic   and  
hydrophilic   layers  were  separated  by  an  organic  extraction  with  1:1  CHCl3:MeOH.  The  
hydrophilic  layer  (containing  the  LPS)  was  subjected  to  acid  hydrolysis,  and  refluxed  for  
one   hour.   Organic   extraction   with   1:1   CHCl3:MeOH   to   extract   the   hydrophobic   layer,  
containing   the   LA,   was   done.   Preparative   TLC   led   to   the   purification   of   six   fractions  
(RA_LA1-­6).  
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4.4.5.  LAL  Assay  
The   Pierce   LAL   Chromogenic   Endotoxin   Quantitation   Kit   was   used   for   this  
purpose.   Four   standards   with   E.   coli   LA,   with   varying   Endotoxin   Units/mL   (EU/mL),  
provided  in  the  Kit,  were  used  for  constructing  a  standard  curve  to  estimate  the  quality  of  
the  experiment.  Rahnella  LA  fractions  1-­6  were  tested  using  the  instructions  in  the  Kit  and  
the  Optical  Density  (OD)  was  read  at  410  nm  using  a  spectrophotometer.  The  OD  values  
of  the  standards  used  were  plotted  as  a  standard  curve.    
4.4.6.  HPLC  
The   crude   E.   coli   and   Rahnella   LA   samples,   obtained   after   extraction   of   the  
hydrophobic  layer  as  shown  in  the  LA  purification  scheme  [14]  were  further  purified  by  
HPLC  using  the  following  method.  The  reverse-­phase  HPLC  purification  was  carried  out  
using   an   Agilent   1100   HPLC   equipped   with   a   photodiode   array   detector   (PDA)   and  
Evaporative  Light  Scattering  Detector  (ELSD).  The  Analytical  C18  column  was  used  as  
the   stationary   phase.   The   mobile   phase   was   composed   of   Solvent   A   as  
methanol/chloroform/water   (57:12:31,   v/v/v)   containing   10mM  ammonium   acetate   and  
Solvent  B  as  chloroform/methanol  (70:30,  v/v)  with  50mM  ammonium  acetate.  They  were  
followed   using   both   the  UV   and  ELSD  detectors.   The  HPLC  method   followed   for   the  
purification  of  Rahnella  and  E.  coli  LAs  is  given  below:  
TIME   %  B  
0   27  
5   27  
45   100  
55   100  
60   27  
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4.4.7.  Bacterial  Cell  Culture  
Nutrient  Agar  and  Broth  were  prepared  for  bacterial  cell  culture  as  per  procedure  
established   by   the  manufacturer   (Difco).   The  media   was   autoclaved   at   121ºC   for   30  
minutes.  Bacteria  were  inoculated  from  glycerol  stocks  to  3mL  liquid  cultures.  The  agar  
plates  were  inoculated  from  the  broth  culture  using  a  spreader.  The  agar  plates  and  flasks  
with  bacteria  culture  were  incubated  in  shaker  incubator  for  24  hours  at  37ºC.  Isolated  
colonies  were  streaked  on  fresh  agar  plates  (Appendix  E),  using  the  Quadrant-­streaking  
method  to  obtain  pure  colonies  of  culturable  bacteria  from  R.  aquatilis.  The  3mL  cultures  
of  R.  aquatilis  were  also  used  to  prepare  glycerol  stocks  for  cryopreservation  in  a  1:1  v/v  
concentration  with  autoclaved  50%  Glycerol.   
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Chapter  5    
5.1.  INTRODUCTION  
Research  has  shown  the  presence  and  contribution  of  bacterial  LPS  in  the  activity  
of  medicinal  herbs  such  as  JTT,  Echinacea  and  medicinal  mushrooms  [1-­4].  As  shown  in  
Chapter  4,  the  LA  of  R.  aquatilis  is  not  completely  devoid  of  endotoxicity.  Yet,  immune-­
boosting  herbs  are  not  known  for  endotoxicity;;  they  are  in  fact  quite  safe.  The  observation  
of   endotoxic   LA   in   immune   boosting   plant   (A.   sinensis)   raised   a   possibility   that   plant  
metabolites  might  attenuate  undesirable  immunological  effects  of  LA  of  R.  aquatilis  and  
perhaps   other   MAMPs   in   JTT.   In   fact,   many   studies   have   demonstrated   the   anti-­
inflammatory  effects  of  plant  metabolites  [5-­9].  In  this  regard,  this  chapter  will  examine  an  
immune-­boosting  medicinal   herb   as   a   complex  mixture   of   both   plant  metabolites   and  
bacterial   LPS,   which   collectively   give   rise   to   a   safe   and   effective   immunostimulatory  
effect.  To  this  end,  the  chapter  will  focus  on  Ashwagandha,  an  immunomodulatory  herb  
of  Indian  origin.  
5.1.1.  Ashwagandha  
Ashwagandha,  scientifically  known  as  Withania  somnifera,  or  popularly  as  “Indian  
ginseng”  or  “winter  cherry”  is  a  medical  herb,  widely  consumed  all  over  the  world,  with  its  
origins   in   Indian   Ayurveda   medicine   (Figure   5.1).   Ashwagandha   is   an   all-­purpose  
medicinal   herb,   which   has   gained   tremendous   popularity   in   the  Western  medicine   in  
recent  times.  It  is  used  for  its  anti-­inflammatory,  immune-­boosting,  memory  boosting,  anti-­
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tumor,   antioxidant   properties   and   has   also   shown   to   be   effective   for   stress,   anxiety,  
depression  and  neurodegenerative  disorders.    
  
 
Figure  5.1:  Ashwagandha  root  and  plant  
  
According   to   the   literature,   the   immunomodulatory  effects  of  Ashwagandha  are  
mainly  conferred  by  the  active  compounds  that  have  been  isolated  from  the  plant.  The  
most   predominant   compounds   found   in   the  medicinal   plant   belong   to   the   category   of  
compounds  known  as  Withanolides.  These  were  first  isolated  from  Ashwagandha,  hence,  
they  are  named  after  the  herb’s  scientific  name  [10].  Withanolides  have  a  steroidal  lactone  
backbone  as  shown  in  Figure  5.2.  Different  types  of  withanolides  have  been  isolated  and  
characterized   from   Ashwagandha   and   related   plant   species   [11].   The   first   ever  
withanolide  that  was  isolated  from  Ashwagandha  was  Withaferin  A  (WA)  (Figure  5.2).  WA  
is  one  of  the  most  pharmacologically  active  constituents  of  Ashwagandha  [12].  It  is  known  
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for   its   anti-­inflammatory,   anti-­tumor,   immunosuppression,   anti-­oxidant   and   neuro-­
protective  properties.  It  has  also  gained  interest  as  anti-­neoplastic  agent  [13-­15].    
  
  
Figure   5.2:  Withanolides   from  Ashwagandha.   Structure   of   the   steroid  
backbone   of   Withanolide   type   A   compounds   (left)   and   structure   of   WA  
(right)  extracted  from  Ashwagandha  and  related  plants.  
The  mechanism  of  action  of  WA  is  still  unclear.  Studies  have  shown  that  it  leads  
to  immunosuppression  by  inhibiting  the  NF-­kB  pathway.  WA  leads  to  down-­regulation  of  
LPS-­induced  COX-­2  or  NF-­kB  activity  [16,  17].  Furthermore,  it  has  been  shown  to  inhibit  
the  NEMO/IKKb  association  complex  formation,  which  further  leads  to  suppression  of  NF-­
kB  activity   [18,   19].  Another  mode  of   action   for   immunosuppression  has  been   shown  
through  inhibition  of  T-­cell  mediated  adaptive  immune  response  [20].  These  studies  have  
shown  that  WA  is  an  anti-­inflammatory  compound.  
Withanolides,   however,   are   not   the   only   immunomodulatory   factors   in  




















that  bacterial  LPSs  are  associated  with  the  immunostimulatory  effect  of  Ashwagandha.  
As  such,  Ashwagandha  contains  a  complex  mixture  of  immunostimulatory  LPSs  as  well  
as   anti-­inflammatory   factors,   including   withanolides.   Although   there   have   been   some  
studies   to   characterize   the   immunological   properties   of   individual   metabolites   in  
Ashwagandha,  it  is  unknown  how  these  compounds  as  a  mixture  interact  and  collectively  
give  rise  to  the  supposedly  beneficial  immunological  effects.  This  problem  is  important  
because  the  knowledge  of  mode  of  action  of  the  immunomodulatory  factors  will  bring  a  
better  understanding  of  the  safety  and  efficacy  of  the  herb.    
5.1.2.  Hypothesis  
The   contribution   of   bacterial   LPS   to   the   immune-­boosting   activity   of   medicinal  
plants,  such  as  JTT  and  Echinacea,  has  been  established  by  recent  studies,   including  
ours  as  described  in  Chapter  2-­4  [2,  3,  21].  Curiously,  however,  LPSs  in  plant-­associated  
bacteria   still   retain   some   endotoxicity.   For   example,   LPSs   of   R.   aquatilis,   which   is  
enriched  in  JTT  and  A.  sinensis,  exhibits  endotoxicity  as  described  in  Chapter  4.  Likewise,  
many   LPSs   of   Gram-­negative   bacteria   in   Echinacea   also   retain   endotoxicity   [4].  
Paradoxically,  however,   these  herbs  have   long  been  used  safely   to  boost   the   immune  
functions   without   causing   inflammation.   Therefore,   there   must   be   a   reason   why   no  
inflammatory  effects  have  been  associated  with  the  immune-­boosting  medicinal  plants.  
The  central  hypothesis  of  the  study  presented  in  this  chapter  is  that  plant  compounds  
attenuate  the  pro-­inflammatory  effect  of  bacterial  LPS/LA  enriched  in  the  medicinal  
herbs.  A  holistic  understanding  of  herbal  medicine  in  its  entirety  is  essential  since  herbal  
medicine  is  mostly  a  mixture  of  plant  compounds  and  the  bacteria  enriched  in  the  herbs.  
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To   test   this   hypothesis,   there  was   a   need   to   differentiate   the   pro-­inflammatory  
effect   from   the   beneficial   effect   that   leads   to   immune   boosting   activity   (protective  
immunity).   The   following   section   briefly   describes   the   pro-­inflammatory   (toxic)   and  
protective  immunity  (beneficial)  pathways  in  innate  immune  cells  that  can  be  activated  by  
LPS/LA.  
5.1.3.  Signaling  pathways  initiated  by  structurally  distinct  LPS/LAs  
Bacterial   LPS   is   recognized  by   the  Toll-­like   receptor   4   (TLR4)   in   humans.  The  
interaction  of  LPS  with  the  receptor  and  the  downstream  pathways  activated  is  shown  in  
Figure  5.3  below.  LPS  is  either  removed  from  the  surface  of  the  bacterial  membrane  when  
the  cell  dies,  or  by  soluble  protein  like  LPS-­binding  protein  (LBP).  LBP  then  transports  the  
monomeric  LA/LPS   to  another  soluble  protein  known  as  CD14.  The  CD14-­associated  
LPS  is  carried  to  the  MD-­2  protein,  attached  on  TLR4    [22].  The  binding  of  the  LA  moiety  
of  LPS  to  MD2  leads  to  a  hetero-­oligomer  formation  with  two  units  each  of  MD2  and  TLR4.  
These   protein-­protein   dimerization   events   occur   outside   the   plasma   membrane,   and  
further  initiate  the  dimerization  of  TIR-­domain  containing  parts  of  TLR4  in  the  cytosol.  This  
interaction   can   lead   to   either   of   the   two   important   downstream   signaling   pathways:  
myeloid   differentiation   primary   response   gene   88   (MyD88)   or   TIR-­domain   containing  
adaptor-­inducing   interferon   (TRIF)   dependent   pathways   [23].  Activation   of   the  MyD88  
pathway   triggers   various   pro-­inflammatory   cytokines,   which,   if   not   properly   regulated,  
could  lead  to  toxicity  due  to  severe  inflammation.  On  the  other  hand,  the  TRIF  pathway  
is  associated  with  beneficial  immune-­boosting  effects.  
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Both   TRIF   and   MyD88   pathways   upregulate   cytokines   that   lead   to   NF-­kB  
expression  [24-­26].  Although,  these  cytokines  lead  to  the  same  protein  complex,  NF-­kB,  
the  difference  lies  in  when  it  gets  activated.  Pro-­inflammatory  cytokines  such  as  IL-­6  and  
COX-­2  are  activated  as  part  of  the  MyD88  pathway,  and  lead  to  an  early  activation  of  NF-­
kB   whereas   cytokines   that   lead   to   protective   immunity   like   CCL5   (RANTES)   are  
associated  with  the  TRIF/TRAM  pathway,  leading  to  a  late-­phase  NF-­kB  activation  [27,  
28].  This  bias  could  be  due  to  the  structure  of  the  foreign  molecule  that  binds  to  the  TLR4.    
 
Figure   5.3:   Cytokines   activated   by   LPS-­TLR4   binding.  The   signaling  
pathways   lead   to   the  production  of  different   kinds  of   cytokines,  pro-­  and  
















The   MyD88   and   TRIF   pathways   can   be   differentially   activated   by   structurally  
distinct   LAs   (Figure   5.4).   Di-­phosphorylated   hepta-­acylated   LA   (DPL)   of   Salmonella  
minnesota  R595  is  endotoxic  in  nature,  whereas  its  detoxified  form,  mono-­phosphorylated  
LA  (MPL)  is  used  as  an  FDA-­approved  immunological  adjuvant  in  clinical  trials  [29].  The  
former  preferentially   activates   the  MyD88  pathway  over   the  TRIF  pathway,   leading   to  
strong  inflammation.  On  the  other  hand,  MPL  activates  the  MyD88  pathway  much  more  
weakly  but  retains  the  ability  to  activate  the  TRIF  pathway,  leading  to  protective  immunity  
[28].  MPL  has  been  shown  to  attenuate  the  negative  effects  of  LPS,  by  leading  to  lower  
expression  of  pro-­inflammatory  cytokines.  Although  most  LAs  in  plants  have  not  garnered  
attentions   in  biomedical   research,  several  LAs  of  plant-­associated  bacteria  have  been  
characterized  structurally  and  immunologically.  For  example,  the  LA  of  Rhizobium  etli,  a  
nitrogen-­fixing   bacterium   in   legumes,   has   a   very   distinct   chemical   structure   (no  
phosphates)  and  exhibits  no  toxicity.  
It   is   currently   unknown   how   complex   mixtures   of   bacterial   LAs   and   plant  
metabolites,   as   seen   in   Ashwagandha,   activate   the   TRIF   and   MyD88   pathways.  
Differentiation  of   these  two  pathways,   therefore,  would  provide   important  new  clues  to  





Figure   5.4:   Structurally   distinct   LAs   activate   different   pathways.  
Salmonella  minnesota  R595  LA   is   highly   endotoxic   following   the  MyD88  
signaling  pathway,  whereas  its  detoxified  form,  leads  to  protective  immunity  
by   differentially   activating   the   TRIF-­pathway.   Some   known   LAs   of   plant-­
associated  bacteria,  such  as  the  LA  of  R.  etli,  exhibits  no  toxicity.  
 
5.1.4.  The  need  to  establish  simple,  economical,  and  reliable  cell-­based  assays  to  
distinguish  TRIF  and  MyD88  pathways.  
As  described  above,  differentiation  of  TRIF  and  MyD88  pathways  is  important  for  
the  characterization  of  complex  chemical  mixtures  in  Ashwagandha.  However,  it  is  not  a  
trivial  task  to  reproducibly  differentiate  the  two  pathways  in  innate  immune  cells.  Although  
many  studies  in  literature  use  primary  macrophages  to  distinguish  the  two  pathways,  the  
use  of  primary  cells  has  some  drawbacks.  For  example,  primary  cells  do  not  propagate  
and  have   to  be  purified   from  blood  samples  every   time   the  assays  need   to  be   run.   In  
addition,  the  quality  of  primary  cells  depends  on  the  donor.  As  such,  they  tend  to  be  finicky  











































































































It  would  be  ideal   if  a  cell-­line,  such  as  THP-­1  monocytic  cells,  could  be  used  to  
distinguish  the  two  pathways.  THP-­1  cells  are  human  monocytes  derived  from  an  acute  
monocytic  leukemia  patient  [30].  Since  their  establishment,  they  have  been  widely  used  
in   immunology   to   investigate   the   effects   on   monocytes   and   macrophages   in   vitro.  
However,  THP-­1  cells,  when  stimulated  with  LA,  do  not  express  CCL5  and  IL-­6  very  well;;  
CCL5  and  IL-­6  are  biomarkers  of  TRIF  and  MyD88  pathways,  respectively.  Therefore,  
THP-­1  cells  are  not  suitable  for  the  differentiation  of  the  two  pathways.  
There   is,   however,   one   possible  way   to  make  THP-­1   cells  more   responsive   to  
immunomodulatory   factors.   THP-­1  monocytes   can   be   differentiated   into  more  mature  
phenotypes,   such   as   macrophages,   which   may   be   more   responsive   to  
immunomodulatory  factors.  Phorbol-­12-­myristate-­13-­acetate  (PMA,  also  known  as  TPA,  
12-­O-­tetradecanoylphorbol-­13-­acetate)  makes  THP-­1  monocytes  lose  the  round  shape  
and  start  adhering  to  the  bottom  surface  of  the  cell  culture  flask  (Figure  5.5).  They  would  
eventually  develop  macrophage-­like  phenotype  by  becoming  flat  and  elongated  with  arms  
extending  outwards   and   lose   their   ability   to   proliferate   [31].  PMA-­differentiated  THP-­1  
cells  have  been  shown  to  express  more  cytokines,  such  as  TNF,  than  undifferentiated  
THP-­1  upon  LPS  stimulation.  At  the  onset  of  the  study  presented  in  this  chapter,  it  was  
unknown   whether   PMA-­differentiated   THP-­1   cells,   when   stimulated   with   LA,   would  
express  CCL5  and  IL-­6  strong  enough  to  be  used  for  reproducible  detection  of  the  TRIF  
and  MyD88  pathways.  
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Figure   5.5:   Differentiation   of   THP-­1   cells.   Undifferentiated   THP-­1  
monocytes  (left)  are  non-­adherent  and  rounded  in  shape,  whereas,  PMA-­






5.2.1.  Immunostimulatory  Activity  of  Ashwagandha  
Ashwagandha   is   known   for   its   immunomodulatory   activity.   As   a   preliminary  
examination   of   its   activity,   we   tested   two   different   samples   of   Ashwagandha   for   their  
immunostimulatory   activities   by   looking   at   the   ICAM-­1   mRNA   expression   in   THP-­1  
monocytes.  One  sample  was  an  USDA  approved  organically  cultivated  Ashwagandha,  
labeled   as   O.A.   (Organic   Ashwagandha),   and   the   other   sample   was   conventionally  
grown,   labeled   as   N.O.A.   (Non-­Organic   Ashwagandha).   Figure   5.6   shows   that   both  
samples   of   Ashwagandha   stimulate   THP-­1  monocytes   to   elicit   an   immunostimulatory  
response.  O.A.  showed  a  45-­fold   ICAM-­1   induction  compared   to   the  negative  control,  
DMSO  and  N.O.A.   induced  a  12-­fold   immune   response.  Therefore,   organically   grown  






Figure   5.6:   Immunostimulatory   activities   of   Ashwagandha.  
Immunostimulatory   activities   of  Organic   (O.A.)   and  Non-­organic   (N.O.A.)  
Ashwagandha   samples   each   at   concentrations   of   5µg/mL.   The   ICAM-­1  
expression  of   triplicate  preparations  was  measured  by  qRT-­PCR.  DMSO  
and   LPS   at   0.2ng/mL   were   used   as   negative   and   positive   controls,  
respectively.  
 
5.2.2.  Presence  of  LPS  in  Ashwagandha  
The   preliminary   analysis   showed   that   Ashwagandha   possessed  
immunostimulatory  activity.  One  possible  hypothesis  to  explain  this  activity  could  be  the  
contribution  of  LPS  in  the  herb’s  immunostimulatory  activity,  as  was  seen  in  JTT  (Chapter  
2).  To  test  this  hypothesis,  conventionally  grown  Ashwagandha  (N.O.A.)  was  treated  with  
affinity-­resin  with   immobilized  Polymyxin-­B   to  assess  bacterial  LPS  contribution   in   the  
herb  [32,  33].  This  led  to  a  substantial  decrease  in  Ashwagandha’s  activity  for  the  PmxB-­
treated  sample  (Ashw_PB)  when  compared  to  both  the  untreated  Ashwagandha  positive  
control  (Ashw)  and  the  mock-­treated  Ashwagandha  (Ashw_Mock),  which  was  treated  with  
Agarose-­resin.  Ashw_Mock  showed  ICAM-­1  expression  similar  to  Ashw,  both  exhibiting  
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a  3-­fold  mRNA  induction  compared  to  the  negative  control,  DMSO,  whereas  Ashw_PB  
showed  almost  complete  loss  of  immunostimulatory  activity  at  1-­fold  when  compared  to  
DMSO  (Figure  5.7).  This  experiment  suggested  the  presence  of  LPS  and  consequently,  
Gram-­negative  bacteria,  associated  with  Ashwagandha  samples  that  might  contribute  to  
the  herb’s  bioactivity.  
 
Figure   5.7:   Presence   of   LPS   in   Ashwagandha.   Immunostimulatory  
activities   of   Ashwagandha   samples   treated   with   Agarose-­resin  
(Ashw_Mock)  and  Polymyxin  B-­resin   (Ashw_PB),  compared   to  untreated  
Ashwagandha.  The  substantial  decrease  in  activity  of  Polymyxin  B-­treated  
Ashwagandha   indicates   bacterial   contribution   due   to   LPS.   THP-­1  
monocytes  were   treated  with  DMSO,   the   samples   (5µg/mL)   and   LPS   at  




5.2.3.  Enrichment  of  LA  in  Ashwagandha  
The   contribution   of   LPS/LA   was   suggested   by   the   nearly   complete   loss   of  
immunostimulatory   activity   after   endotoxin   removal   from   Ashwagandha   as   shown   in  
Figure  5.7.  This  suggested  that  the  LPS/LA  from  the  medicinal  herb  could  be  the  active  
compound   responsible   for   the   immune-­boosting   activity   of   the   herb.   As   such,  
Ashwagandha  was  subjected  to  a  purification  protocol  for  enrichment  of  LA  in  a  sample  
as   shown   in   Chapter   2   (Figure   2.5).   Following   this   protocol,   bacterial   LAs   from  
Ashwagandha   (O.A.)   were   fractionated   using   preparative   TLC.   The   samples   were  
weighed  and  dissolved   in  DMSO  to   treat  THP-­1  monocytes  at  a   final  concentration  of  
5µg/mL.  
Some  of  the  fractions  exhibited  similar  or  even  higher  ICAM-­1  expression  than  that  
of   the   Ashwagandha   extract.   Fraction   5A   caused   24-­fold   ICAM-­1   mRNA   induction  




Figure  5.8:  Immunostimulatory  activities  of  LA  fractions  isolated  from  
Ashwagandha.  Immunostimulatory  activities  of  Ashwagandha  LA  samples  
(triplicates)  were  measured  by  ICAM-­1  mRNA  expression.  DMSO  and  LPS  
at  0.2ng/mL  were  used  as  negative  and  positive  controls,  respectively.  THP-­




Taken  together,  these  results  suggest  that  bacterial  LAs  are  associated  with  the  
immune-­boosting  activity  of  Ashwagandha.    
As   mentioned   previously,   anti-­inflammatory   factors   have   been   isolated   from  
Ashwagandha,  whereas  LPS,  in  contrast,  is  known  to  cause  inflammation.  This  led  to  the  
working  hypothesis  that  some  of  the  active  anti-­inflammatory  plant  compounds  in  
Ashwagandha  may  be  modulating  the  inflammatory  activity  of  LPS  thereby  making  
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it  a  safe  herb.  To  test  this  working  hypothesis,  we  developed  a  cell-­based  immune  assay  
to  distinguish  between  pathways  leading  to  inflammation  or  protective  immunity.    
5.2.4.  Development  of  a  cell-­based  assay  to  study  the  TRIF/MyD88  bias  
THP-­1  monocytes  were  not  a  suitable  choice  of  cell  lines  to  study  the  induction  of  
cytokines  to  test  the  bias  for  the  MyD88  and  TRIF-­dependent  signaling  pathways.  As  per  
the   immune   assay   developed   to   overcome   this   problem,   we   differentiated   THP-­1  
monocytes  into  macrophages  [34].  The  differentiation  of  THP-­1  monocytes  into  primary  
macrophages   is   induced  using  PMA  following   the  scheme  shown  below   in  Figure  5.9.  
The  original  phenotype  of  THP-­1  monocytes  changed  from  small  round  cells,  suspended  
in  media  to  elongated  cells  that  adhere  to  the  surface  of  the  plate  as  they  differentiate  into  






Figure  5.9:  Scheme  for  THP-­1  differentiation  into  macrophages.  PMA  
exposure   and   recovery   leads   to   differentiation   of   THP-­1  monocytes   into  
macrophages.   The   macrophages   were   then   used   for   treatment   and  
evaluated   by   qRT-­PCR   to   test   the   signaling   bias   for   TRIF-­   and  MyD88-­
dependent  pathways.  
 
PMA-­differentiated  THP-­1  cells  have  been  used  in  several  studies  to  evaluate  the  
inflammatory   responses   generally   by   the   expression   of   TNF-­a   on   LPS   stimulation.  
However,   to   the   best   of   our   knowledge,   these   macrophages   have   not   been   used   to  
distinguish  between  the  bias  for  MyD88/TRIF  signaling  pathway.    
To   this   end,   THP-­1   differentiated   macrophages   were   treated   with   structurally  
distinct  LAs   to  assess   the  signaling  pathways   they  activated.   In  order   to  develop  and  
optimize   this   protocol,   known  LAs,  E.   coli  Di-­phosphorylated   LA   (DPL)   and  detoxified  
Salmonella   minnesota   LA,   MPL   were   used.   DPL   is   an   endotoxin   that   causes  
inflammation,  an  overdose  of  which  leads  to  sepsis,  whereas  MPL  is  an  FDA-­approved  
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immuno-­adjuvant.  The  mRNA  expressions  of  pro-­inflammatory  cytokines  as  well  as  the  
chemokine  CCL5,  which  produces  a  protective  immune  response  were  evaluated  by  qRT-­
PCR.    
DPL  led  to  a  massive  pro-­inflammatory  immune  response  (3120-­fold  induction  of  
IL-­6  mRNA  over  DMSO   control)   whereas  MPL   produced   a   significantly   lower   (7-­fold)  
induction  of  IL-­6  mRNA  (Figure  5.10).  On  the  other  hand,  the  modest  but  reproducible  
induction  of  CCL5,  the  biomarker  of  TRIF  signaling,  was  observed  for  both  DPL  and  MPL.  
This  confirms  the  MyD88-­bias  for  DPL,  an  endotoxin,  since  it  strongly  activates  the  pro-­
inflammatory   IL-­6.   Even   though  DPL   also   activates   the   TRIF   pathway,   any   beneficial  
effect  is  overwhelmed  by  the  strong  pro-­inflammatory  activity.  On  the  other  hand,  MPL  
has  substantially  attenuated  pro-­inflammatory  activity  but  still  retains  the  ability  to  activate  
the  TRIF  pathway,  which  seems  to  make  MPL  suitable  for  its  use  as  a  vaccine  adjuvant.  
In  addition   to  CCL5  and   IL-­6,   induction  of   two  other  genes,  namely  COX-­2  and  
ICAM-­1,  were  examined  using  the  PMA-­differentiated  THP-­1  cells.    COX-­2,  a  biosynthetic  
gene  for  prostaglandins,  is  also  involved  in  the  MyD88  signaling  pathway,  whereas  ICAM-­





Figure   5.10:   Structurally   distinct   LAs   lead   to   activation   of   different  
signaling  pathways.  THP-­1  differentiated  macrophages  were  treated  with  
structurally  distinct  LAs,  MPL  and  DPL  each  at  5µg/mL.  CCL5  is  a  probe  for  
testing  TRIF-­bias  whereas  IL-­6  is  a  pro-­inflammatory  gene  involved  in  the  
MyD88  signaling  pathway.  
 
This  assay  was  developed   to  evaluate   the  mixture  of   bacterial   LPSs  and  plant  
metabolites  in  Ashwagandha.  The  working-­hypothesis  is  that  plant  metabolites  attenuate  
the  pro-­inflammatory  effect  of  bacterial  LPS,  thereby  making  Ashwagandha  a  safe  and  
effective  immune-­boosting  herb.  
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5.2.5.  TRIF/MyD88  bias  of  the  water  extracts  of  Ashwagandha  samples  
The  TRIF/MyD88  biases  of  the  two  different  samples  of  Ashwagandha,  O.A.  and  
N.O.A.   were   evaluated   using   CCL5   and   IL-­6   as   the   biomarkers   of   the   respective  
pathways.  These  samples  were  first  extracted  in  hot  water,  dried  and  dissolved  in  DMSO  
at   a   final   concentration   of   5µg/mL.   The   water   extract   of   O.A.   exhibits   both   pro-­
inflammatory  and  adjuvant  activities  similar  to  that  of  DPL  in  differentiated  macrophages.  
A  variation  in  the  inflammatory  activities  (MyD88-­bias)  of  O.A.  and  N.O.A.  is  also  clearly  
observed  (Figure  5.11).  Organically  grown  Ashwagandha  (O.A.)  leads  to  a  significant  65-­
fold   induction   of   IL-­6   expression   as   compared   to   a   7-­fold   change   produced   by  
conventionally  grown  herb  (N.O.A.).  The  positive  control,  DPL  led  to  88-­fold  increase  of  







Figure  5.11:  Immunomodulatory  activity  of  water  extracts  of  O.A.  and  
N.O.A.  PMA-­differentiated  THP-­1  macrophages  were  treated  with  samples  
for  4  hours.  The  concentration  of  O.A.,  N.O.A.  and  DPL  was  5µg/mL.  DMSO  
and  DPL  (0.2ng/mL)  were  the  negative  and  positive  controls,  respectively.  
 
These  Ashwagandha  samples  were  prepared  by  extracting  in  hot  water.  The  first  
step  in  the  scheme  for  purification  of  LPS/LA  from  herbs  as  shown  in  Figure  2.5  enriches  
LPS  in  the  hydrophilic  layer  after  hot  extraction  of  the  herb.  The  TRIF/MyD88  bias  of  the  
water   extract   of  O.A.   suggests   that   active   factors   in   organically   grown  Ashwagandha  
might  be  similar  to  endotoxic  LAs.    
The  distinctly  different  trends  between  O.A.  and  N.O.A.  raised  a  possibility  that  the  
quality  of  Ashwagandha  can  vary  substantially.  In  order  to  further  evaluate  the  variability,  
two  additional  samples  of  commercial  Ashwagandha  were  examined.  
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5.2.6.  Evaluation  of  the  water  extracts  of  the  commercial  Ashwagandha  
supplements  
One  of  the  commercial  supplements  samples  was  capsulated  Ashwagandha  root  
powder  (from  Organic  India,  hereafter  “OIA”).  The  capsule  was  opened  and  the  powder  
inside  was  used  for  preparing  a  hot  water  extract  of  the  supplement,  which  was  evaluated  
for  immunomodulatory  activities  using  CCL5  as  well  as  IL-­6.    
The   study   examined   varying   doses   of   the   water   extracted   OIA   sample.   The  
macrophages  showed  an  increasing  dose-­dependent  response  for  CCL5.  Thus,  the  TRIF  
pathway  was  activated  in  a  dose-­dependent  manner  by  the  water  extract  of  OIA.  Another  
cytokine,  ICAM-­1  showed  similar  gene  expression  profile  to  CCL5  (Appendix  I).  
Curiously,  a  different  trend  was  observed  for  IL-­6  gene  expression.  The  expression  
of   this  pro-­inflammatory  (MyD88)  marker   increased  dose-­dependently  at   lower  sample  
concentrations.  However,  it  reached  the  maximum  at  250µg/mL  (205-­fold  induction  over  




Figure   5.12:   Immunomodulatory   activities   of   water   extracts   of   OIA.  
Ashwagandha  samples  were  prepared  by  hot  water  extraction,  drying  and  
reconstituting  in  DMSO.  PMA-­differentiated  macrophages  were  treated  with  
OIA   in   varying   doses.      The   macrophages   exhibited   increasing   CCL5  
expression   in   a   dose-­dependent   manner.   On   the   other   hand,   the  
macrophages   exhibited   an   initial   increase   and   sudden   decrease   in   IL-­6  
expression   dose-­dependently.   DMSO   and   DPL   (5µg/mL)   were   used   as  
negative  and  positive  controls,  respectively.  
  
 
Another   commercial   sample   of   Ashwagandha   called   KSM-­66   Ashwagandha  
(hereafter  “KSM”)  gave  a  similar  dose-­response  profile  as  OIA.  KSM  is  a  standardized  
water   extract   of   Ashwagandha   root   powder   supplemented   with   plant   compounds   like  
withanolides,  which  ensured  that  sufficient  amounts  of  putative  bioactive  metabolites  exist  
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in  this  supplement.  The  CCL5  expression  of  the  water  extracts  of  KSM  showed  a  dose-­
dependent  trend  similar  to  that  of  OIA  (Appendix  J).  The  gene  expression  profile  of  pro-­
inflammatory  cytokine  IL-­6  also  followed  the  same  trend  as  that  of  OIA  with  initial  increase  
(18-­fold)  and  sudden  decrease  (11-­fold)  in  inflammatory  response  on  increasing  the  dose  
to  500µg/mL  of  KSM  sample  (Appendix  J).  
Incidentally,  ICAM-­1  followed  a  similar  gene  expression  profile  as  that  of  IL-­6  for  
the   KSM   sample   (Appendix   K).   ICAM-­1   in   addition   to   being   a   marker   for  
immunostimulation,  may  also  lead  to  inflammatory  activity.    
The  studies  on  the  four  Ashwagandha  samples  (O.A.,  N.O.A.,  OIA,  KSM)  provided  
several   new   insights.   First,   at   lower   concentrations   (5   µg/mL)   most   Ashwagandha  
samples   exhibited   modest   MyD88   activation   except   for   O.A.   Thus,   the   strong   pro-­
inflammatory  effect  of  O.A.  might  be  rather  exceptional.  Second,  when  dose-­response  
profiles  were  examined  for  OIA  and  KSM,  the  IL-­6  expression  was  consistently  reduced  
at  higher  concentrations.  This   is   interesting  because   it  suggests   that  anti-­inflammatory  
compounds  such  as  withanolides  and  WA  in  the  extracts  could  attenuate  the  activation  
of  the  MyD88  pathway  at  higher  concentrations.  The  observation  also  raised  a  possibility  
that   the   observed  TRIF/MyD88  bias   of  Ashwagandha   samples  might   not   be   accurate  
because  water  extraction  preferentially  enriches  hydrophilic  molecules,  including  LPSs,  
over  hydrophobic  molecules,  including  anti-­inflammatory  withanolides.  In  other  words,  the  
Ashwagandha   samples   might   exhibit   less   pro-­inflammatory   effect   if   organic  
extraction  is  employed.  To  test  this  hypothesis,  DMSO  extracts  of  Ashwagandha  (OIA  
and  KSM)  were  prepared  for  further  immunological  studies.  
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5.2.7.  The  TRIF/MyD88  bias  of  the  DMSO  Extracts  of  Ashwagandha  
OIA  was  first  extracted  with  DMSO,  and  the  resulting  DMSO  extract  was  subjected  
to  qRT-­PCR  assays  of  CCL5  and  IL-­6  to  determine  the  TRIF/MyD88  bias.  In  contrast  to  
the   IL-­6   expression   obtained   with   the   water   extract   of   OIA   (Figure   5.12),   the   IL-­6  
expression  of  the  DMSO  extract  was  much  lower.  On  the  other  hand,  CCL5  expression  
was  similar   for  both  water  and  DMSO  extracts.  Both  CCL5  and   IL-­6  expression  were  
attenuated  as  the  dose  of  the  DMSO  extract  increased  (Figure  5.13).  In  particular,  the  lL-­
6  expression  exhibited  a  significant  decrease   from  67-­fold   to  a  7-­fold   induction  as   the  
dose  of  the  DMSO  extract  increased  from  50µg/mL  to  250µg/mL  compared  to  the  vehicle,  
DMSO.  This   suggested   that   the  DMSO-­extraction  may  be  enriching  anti-­inflammatory  





Figure  5.13:   Immunomodulatory  activities  of  DMSO-­soluble  extracts  
of   OIA.   Ashwagandha   samples   were   prepared   by   dissolving   the   OIA  
powder   in   DMSO   at   different   concentrations.   The   DMSO-­soluble  
component  was  used  for  treatment  of  THP-­1  differentiated  macrophages.  
The  macrophages  exhibited  an  increase  in  both  CCL5  and  IL-­6  expression,  
which  decreased  as  the  dose  of  Ashwagandha  increased.  DMSO  and  MPL  
(5µg/mL)  were  used  as  negative  and  positive  controls,  respectively.  
 
The   similar   trend   was   observed   for   the   DMSO   extract   of   KSM   Ashwagandha  
sample   (Appendix   L).   This   further   strengthened   our   working   hypothesis   that   anti-­
inflammatory   compounds   in   the   organic   in   Ashwagandha   may   attenuate   the   pro-­






Ashwagandha  is  an  immunomodulatory  herb  that  has  been  shown  to  exhibit  both  
immune-­boosting  and  anti-­inflammatory  effects.   It  was  thus,  hypothesized  that  being  a  
source  of  anti-­inflammatory  compounds,  Ashwagandha  may  have  found  a  way  to  override  
the  endotoxic  and  inflammatory  effects  of  bacterial  LPS.  This  could  be  attributed  to  the  
anti-­inflammatory  plant  compounds  enriched  in  Ashwagandha  that  might  modulate  
the   potency   of   LPS/LA.   The   first   question,   in   this   regard,  was  whether   bacteria   are  
enriched  in  Ashwagandha.  
5.3.1.  Are  bacteria  and  their  LPS  associated  with  the  activity  of  Ashwagandha?  
Our   preliminary   data   demonstrated   that   bacterial   LPSs   contribute   to   the  
immunostimulatory  activity  of  Ashwagandha.  This  was  a  novel  finding,  and  to  the  best  of  
our  knowledge  has  not  been  shown  before.  
Both   O.A.   and   N.O.A.   were   shown   to   possess   bacterial   contribution,   there  
appeared   to   be   a   significantly   higher   contribution   in   O.A.   The  O.A.   root   powder   was  
obtained   from  USDA  approved   organically   grown  Ashwagandha   plants.  One   possible  
reason  for  the  higher  immunostimulatory  activity  of  O.A.  could  either  be  the  presence  of  
a  much  higher  percentage  of  bacteria  or  more  potent  LPS  associated  with  its  roots.  The  
rationale  behind  this  explanation  is  that  organic  plants  and  herbs  are  grown  without  the  
use  of  extensive  pesticides,   insecticides  or  harmful   fertilizers  and   this  could  affect   the  
bacterial   population   associated   with   the   host   plant.   Pesticides   or   other   such   control  
agents  could  negatively  impact  the  microbial  populations  by  killing  not   just   insects  that  
harbor  microbes,  but  also  the  endophytic  bacteria  as  well  [35,  36].  The  N.O.A.  sample  
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was  conventionally  grown  and  therefore,  would  have  been  relatively   in  greater  contact  
with   pest-­control   or   artificial   growth-­promoting   agents.   This  might   adversely   affect   the  
bacterial   populations   associated   with   the   roots,   which   would   eventually   affect   the  
immunostimulatory  activity  caused  by  bacterial  LPS.    
Most  LAs  of  Gram-­negative  bacteria  are  endotoxic  in  nature.  However,  since  their  
presence   was   detected   in   medicinal   plants,   it   was   important   to   address   how   these  
bacteria  do  not  exhibit  their  endotoxic  effects  when  these  herbs  are  consumed.  To  this  
end,  we  evaluated  the  role  of  plant  compounds  in  attenuating  the  endotoxicity  of  LPS.  
5.3.2.  How  do  plant  compounds  modulate  the  activity  of  Ashwagandha?  
Plants  produce  several  types  of  compounds  and  metabolites  in  response  to  their  
environment.  Plant  compounds  have  been  shown  to  possess  biological  activities  such  as  
immunomodulatory,  anti-­cancer,  anti-­bacterial,  anti-­inflammatory,  etc.  [37-­42].  The  active  
factors  extracted  from  Ashwagandha  such  as  withanolides  and  WA  are  known  to  be  anti-­
inflammatory  in  nature.  However,  the  presence  of  bacteria  and  the  contribution  of  LPS  in  
the  immunological  activity  of  Ashwagandha  posed  a  conundrum  to  the  anti-­inflammatory  
activity  of  these  withanolides.    
Like   most   medicinal   herbs,   Ashwagandha   is   a   complex   mixture   of   plant  
compounds  and  bacterial  LPS.  The  immunological  activity  of  Ashwagandha  will  therefore  
be   derivative   of   this  mixture.   To   test   how   the   plant   and   bacterial  metabolites   behave  
together   in   the  mixture,   the  cell-­based  assay  was  employed   to  study   the  TRIF/MyD88  
bias.   THP-­1   differentiated   macrophages   were   used   for   cell   treatment.   Although,   the  
differentiation   of   THP-­1   monocytes   into   macrophages   has   been   extensively   used   for  
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producing  better  responses  of  cytokines  such  as  TNF-­a  or  for   inflammatory  activity,   to  
the  best  of  our  knowledge,  this  is  the  first  study  to  use  differentiated  THP-­1  cells  to  
study  the  bias  for  MyD88/TRIF  signaling  pathways.  
The  working  hypothesis  was  that  the  nature  of  extract  (aqueous  or  organic)  could  
determine  as  to  whether  Ashwagandha  would  show  TRIF  or  MyD88  bias.  Bacterial  LPS  
in   Ashwagandha,   being   hydrophilic   in   nature   due   to   the   presence   of   several  
polysaccharide  subunits,  would  be  enriched  in  water  extracts  of  the  herb.  On  the  contrary,  
WA  is  an  organic  compound  with  a  steroid  backbone.  Therefore,  it  should  remain  in  the  
organic  layer  after  the  initial  hot  water  extraction.  It  has  in  fact,  been  extracted  from  both  
Ashwagandha  roots  as  well  as  leaves  using  chloroform  [43,  44].  To  test  this  hypothesis,  
we   employed   the   cell-­based   assay   to   evaluate   the   effects   of   water   extracts   of  
Ashwagandha  as  well  as  DMSO  extracts  of  Ashwagandha.  The  herb  sample  prepared  by  
dissolving   in   DMSO,   an   organic   solvent,   should   incorporate   all   types   of  
immunomodulatory  factors,  including  LPS  and  WA.  The  immunomodulatory  activities  of  
the  DMSO-­soluble  components  from  all  Ashwagandha  samples  were  in  fact,  considerably  
different  than  those  of  the  water-­extracted  Ashwagandha  samples.    
The   anti-­inflammatory   effect   of   WA   has   been   previously   shown   to   be   dose-­
dependent.    It  has  been  previously  observed  that  Ashwagandha  root  and  leaf  extracts  at  
a  higher  concentrations  of  250µg/mL  and  500  µg/mL  could  suppress   the   inflammatory  
activity   caused   by   IL-­6   expression   when   exposed   to   LPS   [45].   Our   study,   therefore,  
evaluated   Ashwagandha   in   varying   doses.   At   lower   concentrations,   Ashwagandha  
showed  a  bias  towards  MyD88  pathway.  However,  it  was  shown  that  the  activation  of  the  
MyD88  pathway  was  attenuated  at  higher  concentrations.    
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The  organic  (DMSO)  extract  showed  an  even  higher  attenuation  of  MyD88  activity  
(Figure  5.14)  as  compared  to  water  extracts  (Figure  5.13).  This  further  corroborated  with  
the  working  hypothesis  that  plant  compounds  may  be  enriched  in  the  DMSO  extracts  of  
Ashwagandha.   This   finding   also   strengthens   the   central   hypothesis   that   the   plant  
compounds  in  Ashwagandha  modulate  the  adverse  inflammatory  effects  of  LPS.  
Further  analysis  to  confirm  the  presence  of  both  LPS  and  WA  in  the  Ashwagandha  
water  and  DMSO-­soluble  extracts  needs  to  be  done.  Preliminary  structure  analysis  using  
Mass  Spectrometry  may  be  employed  to  identify  these  compounds  in  the  extracts.    
Another  herb,  PSP,  a  protein-­bound  polysaccharide   from   the  medicinal   fungus,  
Coriolus   versicolor,   was   also   studied   by   our   lab.   We   investigated   the   presence   and  
contribution  of  LPS  in  the  activity  of  PSP.  Although,  the  results  of  this  experiment  were  
inconclusive,   research   by   other   groups   have   suggested   one   of   the   causes   of   its  
immunomodulatory  activity   to  be   the  bias   for   the  signaling  pathway.  PSP   induces   the  
production  of  pro-­inflammatory  cytokines  like  tumor  necrosis  factor,  TNF-­a,  as  well  as  IL-­
6   [46,  47].  Studies  have  suggested   that  PSP  acts  via   the  TRIF  as  well  as   the  MyD88  
signaling   pathways   [48,   49].   Due   to   this   discrepancy   concerning   signaling-­bias   for  
TRIF/MyD88  pathway  activated  by  PSP,  one  of  the  future  directions  in  this  regard  would  
be  to  investigate  further  with  the  assay  developed  in  our  lab.  
The  cell-­based  assay  developed  by  us  was  shown  to  effectively  characterize  the  
signaling  bias  for  MyD88/TRIF  pathways.  The  bias  for  determining  the  signaling  pathway  
a  molecule  activates  could  be  the  key  to  better  understanding  of  inflammatory  responses  
generated  by  the  body.  The  assay  developed  could  be  used  extensively  for  various  other  
 152 
applications  including,  but  not  limited  to,  investigating  potent  inflammation  caused  during  
allergic  reactions  or  sepsis,  or  antigens  leading  to   inflammatory  pathway  activation,  as  
well  as  to  test  for  adjuvant  properties  of  a  compound.  
Taken   together,   the   data   presented   in   this   chapter   strengthens   the   central  
hypothesis  that  plant  compounds  could  modulate  the  potent  inflammatory  activity  of  LPS.  
Similar  research  with  other  plant  compounds  like  BSSG  leading  to  modulating  the  potency  
of  LPS  has  also  been  done  by  our  lab.  Chapters  2  to  4  focused  on  bacterial  LPS  as  an  
immune-­boosting   species.   However,   this   research   showed   that   active   compounds  
derived  from  medicinal  plant  may  be  responsible  for  modulating  the  adverse  effects  of  
LPS,  thereby  making  the  herb  safe  to  consume.  
In   conclusion,   it   is   sometimes   essential   to   take   a   step   back   and   look   at   the  
medicinal   herb   in   totality,   as   a   mixture   of   microbial   metabolites   and   plant-­derived  
compounds.  
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5.4.  MATERIALS  AND  METHODS  
5.4.1.   Cell  Culture  
Refer  to  Chapter  2  (page  50)  
5.4.2.   RNA  Purification  and  RT  
Refer  to  Chapter  2  (page  51)  
5.4.3.   Water  Extracts  of  Ashwagandha  
The  water  extracts  of  all  Ashwagandha  samples  were  prepared  by  extracting  10g  
of   the  powdered  sample   in  100mL  of  water.  The  mixture  was   then  heated  with  gentle  
stirring  at  approximately  60ºC.  The  resultant  solution  was  vacuum  filtered  to  obtain  the  
filtrate   containing   water-­soluble   components   of   Ashwagandha.   The   filtrate   was  
evaporated  to  recover   the  solid,  which  was  dissolved   in  DMSO  for  cell   treatment.  The  
final   concentrations   in   solution   for   THP-­1   treatment   were   titrated   to   test   the   dose-­
dependent  immunological  activities.  
5.4.4.   Endotoxin  Removal  using  Detoxi-­Gel  
10   mg   of   Ashwagandha   (O.A.   and   N.O.A.)   powder   was   dissolved   in   2mL   of  
Millipore  water  to  prepare  a  stock  solution  of  concentration  5  mg/ml.  Endotoxin  removal  
using  PmxB-­affinity   resin  was   performed  using   the   protocol   established   in  Chapter   2.  
Finally,  the  samples  were  dissolved  in  DMSO  to  achieve  a  concentration  of  0.02  µg/µL  
for  THP-­1  cell  treatment.  Final  concentration  of  samples  in  media  used  for  treatment  was  
0.1  µg/mL.  
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5.4.5.   Extraction  of  LA  from  Ashwagandha  
LA  was  extracted   from  Ashwagandha  using   the  protocol  used   for  LA  extraction  
from  JTT,  as  mentioned  in  Chapter  2.  
5.4.6.   DMSO-­soluble  extracts  of  Ashwagandha  
1g  of  Ashwagandha  was  dissolved  in  1mL  of  DMSO.  It  was  sonicated  and  then  
centrifuged.  The  supernatant  was  collected  to  recover  the  DMSO-­soluble  components  of  
Ashwagandha  and  was  diluted  further  to  obtain  different  concentrations.  These  samples  
were  used  for  cell  treatment  on  the  differentiated  THP-­1  macrophages.    
5.4.7.   Macrophage  Cell  treatment  and  lysis  
THP-­1   monocytes/macrophages   were   plated   at   a   concentration   of   500,000  
cells/2mL   in   a   12-­well   plate.   The   following   day,   cells   were   treated   with   the   LA  
fractions/samples   dissolved   in  DMSO   to   achieve   a   concentration   of   5µg/mL),   positive  
control  (LPS  at  0.2ng/mL),  DMSO  as  the  vehicle  or  negative  control  for  4  hours  in  a  37ºC  
incubator   and  5%  CO2.  After   4   hours   of   incubation,   cells  were   transferred   to   a   15mL  
Falcon  tube  and  centrifuged  at  1300rpm  for  5  minutes  at  room  temperature.  The  medium  
was  aspirated,  without  disturbing  the  pellet.  The  pellet  containing  the  cells  was  lysed  with  
350µL  TRK  Lysis  Buffer  containing  2%  b-­mercaptoethanol.  The  pellets  re-­suspended  in  
the  Lysis  buffer  were  transferred  to  Omega®  Homogenizer  columns  (Omega  Bio-­Tek)  and  
centrifuged  for  2  minutes  at  maximum  speed  (approximately  13,000rpm)  in  a  centrifuge.  
The  homogenized  lysate  was  either  stored  at  -­80ºC  or  immediately  processed  for  RNA  
purification.  
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5.4.8.   PMA-­differentiation  of  THP-­1  monocytes  
THP-­1  cells  were  plated  in  a  12-­well  plate  at  200,000  cells/mL  of  RPMI-­1640  media  
with  the  addition  of  25nM  PMA  and  incubated  for  48  hours  at  37ºC  and  5%  CO2.  After  48  
hours  of  incubation,  the  media  containing  PMA  was  discarded  and  2mL  of  fresh  media  
was  added  to  the  wells.  This  was  followed  by  a  rest  period  of  24  hours  in  the  absence  of  
PMA  to  induce  THP-­1  macrophage  phenotype.  The  THP-­1  differentiated  macrophages  
were  treated  with  DMSO  (negative  control),  MPL  and  DPL  at  5µg/mL  as  well  as  LPS  at  
final  concentration  of  0.2ng/mL  (positive  control).  After  4  hours  of  treatment,  cells  were  
lysed  using  the  lysis  buffer  and  gentle  scraping  of  the  wells  using  a  cell  scraper  to  release  
the  now  adherent  macrophages.    
A  modification  to  this  optimized  protocol  was  also  used.  THP-­1  cells  were  plated  
in  a  12-­well  plate  at  250,000  cells/mL  of  RPMI-­1640  media  with   the  addition  of  25nM  
PMA.  The  plate  was  incubated  for  72  hours.  The  media  containing  PMA  was  discarded  
and  2mL  of  fresh  media  was  added  to  the  wells.  This  was  followed  by  a  rest  period  of  48  
hours  in  the  absence  of  PMA  to  induce  THP-­1  macrophage  phenotype.  Cells  were  treated  
and  lysed  as  mentioned  above.  
5.4.9.   qRT-­PCR  assay  for  bias  for  signaling  pathway  
mRNA  was  purified  from  lysed  cells  and  reverse  transcribed  to  cDNA,  which  was  
used   to  quantify   the  gene  expression  of   the  different  probes,   ICAM-­1,   IL-­6  and  CCL5  
using  qRT-­PCR.  ICAM-­1  is  a  marker  for  immunostimulation,  whereas  IL-­6  and  CCL5  are  
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Appendix  A:  Abundance  of  Gammaproteobacteria  with  P1  and  P3.  The  abundance  
or   total  count  of  Gammaproteobacteria  amplified  with  P1  (a)  and  P3  (b)   for  all   four  A.  
sinensis  samples  followed  the  same  trend  as  with  P2.  The  counts  were  significantly  higher  
for  the  two  Japanese  Angelicas  as  compared  to  the  Chinese  Angelicas,  yet  still  both  P1  





Appendix  B:  Gammaproteobacteria  amplification  by  primer  region.  The  primer  pairs  
for  the  second  sequencing  study  amplified  different  variable  regions  of  the  bacterial  16S  
rRNA  gene.  P1  amplifies  V1.V2  region,  P2  amplifies  V4.V6  region,  whereas  P3  amplifies  




  Appendix  C:  Background  O.D.  from  E.  coli  and  R.  aquatilis  bacterial  pellets.  The  
O.D.   values   of   the   bacterial   pellets   for  E.   coli   and  R.   aquatilis   were   plotted   with   the  
concentrations  tested  (1ng/µL  and  10ng/µL).  The  graph  was  extrapolated  to  0ng/µL.  The  
background  O.D.   at   410nm  at   0ng/µL  was   subtracted   from   the  O.D.   values   at   1   and  




Appendix  D:  TLC  profile  of  E.  coli  and  R.  aquatilis  crude  LA  samples.  The  profiles  
are  different  from  each  other,  indicating  that  the  two  LAs  may  be  structurally  distinct.  The  
condition  used  was  (CHCl3/MeOH/H2O/  NH4OH,  40:25:4:2  (v/v/v/v)).  1=E.  coli  LA;;  2=R.  
aquatilis  LA  
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Appendix  E:  R.  aquatilis  colonies  on  agar  plates.  Isolated  colonies  of  R.  aquatilis  were  
obtained  using  the  4-­quadrant  streaking  method  on  Difco  Nutrient  Agar  plates.  
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Appendix   F:   ESI-­MS   (positive   mode)   analysis   of   MPL.   (a)   ESI-­MS   spectrum   of  
commercially  available  MPL  (Sigma  Aldrich).  (b)  Structures  and  molecular  masses  of  LA  
species  present  in  MPL.  
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Appendix   G:   Culturable   microbes   from  A.   sinensis.   Isolated   colonies   of   different  
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Appendix   H:   Structurally   distinct   LAs   activate   different   cytokines.   (a)   ICAM-­1  
expression  of  MPL  and  DPL  measured  by  qRT-­PCR.  (b)  COX-­2  expression  of  MPL  and  
DPL.  Differentiated  THP-­cells  were  treated  with  structurally  distinct  LAs,  MPL  and  DPL  at  
5µg/mL.  DMSO  was  the  vehicle  control.  COX-­2  is  a  pro-­inflammatory  cytokine,  whereas  
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Appendix   I:   ICAM-­1   expression   of   dose-­dependent   water   extracts   of   OIA.  
Immunostimulatory  activity  of  dose-­dependent  water  extracts  of  OIA  measured  by  qRT-­
PCR.  Samples  were  prepared  by  hot  water  extraction,  drying  and  reconstituting  in  DMSO.  
Differentiated   THP-­cells   were   treated   with   OIA   samples   for   4   hours   at   varying  
concentrations  in  a  dose-­dependent  manner.  DMSO  and  DPL  (5µg/mL)  were  the  vehicle  
and  positive  controls,  respectively.  
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Appendix  J:  Immunomodulatory  effects  of  dose-­dependent  water  extracts  of  KSM-­
66   Ashwagandha.   Samples   were   prepared   by   hot   water   extraction,   drying   and  
reconstituting  in  DMSO.  Differentiated  THP-­cells  were  treated  with  KSM  samples  for  4  
hours   at   varying   concentrations   in   a   dose-­dependent   manner.   The   macrophages  
exhibited  increasing  CCL5  expression  in  a  dose-­dependent  manner.  On  the  other  hand,  
the  macrophages  exhibited  an  initial   increase  and  sudden  decrease  in  IL-­6  expression  
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Appendix   K:   ICAM-­1   expression   of   dose-­dependent   water   extracts   of   KSM-­66  
Ashwagandha.   Samples   were   prepared   by   hot   water   extraction,   drying   and  
reconstituting  in  DMSO.  Differentiated  THP-­cells  were  treated  with  KSM  samples  for  4  
hours   at   varying   concentrations   in   a   dose-­dependent   manner.   The   macrophages  
exhibited  an  initial  increase  and  sudden  decrease  in  IL-­6  expression  dose-­dependently.  
DMSO  and  DPL  (5µg/mL)  were  used  as  negative  and  positive  controls,  respectively.  
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Appendix  L:  Immunomodulatory  effects  of  dose-­dependent  DMSO-­soluble  extracts  
of  KSM-­66  Ashwagandha.  Samples  were  prepared  by  dissolving   the  KSM  powder   in  
DMSO  at  different  concentrations.  The  DMSO-­soluble  component  was  used  for  treatment  
of  PMA-­differentiated  THP-­cells.  The  macrophages  exhibited  an  increase  in  both  CCL5  
and  IL-­6  expression,  which  decreased  as  the  dose  of  Ashwagandha  increased.  DMSO  
and  MPL  (5µg/mL)  were  used  as  negative  and  positive  controls,  respectively.  
  
 
